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PREFACE
■ In October, I97O, I enrolled as a research student in the 
Department of Biochemistry, University of Glasgow, with Professor P.M.S. 
Smellie as my professorial supervisor. On his advice I joined Dr. luH. 
Johnson^s research group to v/ork under his supervision in the University 
Department of Neurology,
Dr, Johnson suggested, in view of my previous experience as a 
pharmacist, that I should begin by studying the metabolic changes with 
fenfluramine, a drug prescribed for the treatment of obesity. This study 
was carried out with a comparative study on the metabolic changes during 
therapeutic starvation for obesity. On acceptance in 1972 as a Ph.D. 
student I extended my research programme to examine the metabolic effects 
of exercise and their alteration by drugs, including fenfluramine, alcohol 
and nicotinic acid.
It was therefore necessary to investigate biochemical and 
hormonal changes during exercise in normal man. During exercise, mobili.zatio] 
of fuels varies with physical fitness, nutritional state and pathological 
condition. Differences may be secondary to changes in hormonal production 
during exercise. The effects of athletic fitness, obesity and dietary 
restriction were studied in order to gain further knowledge of variations 
which may occur in normal man. In addition patients with metabolic en.d 
hormonal abnormalities were studied for comparison. A case of ocular- 
myopathy was also studied.
These studies have necessitated the development of techniques 
to measure human growth hormone and imrnunoreactive insulin. I have 
therefore gained expertise in hiochemical, enzymatic and raddo- 
immunolog'ical techniques. All assays of blood metabolites and hormones 
have been performed by myself and the results form tiie material for thus 
thesis.
INTRODUCTION
1= Preface Knowledge of the regulation of metabolic pathways has 
developed at a remarkable rate during the past decade and has made it 
possible to study the storage, synthesis and utilization of various fuels 
concerned in energy production. Experimental studies on physical 
activity in man and in animals have provided much information on fuel 
mobilization and utilization. Such basic information malces it possible 
to study metabolic control in clinical disorders and the effect of 
various drugs. Most of the research in metabolic and hormonal regulation 
has been carried out relatively recently and some theories are still 
controversial, I have, therefore, summarized the available experimental 
evidence in this introduction and explained the reasons for the develop­
ment of the studies reported in this thesis.
2, Hi s tori cal background.
The human body continually converts chemical energy obtained 
from food into work and heat. An inherent difficulty in studying 
normal metabolism arises because it is not possible to separate accurately 
the processes of catabolism from those of storage and synthesis. Thus 
skeletal muscle not only performs mechanical work but also contains 
important reserves of carbohydrate emd some fat. The energy used by 
muscle in perioimance of work is derived from chemical reactions going 
on within the cells. The nature of these reactions was the subject of
much experimentation and controversy during the latter half of the nine­
teenth century, but quantitative and reproducible results wore not 
obtained until the classical work of Fletcher and Hopkins (I907). Tliey 
showed clearly that fabigue is accompanied by lactic acid production. 
Later, in 1914» Parnas and Wagner showed that lactic acid is derived froju
glycogen. For forty years physiologists concentrated upon the reaction 
in which lactic acid was formed from carbohydrate and considered it the 
only energy-providing reaction. This remained unchallenged until the 
discovery in 192? by the Eggletons, of "phosphagen", Later identified 
as CF and ATP by Lohmann in 1930. Their discoveries made it possible 
for Lundsgaard and other workers to demonstra,te that muscle contraction 
is proportional to the breakdown of phosphagens. In addition to extensive 
studies of the energy supplies for contraction, work has also been 
progressing in the role of stores of fuel in muscle in energy metabolism.
It was long thought that the primary if not exclusive fuel for 
muscle metabolism was carbohydrate. In 1938, Lundsgaard summarized the 
available information responsible for bhis hypothesis and in addition 
cited the work of Blixenkrone-Moller, 1938) which had demonstrated that 
ketone-bodies were utilized by the tissue of a perfused hind-leg of the 
cat. It therefore appeared that other substrates might be involved in 
muscle metabolism. Christensen and Hansen provided evidence in 1939 to 
suggest that fat could also be metabolised by muscle. Their evidence was 
derived primarily from low R values in exercising subjects and in isolated 
muscle preparations. Ten years later Geyer and co-workers (1949) 
provided more direct evidence to indicate that fatty acids can be 
utilized by isolated skeletal muscle. These discoveries threw new light 
on many earlier observations and increased interest came to be shovm in 
the study of the relation of fat and carbohydrate metabolism in clinical 
situations.
3. Carbohydrate metabolism « general considerations.
In carbohydrate metabolism the rate of glucose entry into the
cell and its subsequent phosphorylation with ATP to glucose-6-phosphate 
is the preliminary step for its utilization. Glucose-6-ijhosphate formed 
may either be used for glycogen synthesis or catabolised to pyruvate 
through the glycolytic pathway. The sequence of events up to the 
formation of p^rruvahe are identical in the presence or absence of oxygen. 
Thereafter the products vary with, the available oxygen supply and 
pyruvate is either reversibly converted to lactate or decarboxylated to 
forera acetyl CoA. The oxidation of glucose to pyruvate in the Embden- 
Meyerhof pathway is achieved by hydrogenation with the use of KAD-HAPH 
which act as electron transfer agents.
The liver is the principal source of glucose entering the 
circulation. Glucose output from the liver is regulated partly by a 
homeostatic action of the liver itself and partly by hoiraonal influences. 
Nhpn the level of blood glucose falls, the formation of glucose from 
glycogen (glycogenolysis) or from 2 and 3 carbon fragments (gluconeogenesis) 
is increased. A reverse process occurs when blood glucose tends to rise. 
Various hormones influence hepatic glucose output directly, in conse­
quence of their effect on hepatic metabolism and also as a resu].t of 
their metabolic actions in other tissues. Insulin is knovm to cause a 
fall in blood glucose. This results from increased peripheral glucose 
utilization with increased glycogen deposition in liver and muscle, and 
increased fat synthesis combined with lowered rates of gluconeogenesis 
and hepatic glycogenolysis. Tlie hormones adrenaline, nor-adrenaline,
HGH, glucagon and AGTH are known to stimulate the hydrolysis of both fat 
and glycogen. The primary effect of each may be to increase the 
production of cyclic AMP by activating the adenyl cyclase system 
(Sutherland et al., 196s).
All have a diabetogenic effect, either directly by inhibiting the 
release of insulin from the pancreas adrenaline and nor-adrenaline;
Williams and Ensinck, 1966), or indirectly by decreasing the peripheral 
uptake of glucose and its subsequent oxidation, perhaps by enhancing fat 
mobilization (e,g. KGH, Randle £t al., I963), It appears, therefore, 
that these hormones provide reserve capacity to regulate fat and carbo­
hydrate metabolism,
4 . Eat metabolism - general considerations
In the breakdovai process, fat in the form of triglyceride 
stored in adipose tissues is hydrolysed by lipase to PEA and glycerol. 
Because the enzyme glycerokinase is low in activity in adipose tissue, 
glycerol diffuses out into the plasma from which it is withdravm and 
metabolized by the liver and kidney to a-glycerophosphate, The PEA 
formed by lipolysis can be either re-esterified in the tissue and stored 
as triglyceride or oxidized by the liver and peripheral tissue through 
P-oxidation to acetyl CoA. The preliminary step for PEA oxidation 
requires the availability of ATP and CoA ester to form long chain acyl 
CoA, which then undergoes a series of reactions catalysed by oxidative 
mitochondrial enzymes and co-factors to acetyl CoA. The fate of acetyl
CoA may depend on the availability of carbohydrate. Glucose enhances
the complete oxidation of acetyl CoA to 00^, water and ATP, but when the 
supply of glucose is short as in starvation, ketone-body formation from 
acetyl CoA is increased.
The rate of release of PEA from adipose tissue is affected by 
many hormones that influence either the rate of estérification or the 
rate of lipolysis. Insulin by increasing the oxidation of glucose,
inhibits the release of EFA and enhances the synthesis of triglycerides. 
All these effects are dependent on the presence of glucose in the medium 
and can be explained, therefore, on the basis of increased uptake of 
glucose into adipose tissue, InsuJ-in in adipose tissue also inhibits 
the activity of the enzyme lipase, reducing not only the release of FPA 
but also of glycerol. Other hormones such as adrenaline, nor-adrenaline, 
glucagon, HGH and AGTH act to stimulate the rate of lipolysis by 
activating the adenyl cyclase system ( Sutherland o.t alo, 1968).
3> Supply and use of fat and carbohydrate.
Fat and carbohydrate are the major fuels and with a few 
exceptions notably brain, the various tissues of the body can burrn either 
efficiently, but the amounts used tend to vary under different nutritional 
pathological and with changing demand for energy during exercise.
3a. Nutritional state
1. Post prandials Carbohydrate as glucose after absorption 
is either stored as glycogen in liver and muscle or enters the systemic 
circulation. The energy rich FFA, like glucose enters the tissues 
rapidly and serves as a readily available energy source. During food 
absorptrkn and as a result of increased insulin secretion and uptake of 
diet-derived glucose into several tissues, the uptake and storage of fat 
in adipose tissue is promoted while mobilization is inhibited,
2, Post-absorptive; Owen and Reichard (1971) have found 
that fasting of short duration, depletes stored glycogen whereas stores 
of triglycerides in adipose tissue can continue to supply energy needs 
for one to two months.
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In starvation as the rate of fat mobilization increases, the 
rate of ketone-body production also increases. In this situation, the 
rise of blood ketone-bodies may alter the relative contribution of 
metabolic fuels for working muscle, since ketone-bodies have been shovm 
to inhibit glucose oxidation in muscle and impairs the responsiveness 
of this tissue to insulin (Garland and Randle, I964).
5bo Exercise ; During muscular exercise the immediate fuels include 
high energy phociihate, mainly CP and ATP and the conversion of glycogen 
to lactate (Hultman, I967). Use of stored glycogen, evidenced by 
release of lactate, occurs at the onset of exercise (Pernow and h’ahren, 
3.962)0 This appears to diminish after a few minutes, presumably as 
blood flow increases (jorfeldt, 197C). The use of glycogen seems to 
depend upon the extent to which other fuels, particularly PPA from blood 
can supply energy needs. Their entry into the blood from adipose tissue 
increases rapidly with exercise (Havel £t a_l,, 1963? Havel ot ad., I964) » 
Adrenergic stimulation of adenyl cyclase system in adipose tissue, appears 
to be mainly responsible for release of PPA (Havel, 1965)0 Levels of 
HGH in plasma also rise with exercise (Hunter et al., I964). Increased 
secretion of HGH may contribute to fat mobilisation aftci- exercise of long 
d.uration, but is unlikely to be responsible for rapid mobilrzation 
(Hartog et al., I967). Increased sympathetic activity could inhibit 
secretion of insulin (Porte and hilliams, I966) and increase the 
production of glucose, lactate and pyruvate from liver and muscle (Young 
et ado 5 1967)o
Subjects in athletic training however tend to have a smaller 
rise of blood PPA and lactate concentrations during exercise and lower
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blood ketone-bodies in the post-exercise period (Johnson ojt a l , 1969). 
Training has been found to induce changes in pathways regulating fat and 
carbohydrate oxidation (Mole et ad., 1971; Oscai and Holloszy, 1971).
Since most of the metabolic processes which are known to be altered by 
physical training are influenced by endocrine activi. !,y_ i L Is possi'nle 
that training modifies the release of hormones including hGIi and insulin. 
Although an increase during exercise in plasma concentration of HG-n and 
a decrease in lEI concentration have been reported (both et al., 1963 ; 
Hunter and Greenwood, I964; Hunter and Sukkar, I968), there is however 
little information about the changes of these hormones when related to 
physical fitness.
6. Pathological states :
6a. Obesity. Studies in man have provided evidence that 
individuals who exercise regularly have a greater lean body mass than 
sedentary individuals of the same weight (Parizkova, I965). In studies 
on growing rats, animals which were exercised regularly were found to be 
leaner than sedentary animals living on a restricted diet (Crews et al., 
1969). These observations suggest that lack of physical training leads 
to a mild relative degi'ee of obesity which would alter the relative 
contribution of fat and carbohydrate as fuel. In obesity, fat synthesis 
is increased, and the rate of fat mobilization and oxidation appears to be 
decreased (Gordon ot al_., I962). Obese individuals appear to handle a 
glucose load quantitatively differently from normal subjects. Glucose 
tolerance is often lower in obese subjects and this may reflect difference: 
in peripheral uptake of glucose whioh is often defective in obesity 
(Butterfield et al.. 19651. This abnormal i Ly, w.i Ih ihe raised plasma
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insulin levels frequently seen in obese subjects (Karam ejt al., 1963) 
would facilitate lipogenesis in adipose tissue. Higher concentrations 
of plasma FFA than noxraal are found in obese subjects after overnight 
fasting (Opie and Walfish, I963) although HGH levels are low (Beck et al., 
1964). It would seem tha.t energy in obesity results much more from fat 
oxidation, although fa.t stores in obese subjects are found to be less 
sensitive to the effect of starvation (Heck et al., I964). During 
starvation in the obese the increase of plasma 3HFA is frequently less 
which may be due to decreased adrenergic activity (januszewicz _et al., 
1967) or to lower HGH concentrations (Deck et al,, I964). Obese subjects 
also produce ketone-bodies at a slower rate during sraxvation and develop 
less ketosis (Kekv/ick et. 9 1959) «
6b. Diabetes mellitus: Diabetes mellitus is due to insufficiency
of insulin relative to the requirements of the tissues. The juvenlD.e 
diabetic has little detectable circulating insuD.in and his pancreas 
fails to respond to a glucose load. On the other hand the maturity 
onset diabetic may show insulin resistance, and with a glucose load has 
continued elevation of glucose concentrations. He may however secrete 
more insulin for a, given glucose load than do normal subjects (Seltzer 
et al., 1967). Thus, plasma glucose/insulin ratios are usually much 
higher than normal in these subjects (Hales ,et al., I968).
Insulin deficiency results in an abnormal balance of homonal 
control. Thus the relatively insulin deficient subject is in a state of 
hormonal imbalance favouring the action of corticosteroid, HGH and 
glucagon which add to the stimulation of gluconeogenesis, lipolysis and 
decreased intracellular metabolism of glucose (dandle 0t_ al., I965)*
6o, Mus cle di senses: A number of chronic myopathic disorders
characterised by apparently specific histo-pathological abnormalities 
in voluntary muscle have been described. These have included myophos- 
phorylase deficiency (McArdle's syndrome) and other conditions in which 
there seems to be y truc tarai and furie li on al. abnormal n ties in the muscle 
mitochondria (McArdle, 1951? L'oft et al., 1962; Shaf iq et slI ., I968; 
Bradley et ai., I969). McArdle (195I) has found that individuals with 
myophosphorylase deficiency cannot utilize their store of glycogen in 
skeletal muscle effectively. Lactate therefore does not accumulate 
during exercise or hypoxia.
In one patient with an abnormality of the mitochondria 
(Bradley ^  al., 1969) there were excessive amounts of PEA in the muscle 
fibres and a defect in EEA oxidation was suggested. It, therefore, 
seems likely that alteration in the supply of fuel for energy under 
these conditions may cause a considerable effect on substrate utilization 
as well as the ability to perform physical activity,
7. Pharmacological agents effecting fat and carbohydrate metabolism
In recent years many studies have concentrated on the use of 
drugs as a tool for the elucidation of the biochemical mechanisms 
involved in regulation of fat and carbohydrate metabolism. Two factors 
have contributed towards this progress. One is the improvement of 
analytical methods, the other is the development of pharmacological 
agents which directly affect biosynthesis, degradation, storage or release 
of metabolic substrates. In general, liver and peripheral tissues are 
primarily responsible for the supply and utilization of fat and carbo- 
hydratn-, Some drugs act by interfering with one or more metabolic
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pathways. Since most of the metabolic processes in liver and peripheral 
tissues are influenced by hormones, some drugs may also act by altering 
endocrine activity,
7a« Fenfluramine ; This drug is a derivative of amphetamine 
which has had an extensive clinical use for the management of obesity.
It was originally suggested that its action may be dependent on appetite 
suppression, but evidence has accumulated that the drug a3-so has an 
action on tissue metabolism. It appears to improve the peripheral uptaiit 
of glucose (Butterfield and Vhiohelow, I966), although the basis for 
this action is not clear. It also causes a fall in concentrations of 
serum triglyceride (Pawan, I969). During therapy with fenfl'uramine 
concentrations of plasma FPA, glycerol and total ketone-bodies increase 
(Pawan, I969). Miether these effects of fenfluramine are direct or 
secondary to dietary restriction or to possible effect on centres 
regulating hormonal activity is not certain. Observations in animals 
have indicated that the hypothalamus is a possible site for the action 
of the drug (Anand, 1971)•
7b. Nicotinic acid: This drug is a potent agent in reducing
fat mobilization from adipose tissue (Carlson and Oro, I962) and this 
may in tui'.n affect the utilization of glucose by peripheral tissues. 
Although nicotinic acid inhibits the activity of adipolytic lipase both 
in vivo and ^  vitro, the precise details of its action on fat metabolism 
are not clear." The effect of nicotinic acid on carbohydrate metabolism 
is even less defined and both hypo- and hyperglycemia have been 
reported (Mirsky et alo, 1957? Parsons. I96I).
15
7c, Ethyl aJ-cohol; Ethanol exerts several different types of 
action on body metabolism. Alcohol is mainly metabolized in the liver 
by enzymatic mechanisms which are common to the metabolic pathways of 
fat and carbohydrate metabolism, particularly those dependent on the 
availability of HAD and NADH. Following either acute or chronic 
administration of ethanol to mammals, the hepatic concentrations of NAD 
and NADH change, shifting the redox state of the liver to a more reduced 
state (Gordon, 1972). This may, in turn, reduce the production of 
glucose and increase the synthesis of fat (Hawkins and Kalant, 1972). 
Other interesting metabolic effects of alcohol include its ability to 
depress secretion of posterior pituitary antidiuretic hormone and 
stimulation of corticosteroid secretion (jenlcins and Connolly, I968; 
Ballet .et al., 1970)* Since alcohol is believed by some investigators 
to activate hypothalamic, pituitary and adrenal activity, it is possible 
that alcohol also interferes with the release of HGH, as the hypothalamus 
regulates the release of HGH (McCann, 1970? Martin, 1973)»
8. Scope of the present studies.
Tolerance tests :
8a. Acetoacetate tolerance test; Following the administration 
of ketones to animals or man, a decrease in the concentration of blood 
glucose and EFA has been observed by many workers (Madison _et pi., I96A;
II
Bjorntorp and Sobersten, 1967? Balasse and Corns, I968; Senior and 
Loridan, i960). This effect of ketones has been accepted as compatible 
with stimulation of the release of insulin (Madison et al., I964). 
Although a rise in plasma insulin after administration of ketones has
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been demonstrated, in dogs, the relationship between ketone-bodies and 
insulin release is less clearly defined in man. The effect of aceto­
acetate administration upon fat and carbohydrate metabolism in man was 
therefore studied to determine its effect on insulin and growth hoxmone 
release at rest in normal subjects,
8b. Glucose tolerance test; This was performed before and 
after the administration of fenfluramine on patients with obesity and of 
nicotinic acid in normal subjects in order to investigate the action of 
these drugs on carbohydrate metabolism in relation to insulin release.
8c. Observations after an overnight fast ajid during dietary 
restriction: Serial measurementsof FFA, glucose, glycerol, aceto­
acetate and 3"bydroxybutyrate were made in two groups of obese subjectsc 
One was talcing fenfluramine, the other were maintained on reduced diet.
This was carried out in order to examine whether fenfluramine action on 
fat and carbohydrate metabolism is related to a reduction in dietary intake,
8d. Exercise studies: In the past decade while considerable
interest and effort have been devoted to increasing our understanding of 
factors regulating energy metabolism during exercise in normal subjects, 
little information is available, however, on the changes during exercise 
in patients with altered metabolic and nutritional situations such as 
obesity and starvation. Exercise studies were designed to compare the 
patterns of blood metabolites and hormonal responses to exercise between 
physically well trained subjects and healthy untrained subjects.
Comparative studies between patients with obesily and normal non-obese 
subjects were also carried out. The reason for carrying out these 
investigations was both to establish the usual response of blood
17
metabolites and hormones to exercise and to measure these responses 
after the administration of drugs such as fenfluramine, nicotinic acid 
and alcohol.
Exercise was chosen because it produces considerable demands 
on fat and carbohydrate metabolism and changes in endocrine activity.
In this S3 tuation any metabolic or hoxmonad effect of pharmacological 
agents, pathological and altered nutritional states could be expected to 
be magnified.
METHODS - A Sm^MARY
A full account of all methods used in the■present work 
appears in Appendices I and II. This section gives a short 
description of the main techniques.
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(a) Experimental Jtrrocednree
1. Catheterizationt The subjects undergoing clinical investigations 
were brought to the laboratory between 09o00-10o00 hours alter an
overnight fast* A catheter (gauge 18-20) was placed in the ante-
cubital vein under local anaesthesia? flushed with saline (0«9$o) 
and strapped to the forearm,
2, Exercise : After catheterization, two resting blood samples were
taken. The subjects then exercised on either a bicycle ergometer 
(Elma Schonander Constant load ergometer EM $69) or a treadmill for 
a, period of 20-$0 min, followed by a period of rest of 90 min.
Heart rate was recorded during the investigation and for a fur-bher 
15 min using miniature chart electrodes with an electrocardiograph. 
Blood samples were talcen at 5 min intervals during exercise and then 
at 159 $0, 60 and 90 min afterwards,
5* Glucose Tolerance Test: 200 ml of 25% w/v glucose was taken orally
in about 2 min, .The subjects remained at rest t hr cutout the test.
. Venous blood sanples were talcen beforehand and at 50 min intervals 
after glucose ingestion for 180 min,
4 , Acetoacetate Tolerance Test: 200 ml of 0«/^ M sodium acetoacetate,
prepared according to the method of Krebs and Eggleston (1945) was 
taken orally. The subjects remained at rest throughout the test. 
Venous blood samples were taken beforehand, after 4O min and then at 
subsequent 20 min intervals for a further hour.
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(b) Biochemical techniques
Venous blood (I4 ml) was taken on each occasion and divided 
into tv/o parts, 4 ml of this blood was immediately deproteinized with PCA, 
The remaining 10 ml of blood was heparinised and the plasma was separated 
later from the cells by centrifugation. The acid extract of the first 
sample was neutralized with KÜH and used for the estimation of metabolites 
in the blood. Lactate, pyruvate, acetoacetate, ^-hydroxybutyrate and 
glycerol were analysed by enzymatic methods. The disappearance of HADE 
was measured at 540 nm using a spectrophotometer. Glucose was estimated 
by a colorimetric method using glucose oxidase and orlbo-dianisinine as 
an indicator. The plasma sample was analysed for EFA by a colorimetric 
method after chloroform extraction and soap formation with a copper salt. 
Details of the methods are given in Appendix I.
(c) Hormonal assays
A radio-iimmuno-assay has been developed for the measurement 
of both HGH and IRI in plasma. In the HGH estimation a double antibody 
technique was modified in order to precipitate the bound HGH. Albumin 
coated with charcoal was used to absorb free insulin. The immunologica,l 
activities of both hormones were derived from graphs of results from 
control samples in which the percentage of hormone which was bound had 
been plotted against the log of the total concentration of the hormone. 
Details of the hormonal assays are given in Appendix II.
CHAPTER 1
TRAINED CYCLISTS COMPARED WITH NORMAL SUBJECTS
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INTRODUCTION
Several drugs which affect fat and carbohydrate metabolism 
have been used in the management of either obesity or diabetes? disorders 
in which such metabolism is altered. Among the drugs are derivatives 
of amphetamines and biguanides. Their modes of action are still not 
fully understood. There is also little information about their effect 
on metabolism during exercise. In order to elucidate these actions in 
patients suffering from metabolic abnormalities, such as obesity and 
diabetes? it is necessary to be aware of the metabolic changes which occur 
during exercise in normal subjects. The study of exercise is of value 
because metabolic processes and the mechanism regulating the fuel supply 
are accelerated.
Normal subjects are not, however, homogeneous for their 
degree of physical fitness varies considerably. In order to investigate 
the range in normal subjects, I have studied well-trained athletes as well 
as untrained subjects. In previous studies athletes have been shorn to 
have lower concentrations of blood lactate and pyruvate during exercise 
(Robinson and Harmon, 1941» Holmgren and Strom, 1959» Cobb and Jolmson, 
1965; Sal tin and Karlsson, 1971)? and lower concentrations of plasma FPA 
and blood ketone-bodies in the post-exercise period (Johnson et al., 1969; 
Johnson and Walton, 1972). Nevertheless they had higher blood glucose 
a.nd glycerol concentrations during exercise than untrained subjects 
(Rennie. ed al,, 1974)« As there are differences in the rate of fuel 
mobilisa lion, endocrine activity is also probably altered as a result of 
athletic training. Although some alterations, in the response of
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catecholamine (von Euler and Kellner, 1952) and HGH (Sutton at_ , I969) 
as a result of physical training, are kno\m during exercise, there is? 
however, little information about changes in the plasma IRI in relation 
to physical fitness.
To establish the hormonal changes with exercise further, 1 
have studied trained and untrained subjects during exercise of an 
increasing severity. This investigation was carried out in conjunction 
with M.J. Rennie who has reported the catecholamine changes in his thesis, 
but I was alone responsible for the observations which follow,
METHODS
Six male racing cyclists and six male untrained subjects 
(table 1 ,1) have been studied. They were investigated on two occasions.
On the first occasion, the maximum work capacity for all the subjects was 
determined after cycling at work loads increasing by 100 kpm every minute 
until exhaustion. On the second occasion, the subjects were studied 
during and after $2 minutes of exercise on a bicycle ergometer. They were 
studied between I7OO and I9OO hr and had not eaten since mid-day. The 
exercise consisted of continuous cycling at 60 rprn for four periods of 8 
minutes, each at work loads were approximately $0 , 45» 60 and 75 per cent 
of maximal capacity. Blood samples were taken from a catheter placed in
an antecubital vein. One resting sample was taken and further samples
were also taken at 8 min intervals during exercise and then at 5 min after 
the exercise. Samples were treated as described in appendices I and II 
and analysed for lactate, pyruvate, glucose, glycerol, ketone-bodies, EPA, 
IRI and HGH. Heart rate was recorded with a continuous electrocardiogram.
Table 1-1: Individual data on age, height, weight, maximum work
load and heart rate of 6 trained cyclists and 6 untrained
subjects
(a) Trained
Age Height Weight % increase Maximum Heart rate
yr cm K g
above 
ideal weight
work load 
kpm beats/min
Rest End of 
exercise
M.D. 27 162 79 8 2500 58 195
D.M. 27 168 62 5 2100 46 195
A.T. 27 185 80 6 2500 96 192
V/.M. 2o 168 60 2 1900 70 196
E.McD. 22 172 67 5 2100 55 193
A.McD. 26 175 65 2 1900 48 198
Mean 26 175 68 4 2155 65 195
SEM t 1 i 5 ± 4 ± 1 ± - 7 ± 1
(b) Untrained subjects
W.G. 25 182 65 5 1400 ■ 84 196
M.R. 27 188 90 17 1600 88 182
S.H. 28 186 68 4 1700 81 185
8 .8 . 28 176 78 16 1500 94 192
W.8. 55 168 . 75 18 . 1200 85 182
D.P. 55 178 75 8 1400 67 185
Mean 29 180 75 11 1466 85 186
SEM ± 1 -±  4 ± 4 I 5 - 71 i 4 ± 2
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RESULTS
The trained subjects were relatively younger and somewhat 
shorter and lighter than the untrained group (table 1 :l). Significantly 
greater work loads were achieved by the trained subjects with relatively 
similar maximum heart rates to that of the untrained subjects.
ERA and alycerol (table 1.2); Resting PEA concentrations were similar 
in both groups. Exercise caused a slight fall in PEA at 8 min in the 
control group? but the fall was more marked for the cyclists whom it was 
observed for 16 min of exercise. In both groups PEA concentrations rose 
after the initial fall both in the remaining part of exercise and at the 
end of the investigation, but the rise was greater for the controls (66% 
of resting) than the cyclists (8% of resting).
Glycerol concentrations were similar at rest in both gx'oups, 
but with exercise there was a rapid elevation in the cyclists. In both 
groups the highest concentration was achieved at the end of the investiga­
tion, but the values were higher in the cyclists O.3O8 jmol/ml (- O.O5 pjmol 
SEM) compared with 0,158 ^unol/ml (- 0,02 paol 8EM) in the controls.
Lactate and pyruvate (fig l.l); Resting concentrations of blood lactate 
were similar in both the trained and untrained subjects. After 16 minutes 
of exercise, the mean lactate values were O .98 ^imol/ml (- 0.25 }#ol SP2'l) 
and 3 -*65 pmol/ml (- 0,85 pmol SEM) respectively. At the end of the 
exercise period, the cyclists had a mean value of 5*84 iJmol/ml (- I.I5 pmol 
SEM) and in the untrained subjects? lactate conoAntrations had risen to 
8041 pmol/ml (-0,97 lumol SEM), After exercise lactate concentrations fell
E 3: E R 0 I S E
Time (min) 0 8 16 24 32 57
plasma U 1,02
t
1,00
i
1 .04
t
1.12
+
1.50
‘h
1.70
p
PPA 0.08 0.12 0.01 0.09 0.09 0.16
(pequiv/ml) T 0.98
"K
0.90 0.96
4"
1.02
+
1.02
p
1.06
t
0 .04 0.06 0.02 0.04 0.05 0.07
NS PcO.O^ P<0.05 NS P<0=01 r^OtOOl
Blood U 0,096
i
0.098
4-
0.099
+
0.112
j.
0.119
'h
0.158
4-
0.010 0.010 0.010 0.015 0.015 0.020
glycerol
(pmol/ml) T 0.085
i
0.120
4*
0,166 0.215  
+ .
0.275
p
O.5O8
H-
0,005 0.012 0.027 0.028 0.057 0.050
m P-cO.05 P40.01 P<0,001 P<0.001 P<0.001
Table 1“2 s Plasma ¥FA (|j,equiv/ml) and blood
glycerol (limol/ml, mean ~ SM) during 
and .after exercise in 6 trained 
cyclists (t ) and 6 untrained subjects (u) 
All subjects exercised for four 
successive periods of 8 min, each at 
. 45/Û» 60^ ' and 75% of their maxj.mum
capacity.
Pig, 1-1. Blood lactate and pyruvate (ymol/ml, mean - SM''l) during
and after exercise in 6 trained cyclists ( G-—  ---
and 6 untrained subjects ( H ------ -B). All subjects
exercised for four successive periods of 8 min, each at 
5096, 45%j 60% and 75% of their maximum capacity.
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in the cyclists, but continued to rise in the untrained subjects so that 
the difference during the first few minutes after ceasing exorcise was 
considerable »
Q'he changes in pyruvate concentrations were similar to those 
of lactate both during and after exercise.
Glucose (fig 1 .2) At rest, blood glucose concentrations 
were not significantly different between the trained and untrained groups 
(p >  OoOh). After 24 minutes of exercise, the mean glucose vaJ-ues were 
116 mg% 7 itig SEM) and 85 mg^ 6 (- 7 ifig SM4) respectively. At the end 
of the exercise period., the concentrations were greatly elevated in the 
cyclists, whereas there was a much smaller increase in the value for Ihe 
untrained subjects (p <  0,01), The differences between the two groups
were maintained in the post-exercise period. '
Plasma IRI (fig 1.2) Resting concentrations of plasma IRI
were similar in both gi’oups. The concentrations fell during exercise in 
the untrained subjects, but remained unchanged in the cyclists so that the 
differences in the concentrations of IRI between the two groups were 
significant throughout the exercise (p < O.Ol), After exercise the 
concentrations rose considerably in both groups, but the rise was much 
greater in the untrained subjects.
Plasma HGH (fig 1.5) At rest plasma HGH concentrations
were not significantly different between the two groups (p>-0 ,05). 
Exercise caused a rise in the concentrations of HGH in both groups, but 
the increase was much greater in the untrained subjects. At the end of
the investigation the concentrations fell in the cyclists whereas in the
Fig. 1-2. Blood glucose (mg/lOO and plasma IRI (p units/ml, 
mean ~ SM) during and after exercise in 6 trained
cyclists (©  --- ■—" @) and 6 untrained subjects (b8— ® ).
All subjects exercised for four successive periods of 8 min, 
each at $0^ 6, 45%» 60^ 6 and 75% of their maximum capacity.
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Fig, 1-$. Plasma HGH (fi ■units/ml, mean - SEÎ'l) during and after
exercise in 6 trained cyclists —  -----®) and 6
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exercised for four successive periods of 8 min, each 
at 30%, 45%» 60^^ and 75% of their maximum capacity.
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■untrained subjects they remained elevated so that the values of HGH 
during and after exercise were significantly higher in the untrained 
subjects than the cyclists (p*<OcOl),
DISCUSSION
There were considerable differences in the biochemical 
responses to exercise between the two groups. The trained cyclists had 
a significantly lower concentration of blood lactate and pyx'uvate. These 
changes persisted even when the trained subjects had worked harder in 
absolute terms than the control subjects as evidenced from the work loads. 
Thus these results are compatible with previous reports (Robinson and 
Harmonj I94I? Holmgren and Strom, 1959» Cobb and Johnson, I965;
Johnson £t ad., 1969)* Metabolic mechanism ma,y be adapted in athletes 
resulting in more efficient aerobic pathways, Evidence for this has been 
obtained in animals. Higher concentrations of certain oxidative enzymes 
have been reported after adaptation via training programme (Holloszy et ad.,
1971).
In these investigations there were also marked differences 
between the two groups on the effect of exercise on the blood concentrations 
of other metabolites.
The much greater rise in blood glycerol concentrations, in 
the trained cyclists, suggests that they have a great degree of fat mobil­
ization, Both the concentrations of RFA and the rate of -their increase 
with exercise were, however, lower in the o.yclists and it therefore appears
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that the cyclists utilise FPA liberated during exercise much more rapidly 
than the controls.
The rapid rise of blood glucose concentrations with exercise 
in the cyclists compared to the changes in the controls was remarkable 
and similar to the observation of Rennie et , (1974)« Working muscle 
at high work loads does not use circulating glucose as a fuel until 
muscle glycogen falls to a low level (Hultman, 196?; Wahren, 1970) and 
as reported above, FFA is probably metabolised to a greater extent by 
cyclists. It therefore appears that the large increase in blood glucose 
concentration was due to a decrease in the peripheral utilisation uf 
glucose. This might be exaggerated by glucose entering the blood after 
stimulation of the liver by catecholamines and glucagon (Sutherland, 1950? 
Sutherland and Cori,  ^ I95I),
In this study there were also striking differences in the 
hormonal responses to the exercise between the two groups. Plasma IRI 
was depressed to a lesser extent in the cyclists during exercise and they 
also had a smaller increase in plasma IRl after the end of exercise. 
Normally, the major mechanism regulating insulin secretion from the 
pancreas is blood glucose concentration. Experiments using infusion 
techniques have produced evidence that adrenalin in animals (Kris »
I9Ô6) or noradrenaline in man (Porte and Williams, I966) result in reduction 
or prevention of an increase in circulating insulin even after ingestion of 
glucose. During exercise there is knov.n to be an increase in output of 
catecholamines (von Euler and Kellner, 1952; Vendsalu, I96O; Kotchen 
âir9 1971). Therefore, it seems reasonable to suppose that in both 
gi’oups the failuj:e of exercise induced hyperglycaemia to stimulate insulin
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release cou3.d be due, at least in part, to an increased secretion of 
catecholamines, lower concentrations of catecholamine metabolites in 
the urine of fit individuals compared with untrained subjects have been 
reported during exercise (von Euler and Kellner, 1952). The differences 
in adrenergic activity duicing exercise berween the two groups may explain 
their differences in plasma IRI concentrations. It is also possible 
that increased aerobic oxidation of fat and lactate as a result of 
training may reduce the need for insu].in in the cyclists as FFA and lactate 
transport across the cell membranes is independent of insulin (Williams 
and Ihsinck, I966).
.
This suggestion is consistent with the observation of Devlin 
(1965) who observed insulin-like activity (iLA) before and after a 
'training programme in man and found that the fall of ILA during exercise 
was less after the programme.
During exercise plasma HGH concentrations were lower in the 
cyclists and they returned to resting values rapidly after the end of 
exercise. Similar observations related to physical fitness have been 
reported (Sutton £t al., I969). Although the role of HGH during exercise 
has not been clearly established, it has been suggested that it causes 
lipolysis and enhances the availability of FFA as a fuel (Hunter ejt , 
1965)0 The early changes in FBA concentrations are, however, probably 
due to adrenergic activity (Havel and Goldfien, 1959), The action of HGH 
is delayed (Raben and Hollenberg, 1959), However, HGH may enhance glucose 
utilisation soon after its release (Frohman al •, I967).
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The present results demonstrate significant differences in 
IRI and HGH. responses to exercise between athletically trained and 
untrained subjects, even when the physically active groups worked at 
the same percentage of their maximum capacity as the untrained subjects*
As there are differences in the concentrations of IRI with 
exercise between the two groups, there could be differences in tissue 
sensitivity to insulin. Increased body weight as well as fat content is 
knovm to reduce the sensitivity of insulin in obesity (Rabinowitz and 
Zierler, I962)* Although no direct measurements have been made in this 
study to assess the degree of obesity, there is evidence to suggest that 
individuals who exercise regularly have a greater lean body mass and 
smaller fat tissue than sedentary individuals of the same weight 
(Parizkova, 1965? Bjorntorp et al., 1972). The cyclists were, however, 
lighter and nearer to their desirable weight than the controls and this 
may have resulted in higher insulin sensitivity in the peripheral tissue 
of the trained subjects.
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SUimKY
Is In order to obtain information on the range of hormonal
and metabolic changes which occur in normal subjects, six well-trained 
subjects a.nd six untrained subjects have been studied. They were 
investigated on two occasions. On the first occasion, the maximum 
work capacity for all the subjects was determined by increasing the work 
loads until exhaustion. On the second occasion the subject exercised' 
for four successive periods for 8 minutes each at $0)c, 60)1 and 75%
of their maximum capacity. Venous blood samples were taken before, 
during and after exercise and were analysed for blood hormones and 
metabolites.
2. There were remarkable differences in the patterns of blood
hormones and metabolite responses to exercise between the two groups.
During exercise the fall in plasma IRI and the rise in plasma HGH were 
much less in the cyclists even when they exercised at similar percentages 
of their maximum capacity as the untrained subjects. The cyclists also 
had lower concentrations of blood lactate, pyruvate and FFA and higher 
concentrations of blood glucose and glycerol,
5* These observations indicate that physical training alters
IRI and HGH values in relation to exercise. There may be not only changes 
in concentrations, but also changes in tissue sensitivity to 11:1.
CHAPTER 2
STUDIES OP PATIENTS WITH OBESITY COMPARED V/ITH N01ÎMAL SUBJECTS
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INTRODUCTION
In the study reported in chapter 1 there were differences 
in metabolic responses to exercise between well trained cyclists and 
untrained subjects. The cyclists had lower blood concentrations of 
lactate, pyruvate, and FPA and higher concentrations of glucose and 
glycerol during exercise. Hormonal differences between the two groups 
were also observed both during and after exercise. These might be 
true metabolic differences between athletes and untrained subjects 
which could be due to adaptation as a result of athletic training.
It was also suggested that there could have been differences in 
metabolism due to mild obesity, which was relatively greater in the 
untrained subjects (table l.l).
Many metabolic and hormonal abnormalities have been reported 
in obesity. These have included an increase in total number of adipose 
tissue cells (Hirsch ^  , I966), increase in serum fatty acids (Opie
and V/alfish, I965) and also in triglycerides (Albrink and Meigs, 1965)0 
The fasting concentration of IRI is elevated (Dagdade at al., I967), and 
although the secretion of IRI in response to glucose load is greater than 
in lean subjects (itarara ^  » I965); glucose tolerance may be decreased
due to reauced peripheral uptalee of glucose (Butterfield £t al., I965),
A  decreased HGH response to starvation and insulin induced hypoglycemia is 
also reported in obesity (Beck ^  , I964). These changes in obesity may
result in abnormal energy metabolism during activity for although the rate of 
lipogenesis increased in obesity, the rate of fat mobilization appears to 
decrease in response to various stimuli such as starvation (Gordon, I96O), and
nor-adrenaline infusion (Ortho and V/illiams, i960). Exercise is known 
to accelerate metabolic activity. This chapter reports a, study of 
fat and carbohydrate metabolism during and after exercise together 
with studies of HGH and IRI made in patients with obesity and the 
results compared with normal controls. These investigatione were 
carried out to provide further information about the metabolic effects 
of exercise. Such observations were necessary to give a background to 
studies reported later in this thesis upon the effects of drugs upon 
metabolism in obese subjects.
METHODS 
Subjects ;
Five patients (three female and two made) with obesity and 
six healthy male controls (table 2-1) were studied. No patient had 
undergone dietary restriction in the year before the study and were not 
receiving drugs at the time of the investigation. The obese subjects 
were 78% (- 8) overweight. The control subjects were from the medical 
staff and research workers at the hospital. They were slightly
overweight (ly% - 2) but none w^ as known to have a metabolic disorder,
n
Procedures
Patients and controls were brought to the laboratory after 
an overnight fast, and exercised for a period of $0 min on a bicycle 
ergometer fixed at a work load of 5OO - 100 Kpm/min. Heart rate was 
recorded during the investigation emd for a further I9 min using an 
electrocardiograph, A catheter was placed in the antecubital vein and 
blood samples were taken before exercise, at 5 min intervals during
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exercise and then at 15, $0, 60 and 90 min afterwards. The samples 
were trea.ted as described in appendices I and II and analysed for 
lactate, pyruvate, glucose, glycerol, ketone-boaies, IJTA, HGh and Ikl,
RESULTS
Heart Rates (Pig 2:1):
The resting heart rates were 85 beats/min (- 5 SEM) in the 
patients and 77 beats/min (~ 5 SIM) in the controls. In both groups 
heart rate increased duning the first Ip min of exercise (controls 84/o, 
patients Q0%) after which the rate was steady until the end of exercise 
when a rapid fall occurred to within 11 - Id^-o of the resting heart rate 
15 min after exercise. The percentage heart-r-abe changes in the 
patienxs and the controls were not significantly different at any time 
during exercise or the post-exercise period.
Pyruvate (Fig 2:2):
Resting jjyruvate concentrations were similar in both groups. 
Blood pyruva,te concentrations rose to a maximum at I5 min of exercise 
in the controls wliereas in the patients the maximum occurred at the end 
of exercise. IPyruvate concentrations were relatively higher in the 
patients both dur-ing exercise and in the post-exercise period, but they 
were not significantly different. The concentrations then fell towards 
normal levels by the end of the investigation.
Lactate (Fig 2:2):
Resting concentrations of blood lactate were not significantly 
different between the two groups (p >  O.O5)» Rapid elevation of blood
Fig. 2.1, Heart rate (‘beats/min, mean - SEM) in 6 control
subjects ( S  ^ ) ^ id 5 obese patients (©   ®)
during and after $0 min of exercise.
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lactate values to a peak at 1^ min of exercise occurred in both groups* 
The maxlraujn being significantly greater in the patients. The concen­
trations in the patients remained significantly different (P < O0O5) 
from their resting values for the remaining part of exercise and for 
50 min after the end of exercise. The controls, however, showed a more 
rapid return to approximately pre-exercise values so that there was no 
significant difference between the resting concentrations and those 
50 min after the end of exercise.
Glycerol (p^ 2*5):
Blood glycerol concentrations were significantly higher 
(P O0O5) at rest in the patients compared with those of the controDs. 
The peak values were significantly higher in the patients than of the 
controls, but the percentage i n c r e a s e w o , s  similar in both groups. 
The concentrations in the patients remained elevated I5 min after 
exercise and returned slowly to resting values at the end of the 
investigation. Glycerol concentrations in the controls, however, 
showed a rapid return towards resting values and at I5 min after exercise 
the values were not significantly different from those at rest.
Ketone-bodies (Pig 2*3)s
Blood ketone-body concentrations (acetoacetate 4- 5 hydroxy™ 
butyrate) were significantly higher at rest in the patients compared 
with controls (P <1 0*01). Concentrations at rest and at the end of 
50 min of exercise were not significantly different in both groups.
After exercise the concentrations increased considerably both in controls 
and in the patients, but the maximum valuos occurred in the obese 
patients 5O min after the maximum in the controls.
Pig. 2.5. Plasma, PPA (p%uiv/ml), blood glycerol and
ketone-bodies (pmol/ml, mean « SEM) in 6 control
subjects (^   H) and 5 obese patients
( 0 — -- -O) during and after 50 min of—
exercise.
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W k  (Pig 2*5);
Resting plasma PPA concentrations were significantly/ higher 
(p ^  O0O5) in the patients than in controls* Daring exercise the 
concentrations rose in both the patients and controls to a maximum at 
the end cf exercise when there was no significant difference between 
the two groups (p > 0 »05). The patients showed a small fall in IPA 
concentration 5 min after the beginning of exercise. Although PPA 
concentrations were relatively higher in the patients both during the 
second half of exercise and in the post-exercise period, they were 
significantly different at only I5 min after exercise. On both 
occasions the concentrations returned to approximately pre-exercise 
values by the end of the investigatiohc
Glucose (Pig 2*4)Î
Resting blood glucose concentrations were not significantly 
different between the groups (p>0o05). Exercise caused a fall in 
the concentrations earlier in the controls. The minimum occurred at 
20 min in both controls and patients, and values increased both in the 
remaining period of exercise and for 50 rain afterwards. Controls 
values were significantly lower througho it exercise and at I5 and f>0 
min afterwards.
Plasma HGH (Pig 2*5)î
Plasma HGH levels were similar at rest in both groups.
They rose by 600% in the controls and 550% in the patients by the end
if
Fig, 2.4» Blood glucose (mg/lOO ml) and plasma IRI (p units/ml,
mean - SM) in 6 control subjects ( H —   S) and
5 obese patients (©------©) during and after 50 inin
of exercise.
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of exercise. The patients showed a small change in the first 10 min
of exercise. The concentrations at 10, 15, 20, 25 and ^0 min were
significan.tly higher (p-riOsOl) during exercise in the controls 
compared with the patients. In the 90 min following exercise HGH fell 
to resting levels in both controls ana patients.
Plasma IRI (fig 2,4):
Resting concentrations of IRI were significantly higher in 
the patients than the controls (p 0,09)u The concentrations fell 
during exercise earlier in the controls, whereas in the patients they 
rose slighuly in the early part of exercise and fell as the exercise 
continued. The minimum concentrations occurred a.t 2h min 'of exercise 
in both groups and values increased in both the remaining period of 
exercise and for 19 min afterwards. Although plasma IRI concentrations 
were higher in the patients both during exercise and in the post­
exercise period, they were significantly different at only 9» 10, 19 
and 20 min of exercise.
DISGÜSSIOH
V -
Exercise is known to cause elevation of both blood glycerol 
and plasma PEA levels in normal subjects. This probably occurs as a, 
result of increased rate of fat mobilization, stimulated by increased 
adrenergic activity. In this study the concentrations of blood glycerol 
were higher in the patients with obesity both during and after exercise. 
This suggests that the patients had a greater degree of fat mobilization. 
The concentrauioiis of plasma FFA at the end of exercise were, however,
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similar in both groups, but the concentrations at rest were higher in 
the patients and had fallen in the early part of exercise. It therefore 
appears that patients with obesity have the ability to mobilize and 
utilize more fat than the controls. The patients also showed a 
greater blood glucose level throughout and this may be further evidence 
for the greater reliance on fat as a fuel for energy during exercise 
in obesity (H.arr et eh., 1969)»
After exercise the concentrations of both FFA and glycerol 
showed a rapid return to resting values in the controls whereas in the 
patients they remained elevated. Similar results have been reported 
by Shwarz and co-workers (I969) who suggested that the patients might have 
been able to mobilize fat in excess of their needs. As the concentrations 
of blood ketone-bodies hardly altered during exercise, there is probably 
an equilibrium between production and utilization. After exercise, 
however, when muscular utilization of fuel decreases, there is a rise 
in the ketone-body concentrations (Johnson ^  , I969; Johnson and
V/alton, 1972). The much greater rise after exercise in the patients 
may reflect a decrease in their ability to oxidise acetyl CoA through 
the citric acid cycle. The inadequate carbohydrate utilization and 
also insulûn resistance which have been reported in obesity, would also 
tend to increase ketone-body production. The patients also had 
increased concentrations of lactate and pyruvate. Increased rate of 
fat oxidation increases the level of acetyl CoA which in turn blocks 
pyruvate oxidation, resulting in the accumulation of both pyruvate aiid 
lactate (Garland et al.* I964).
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In this study bhe fall in the concentrations of plasma IRI 
and the rise in the concentrations of HGH in response to exercise were 
much less in the patients than of the controls. This could he 
explained if the patients were more fit than the controls (Sutton et al., 
1968), hut it is unlikely since the concentrations of blood lactate 
during exercise and of ketone-bodies after exercise were higher in the 
patients. They might have been expected to be lower than those of tie 
controls if the degree of fitness was the explanation. There was a 
relatively poor response of HGH. to hypoglycaemia in the obese subjects, 
as previously reported (Beck ojî al.. 9 1964)° This may account for the 
differences of HGH response between the two groups, if the fall in blood 
glucose during exercise was the stimulus. Another possibility is thp.t 
the patients had a higher rate of fat mobilization as indicated by 
higher glycerol concentrations. This might-have caused a reduced 
response of HGH to exercise since it has been found that increased fat 
mobilization has an inhibitory effect on the release of HGH. This 
occurs in response to hypoglycaemia induced by insulin whereas decreased 
mobilization stimulates the release of HGH in response to hypoglycaemia 
(Quabbe et ad,, 1972) and to exercise (Hartog et; ad.., I967).
It can be concluded that exercise causes changes an blood 
metabolites of carbohydrate and fat in obese patients of a similar 
pattern to controls, although the changes tend to be more marked. The 
changes in the concentrations of HGH ond IRI, however, are less marked in 
obese patients and are probably related to obesity rather than differences 
in physical fitness.
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SHMMRY
lo Five patients with obesity and six healthy volunteers were
studied before, during, and after '^ 0 min of moderate steady 
exercise on a bicycle ergoraeter. Venous blood samples were 
taken for estimation of blood metabolites and hormones,
2, Exercise caused changes in blood metabolites in obese patients
of a similar pattern to controls. Pyruvate, lactate and 
glycerol were considerably elevated and post-exercise ketosis 
developed. These changes were more marked in the patients. 
Throughout the test FFA and glucose concentrations were 
higher in the obese than in the normal subjects,
5* During exercise the rise in plasma HGH and the fall in plasma
IRI were less marked in the patients.
4* The differences in blood glycerol, FFA, and ketone-bodies
between the patients and controls, may suggest a great reliance 
on fat metabolism in the patients. They also suggest that the 
higher rate of fat mobilization in the patients may reduce the 
response of both HGH and IRI to exercise.
9« It is concluded that these changes were related to metabolic
adaptation due to obesity rather than differences in physical 
fitness.
CÎTIA.PTER 5
PATIENTS WITH OBESITY DURING AND 
AFTER DIETARY RESTRICTION
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INTRODUCTION
In the comparison of exercise by patients with obesity and 
by healthy controls reported in chapter 2 there were differences in 
metabolic responses between the two groups. The patient had higher 
blood concentrations of lactate, pyruvate and glycerol during exercise 
and higher concentrations of blood ketone-bodies in the post exercise 
period, A decreased elevation in the concentrations of HGH and a 
smaller depression in the concentrations of insulin were also observed 
in the obese subjects during exercise. The physical activity of the 
obese patients v/as limited and, therefore, it wa.s suggested I. Lhe 
differences in physical fitness between the two groups could account 
for the differences in metabolism. A further possibility was that 
there was altered energy metabolism (Gordon ^  al,, 1962) because of 
metabolic and endocrine adaptations to obesity (Sims and Horton, I968), 
It was concluded that these changes were probably related to metabolic 
adaptation to obesity rather than to differences in physical fitness.
Resting observations have been made in obese patients during 
starvation therapy for 2-4 weeks and are reported in chapter 7° During 
starvation by patients with obesity the blood concentrations of glucose 
fell, whe:i eas concentrations of FFA and ketone-bodies rose, A rise 
in the ratio of 5"“hydroxybutyrate/acetoacetate was also observed. As 
there are changes in blood concentrations of metabolites, the patterns 
of utilization of metabolic fuels by active tissues including muscle are 
also probably altered as a result of dietary restriction. Recent work 
in man has demonstrated that metabolic pathways of fat and carbohydrate 
are altered during the adaptation to starvation (Cahill et al., 1966;
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Owen ejî. ^ ,0 9 I969)® Although some alteration in metabolic and 
hormonal responses as a result of sbarvation have been recognised at 
rest, there is little information about changes in metabolites and 
hormones with starvation when related to exercise.
An opportunity to study the metabolic and hormonal changes 
during exercise is provided by the study of a group of patients under­
going starvation therapy for obesity. Observations in this situation 
are described in this chapter and indicate remarkable differences in the 
patterns of metabolites, which are discussed in relation to plasma HGH 
and IRI concentrations.
METHODS
Subjects
Six. adult female patients (table 5.I) with obesity were 
studied on two occasions. On the first occasion they were in hospital 
undergoing starvation therapy. One patient (A.B.) was receiving a diet 
of 400 kcal/day and. the remainder were receiving water with added 
vitamins. The subjects were studied on secona occasion after they had 
left hospital and were eating normal diet with no restrictions, but had 
fasted overnight before the investigation. One patient (M.S.) was only 
studied while being starved and was not prepared to have a further 
investigation after discharge.
Procedure
The investigation had been explained to all the subjects and 
their consent had been obtained. On the day of the investigation the
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subjects carne to the laboratory between 09^00 and 10.00 hours. A 
catheter was placed in the antecubital vein and a first resting sample 
was taJœn, A fux’ther resting* sample was taken 10 min later. They 
then exercised on either a bicycle ergometer or a treadmill for ^0 min, 
followed by a period of rest of 90 min. The work on the bicycle and on 
the treadmill was regulated according to the subjects ability to aciiieve 
a mean heart rate of 150 beats/min towards the end of exercise. Heart 
rate was recorded using an electrocardiograph. Blood samples were taken 
at 5 niin intervals during exercise and then at 19, 50, 60 and 90 min 
afterwards. The blood samples were treated as described in appendices 
I and II and analysed for lactate, pyruvate, glucose, glycerol, ketone- 
bodies, FFA, HGH and IHI.
HESULTS
Heart Rate (fig.5.1) In all subjects similar heart rates were 
achieved at the end of exercise and the heart rates for the last 10 min 
of exercise were not significantly different on the two occasions 
(P > 0 ,05) although the rate of increase at the beginning of exercise 
was greater during starvation.^
Glucose (fig 5®2) Blood glucose concentrations were significantly
higher at rest in the control investigation compared with those dur*ing 
sttrrvation. At the end of thirty min of exercise glucose concentrations 
had risen 16% from resting levels in the control investigation, but with 
starvation the concentrations showed a greater rise, 6C% above resting 
levels, so that there was no significant difference at that stage between
Pig 5 .1 . Heart rate (beats/min, mean - SEM) in 5 patients with obesity 
after two periods of 50 min exercise.
Starvation ( 0-- ©) ; normal diet ( a ----8).
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the two occasions. During recovery glucose concentrations were 
relatively higher on the control occasion and they returned to resting 
levels 60 min alter exercise, whereas with starvation the concentrations 
remained about 26% above the resting values for the remainder of the 
investigation.
Lactate (fig 5«3) At rest lactate concentrations were significantly 
lower with starvation than on the control occasion, Rapid elevation of 
blood lactate vaines to a peak at 10 min of exercise occurred with 
starvation* whereas in the control investigation tne peak occurrecl at 
20 min. Although lactate concentrations were relatively higher with 
starvation both during exercise and in the post-exercise period, they 
were significantly different at only p? 10 and 15 min during exercise 
and at I5 and 60 min after exercise. On both occasions lantate concen­
trations returned to resting levels by the end of the investigation.
Pyruvate (fig 5.5) Resting pyruvate concentrations were significantly 
(p < 0 .05) lower with starvation than on the control occasion. During 
exercise the concentrations rose to a maximum at 25 min when there was 
no significant difference between the two occasions. Pyruvate concen­
trations returned to resting values 60 min after exercise in the control 
inver, uigation* whereas with starvation the concentrations remained aoout 
16% above the resting levels for the remainder of the investigation* but 
as the resting concentration during starvation was much lower the post­
exercise levels were below the control values.
PPA (fig 5.4) With starvation PFA concentrations were significantly 
higher at rest before exercise than on bne control occasion (p -cO.Ol)
tPig 5»5* Blood pyruvate and lactate (pimol/ml, mean - SBM) in 5 patients 
with obesity after two periods of $0 min exercise.
Starvation (0 — ---—  ©) ; normal diet (s — ----- ® ).
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Exercise caused a slight fall in concentrations on the control 
investigation (4% of resting), but with starvation the fall was greater 
(1670 of resting). On both occasions EEA concentrations rose after 
the initial fall to maximiua towards the end of exercise. The maximum 
valu_e was higher with starvation, but the percent,age rise was greater 
on the control occasion (42% of resting) tha.n with starvation (lp% of 
resting). On the control occasion PFA concentrations returned to 
resting levels vy the end of the investigation, whereas with starvation 
FFA remainea elevated in the post-exercise period,
Glycerol (fig 3-i) Resting glycerol concentrations were significantly 
higher with starvation than in the control investigation (p . 0*01).
Blood glycorcl concentrations increased during exercise earlier on the 
control occasion. The pealc values were not significantly different, but 
they occurred at different times. With starvation the peak v;as at 25
min of exercise, whereas in the control investigation it was at the end
of exercise. The concentrations at 5? 10 and I5 min were significantly 
(p h Go05) higher during exercise on the control occasion than with 
starvation. On both occasions glycerol concentrations returned to 
resting levels by the end of the investigation,
Ketone-bodies (fig 5*5) At rest, blood ketone-bodies (5-hydrox2>- 
butyrate 4- acetoacetate) concentration was CuOdO pmol/ml (™ 0,02 SEM) 
on the control occasion and 1,5 pmol/ml (- 0,2 SEM) with starvation.
On the control occasion, exercise caused a slight fall in concentrations 
for 15 min (l44o of resting) but with starvation the fall was more
marked (45/^  ^of resting) and the maximum fall was observed at 20 min.
On both occasions the levels rose after the initial fall both
Fig 5,4 , Plasma Fb'A (pequiv/ml) and blood glycerol (|jjnol/ml, mean - SEM) 
in 5 patients with obesity after two periods of )0 min 
exercise.
Starvation (® — — ~— @); normal diet ( a --------------□ ) ,
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in the remaining part of exercise and for 30 min afterwards. The 
concentration was nmch greater at 30 min after exercise on the control 
investigation (33^% of resting) than with starvation (28% of resting).
Plasma HGH (fig 3*6) With starvation HGH concentrations wore 
significantly higher before exercise than on the control occasion 
(p <- 0.01), On both occasions exercise caused a rise in the concen­
trations to maximum at 30 min of exercise. With starvation the changes 
in absolute values were much greater (up to I5 (iU/inl mean increase) than 
on the control occasion (up to 7 h'u/ml mean increase). In the recovery 
period the concentrations of HGH returned to approximately pre-exercise 
values at 90 min after the end of exercise in both with starvation and 
control investigationso
Plasma IRI (fig 5 *2) Resting plasma IRI concentrations were not 
significantly different between the two occasions? they rose slightly 
in the early part of exercise and fell as the exercise continued. The 
minimum concentrations occurred at 25 min on both occasions and values 
increased in both the remaining period of exercise and for I5 min after- 
war-ds. Control values were higher throughout exercise and during 
recovery but the uifferences in concentrations of IRI between the 
occasions were significant at only 13, 20 and 30 min of exercise.
DISCUSSION
With starvation, the subjects had higher concentrations of 
FPAj glycerol and ketono-bodies and lower concentrations of blood glucos
than on the control occasion. Thus these results are compatible with 
previous reports (Cahill £t , I966? Owen et al., I969).
Sympathetic activity is probably increased during starvation 
resulting in fat mobilization. The high concentrations of HGH together 
with low concentrations of IRI may also have contributed to the observed 
changes. The high concentrations of blood ketone-bodies during 
starvation were probably related to the concentrations of plasma PFA as 
the rate of formation of ketone-bodies depends on PPA concentrations 
(wieland, 19635 Krebs, 1966)*
In this study exercise caused an initial fall in the concen­
trations of PPA both when the subjects were starving and on the control 
occasion. This may be explained by increased PFA uptaRe by working 
muscle via increased peripheral blood circulation at the beginning of 
exercise. With starvation, the fall in the concentrations of FFA was 
more sustained and the percentage rise at the end of exercise was much 
less than on the control occasion, suggesting that during starvation the 
subjects- are able to utilize more fat during exercise. Utilization of 
ketone-bodies by skeletal muscle has been demonstrated in animals 
(Blixenkrone-Moller, 1938) and in man (Hagenfeldt and Wahren, I968),
In the present studies exercise caused a fall in the concentrations of 
blood ketone-bodies on both occasions and this may have been due to 
increased rate of utilization. The change was greater with starvation, 
but the enzymes capable of utilizing ketone-bodies are widely spread 
among other tissues such as kidney, heart and brain (Medes uk al,, I946; 
Williamson and Krebs, 1961? and Owen £,t al., I967)» It is likely 
therefore that the utilization of ketone-bodies by these organs is also
45
increased under the influence of starvation.
The rapid rise of blood glucose concentrations with exercise 
when the subjects were starving compared to the changes on tVie control 
occasion was remarkable and compatible with the observations of Hagenfeldt 
and V/ahren (1971), Since all the subjects were overweight, it is 
possible that there was a decrease in the peripheral uptake of glucose 
and its subsequent oxidation (Butterfield et ad., I965). This could 
have been exaggerated by both increased fat and ketone-body utilization 
and also active glucose production by the liver during staivation. The 
rise of blood lactate and pyruvate in response to exercise was greater 
with starvation than in the control study. This is unlikely to be 
related l.o the concentration of glycogen in the exercising muscle since 
diminished glycogen stores of muscle have been found after a short period 
of starvation (Hultman and Bergstrom, I967). It is possible that 
ketone-bodies may facilitate an aerobic glycolysis and lactate production 
by decreasing the intracellular oxidation of glucose (Williamson and Krebs, 
1961), Blood levels of amino acids including alanine have been reported 
to increase during exercise by normal subjects (Felig and V/ahren, 1970) 
and since starvati.on stimulates alanine uptake (Felig et al., 1969) by 
the liver, it is likely that alanine may be converted to pyruvate and 
later to lactate.
There were also differences in the hormonal responses to the 
exercise between the two occasions. Tne patients were able to raise 
their plasma HGH considerably during exercise on both occasions. The 
concentrations of plasma HGH were higher, however, at rest with starvation. 
They also rose to a greater extent during exercise with starvation compared
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with the control occasion. This could have been due to a greater 
stress of exercise during starvation as was suggested by the more rapid 
rise of heart rate on that occasion. 3?rotein ca.tabolism, which is 
increased during starvation, may have also contributed to the greater 
rate of increases in the levels of HGH with starvation as this is a 
known stimulator of HGH release (Habinowitz e_t al., I968).
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STJIk'IARY
lo B-tx adult female patients with obesity were studied before,
during and after $0 min of moderate exercise on two separate
occasions. On the first occasion they were in hospital undergoing 
starvation therapy. The subjects were also studied on another 
occasion after they had left hospital and were eating a normal 
diet, heart rate was recorded and venous blood samples were taken 
for the estimation of metabolites and hormones,
2, Exercise caused a rise in the heart rates to a similar value e.t
the end of exercise on both occasions, but the rate of increase at
the beginning of exercise was greater during starvation,
3, During starvation the concentrations of pyruvate, lactate and
glucose were lower at rest and rose during exercise to much greater
extent than on the control occasion. The rise of blood glucose
with starvation was 60%, whereas in the control study the rise was 
only 16% of resting.
4 p Concentrations of PPA were higher at rest with starvation, fell in
the early part of exercise and rose as the exercise continued.
With starvation the fall was greater (l6% of resting) compared with 
the control study (4%)* The rise was smaller with starvation (13%) 
compared with the control findings (42% of resting),
5* In the control study there was a fall in the concentrations of
ketone-bodies during exercise and a rise in the post exercise period, 
but with starvation the concentrations were considerably higher at 
rest and showed a, remarkable fall with no further rise in the post 
exercise period.
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6. Plasma IIGH concentrations were higher at rest with starvation 
and rose during exercise to a much greater extent thsin on the 
control occasion.
7o IT 18 CONCLUDED that exercise during starvation causes remarkable 
differences in metabolites? particularly PEA and ketones, and also 
hormonal concentrations in the blood compared with control 
observations.
These studies of exercise in starvalion indicate that the 
sensitivity of the growth hormone release mechanisms are greatly increased 
in starvation. In addition support is given for previous observations 
that fat is the major fuel during starvation. These investigations 
also indicate that ketone-bodies are a major fuel in starvation contiary 
to some other reported studies.
CHAPTER 4
THE EFFECT OF ACETOACETATE UPON HUMAN GROWTH HORMONE 
AND INSULIN RELEASE
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INTRODUCTION
When the blood levels of insulin and grovrbh homone were 
studied in trained cyclists and non-cyclists during and after cycling 
on a bicycle ergcmoter for $2 min, the cyclists shewed a slight fall 
in the concentrations of IRI during exercise, but hardly any rise in 
IRI concentrations in the post-exercise period. The non-cyclists, 
however, showed a greater fall during exercise and a considerable rise 
in IRI concentrations after exercise, observations previously reported 
in cha.pter 1. A rise in the concentrations of ketone-body is known to 
occur :in the post-exercise period and subjects in regular athletic 
training have a smaller rise compared with non-athletes (jolmson et al.,
1969). The differences in ketone-body production and IRI release in 
athletes compared with non-athletes suggest that there is a relationship 
between ketosis and insulin release. The literature on this problem
is confusing. In dogs increased level of IRI after ketone administration 
has been shown by many workers (Madison et al,, I964; Xavier et al.,
1970)' However, orhers have suggested that in man, the effect of 
ketones of lowering glucose and FFA is secondary to the inhibition of 
both fat mobilization from adipose tissue and glucose output from the 
liver (Balasse and Ooms, 1968; Senior and Loridan, I968). To 
investigate the effect of ketone-body on the release of IRI, I therefore 
studied six subjects during an oral acetoacetate tolerance test.
METHODS 
Subjects :
Six subjects, five males and one female (aged 3O-36 yr) were 
studied. None of the subjects was known to have abnormal fat and
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carbohydrate metabolism and they were eating nomial diets with no 
restriction.
Procedurei
The subjects were brought to the laboratory after an over­
night fast and remained at rest Un-oughout the investigation, which was 
carried out between 0800 hr and 1000 hr. After catheterization, venous 
blood samples were taken before the ingestion of sodium acetoacetate 
(200 ml, 0*4M) (see page ig )« 40 min later and then at 20 rnin intervals 
for a further 80 min. The blood samples were treated as described in 
appendices I and II and analysed for glucose, acetoacetate, 5-bydrcry- 
butyrate, PFA, HGH and IRI,
RESULTS
The ingestion of sodium acetoacetate produced a peak level 
of total blood Icetone-bodies of between 0„5 and 0,9 i-unol/ml at 60 min 
a,nd thereafter the blood level declined towards pre-ingestion value 
(Fig 4«l)' Blood glucose fell from a fasting value of 85 mg'/o (~ 5^gGEM) 
to 62 mg% (- 8 mg SEM) at 60 min and returned to pre-test value during the 
remaining period of the investigation. The concentrations at 60 and 
80 min were significantly lower (p k 0,0l) than fasting concentration.
Plasma IRI rose from 8 pb/ml (« 5 pU SEM) to 25 pU/ml (- 6 pU SM) at 40 
rain after the ingestion of acetoacetate, followed by a graaual decline to 
pre-ingestion value by the end of the investigation. The values 48 and 
60 min were significant]y higher (p < 0,05) thmin fasting concentration. FFA 
concentrations fell promptly and reached a nadir at 60 min after the 
ingestion of acetoacetate. The concentration then returned towards the
Fig (4*1): The changes (mean+SEM) in the five subjects of total
ketone-bodies (acetoacetate plus 5-hydroxybutyrate), 
-HGH, IRI, glucose and FFA. after Ingestion of a solution 
of sodium acetoacetate (200 ml; 0*4M) at the time 
indicated.
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pre-test value by the end of the investigation» The values at 4-0? 
60^ 80 and 100 min wore significantly lower (p <  0 »05) than the 
pre-ingestion value «
Wtiereas the glucose lowering effect of ketone-bodies in 
dogs and in man has been known for many years (Neptune* 1956; Jenkins, 
1967)} the mechanism of the hypoglycaemia remains unclean:, keb-ne 
and Madison (I964) have reported that in dogs the hypoglycaemia results 
from a greatly decreased hepatic glucose output» They also hcJ.ve 
demonstrated that infusion of ketones was associated with a rise in 
insulin concentration in the pancreaticoduodenal vein (Madison ^  al,, 
1964)0 The present study shows that in man a. significant enliancement 
occurred in the peripheral concentration of insulin with the ingestion 
of Oo4M acetoacetate. Insulin rose to a peak at 60 min after the 
ingestion of acetoacetate. This response was paralleled by those of 
ketones, suggesting a close relationship between the two. Subsequently, 
the fall in insulin concentrations coincided with the disappearance of 
the ketone-bodies. This finding is compatible with the observations 
reported by Xavier e^t el,, (197O) and consistent with studies of 
isolated perfused pancreas which indicate that the secretion from this 
organ stops once the stimulatory substances disappeared (Grodsky ^  al,, 
1967)» The rise in insulin concentrations obtained in this study may 
be sufficient to explain the observed fall in blood glucose. The FFA 
concentrations were also lowered after the ingestion of acetoacetate.
This may be due to both increased insulin secretion and the direct effect 
of ketone bodies inhibiting FFA release (Bjorntorp and Scherstcn, I967).
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The degree of ketosis obtained in this study is within the range which 
may be observed in exercise, nevertheless no significant change in 
gT'Owth hormone occurred even though there were changes in glucose, 
insulin and FFA as a result of the ketone ingestion» V/hen blood 
ketone bodies are raised during exercise, an increase in Insulin 
secretion might be expected. Observations supporting this possibility 
are to be reported in the next chapter. It is therefore possible that 
ketone-bodies by stimulating the secretion of insulin, lower the blood 
concentrations of FFA and limit their production*
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SUMMARY
1 * In order to investigodo the relationship between ketone bodies
and hormone release, six subjects, five male and one female 
(aged 50-56 yr) were studied after the ingestion of acetoacetate= 
Venous blood samples were talœn for the estimation of metabolites 
and hormoneso
2» The ingestion of acetoacetate caused a rise in the concentrations
of IRI and a fall in the concentrations of FFA and glucose. 
Acetoacetate however caused hardly any change in 'the concentrabions 
of HGH. Those observations indicate that the degree of post­
exercise ketosis may depend on differences in growth hormone 
secretion rather than vice versa»
5® It is also suggested that the rate of production of ketone bodies
may be limited by a feedback mechanism dependent upon insulin 
release*
CHAPTER 5
M  EXAMINATION OP THE RELATIONSHIP BETWEEN 
KETONE-BOBY CONCENTRATIONS AND INSULIN VALUES 
IN PATIENTS WITH ACROMEGALY
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INTRODUCTION
In the previous chapter the following findings were reported” 
a fall in p].asma FFA and. blood glucose concentrations after the ingestion 
of acetoacetate was associated with a rise in concentrations of plasma 
IRI. These results indicated that fab mobilization is reduced by the 
presence of ketones. They also suggest that in man, ketone^body 
production may be limited by feed-back control dependent on insulin 
release. An opportunity to examine further the relationship between 
ketone-bodies and insulin release is provided by the study of patients 
with acromegaly. Acromegaly is an endocrine disorder of the pituitary 
associated with an eosinophil tumour of the gland in which there is 
abnormally high production of HGH which not only affects bone growth but 
also metabolism (Martin, 1975)» Patients with acromegaly show an 
abnoi-mal peak in blood ketone-bodies and insulin during exercise and 
hardly any post-exercise ketosis (Johnson Ipfc al., 1971). These changes 
might have been due to the effect of the chronic elevation of HGH in the 
plasma as this hormone is known to reduce tissue sensitivity to insulin 
and to activate fat re-esterification (Merimee and Rabin, 1975)* In 
normal subjects a second period of exercise carried out within several 
hours 01 the first results in a greater degree of post-exercise ketosis 
after the second exercise compared with that observed after the first 
exercise period. Studies of two periods of exercise should therefcte 
provide an opportunity to examine the relationship of different 
concentrations of ketone-bodies and insulin in the same patient. Two 
patients with acromegaly have been studied a.nd the results compared with 
tfxi’ee normal subjects.
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METHODS
Subjects : two female patients (aged 2/}. and 57 yr) with acromegaly
and three controls (one female and two male, aged 25 and AO yr) were 
studied. The patients had clinical symptoms of a pituitary tumour and 
acromegaly. The control subjects were matched as far as possible for 
height and weight (table 5»l) and did not have a metabolic disorder.
The acromegalic patients were investigated before therapy was instituted 
and they were not receiving drugs at the time of the investigation. All 
subjects were eating normal diets with no restriction.
Procedure % patients and controls were brought to the laboratory 
between 09*00 and 10,00 hours after overnight fasting. The subjects 
were exercised for two periods of 50 min with an interval of 90 min, on 
a bicycle ergometer fixed at a work load of, 5OO - 100 kpm/min. The 
observations were made for a further 90 min after the second period of 
exercise. Venous blood samples were taken before exercise, at 5 min 
intervals during each period of exercise and then at 50, 60 and 90 min 
afterwards. Heart rate was measured and the blood, samples taken and 
treated as described in appendices I and 11, The samples were analysed 
for ketone-bodies and plasma IRl,
RESULTS
Ketone-bodies (Fig, 5»l): Resting concentrations of ketone-bodies
(acetoacetate + 5“hyd-roxybutyrate) were similar in both groups, but 
changes during and after the two periods of exercise were different.
After a decrease in the first 10 min the values in the patients rose
Table 5*1 : Individual data on age, weight, height and plasma HGH
Patients Sex Age Weight Height
yr kg cm
Plasma HGH 
pH/ml
Rest End of exercise
1st period 2nd period
A.T, F 57 68 165 116 505 348
J.H. F 24 65 160 68 94 116
controls
M 26 88 182 3.0 28 36
R.H, M 59 75 175 2.1 25 58
M.S. F 55 68 163 2.4 53 45
Fig (5,1) Changes in blood ketone-bodies (u mol/ml) in two acromegalic 
patients (fa— — ta, — -□) and three control subjects
( o----- 0 ) during and after two 50 min of exercise.
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rapidly to a peak at the end of the first period of exercise and then 
fell in the recovery period. The concentrations rose again daring the 
second period of exercise hat to a much greater extent, and remained 
elevated both dur-ing the remaining part of exercise and for 15 min 
afterwards- The concentrations then fell prog-ressively to pre-exercise 
values 60 min later. In the control group ketone-body concentrations 
changed little during the two periods of exercise, but they rose after 
the end of each period, more so after the second.
Plasma IRI (Pig. 5*2): Resting concentrations of plasma, IRI were
higher in the patients than in controls. The concenbra liens fell in Lhe 
control subjects during the two periods of exercise and rose slightly 
above their initial values in the second post'-exercise period. The 
patients however showed a rapid rise in the concentrations of IRI both 
at the end of the first exercise period and the end of the second period. 
The rise was much greater on the second occasion. In the acromegalics 
plasma IRI concentrations returned to resting values 60 min after each 
period of exercise,
DISCUSSION
There were considerable differences in the pattern of ketone- 
bodies and insulin changes during exercise between the two groups. The 
patients had a considerable rise in blood ketone-bodies which was absent 
in the control subjects. Plasma IRI concentrations were increased in 
the patients, whereas in controls they were depressed. These changes 
were remarkable and were similar to the observations of Johnson and 
Rennie (1975)» Throughout exercise for 30 min by acromegalics Joimson
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and Rennie found no change in blood glucose concentrations and therefore 
the changes in plasma IRI are not related to hyperglycemia.
Growth hormone reduces tissue sensitivity to insulin and the 
higher than normal concentrations of plasma HGH which occur in acromegaly 
may indirectly result in greater amounts of insulin being released. 
However a rise in plasma IRI was absent in the controls despite a greater 
elevation of HGH in their blood during the second period of exercise. 
Other factors must therefore be involved in causing insulin release.
The increased IRI concentration in the acromegalic patients might be in 
response to the rapid increases in ketone-bodies. These e\-e ki.iown to 
stimulate insuldn release and observations are described in chapter 4« 
Evidence is provided for this explanation by the high correlation 
(r, 97; P 0 ,05) between the highest observed concentrations of plasma 
IRI and blood ketone-bodies in the acromegalics (Pig 5*5)» After 
exercise the blood ketone-bodies fell in the patients so that no post- 
exercise ketosis developed. This may have been related to the rise in 
plasma IRI as insulin is known to limit fat mobilization and therefore 
inhibits ketone body production (bieberdorf „lt al., 1970), The present 
observations imply that the action of ketone-bodies in stimulating 
insulin release and the ability of insulin to suppress ketone-body 
production are active in spite of high concentrations of HGH, These 
findings support conclusions based on animal work (Jenkins, 196?) that 
the explanation for the raised plasma insulin concentrations associated 
with reduced uptake of glucose often seen in certain diseases such as in 
obesity and diabetes may depend upon the high plasma FFA and blood 
ketone-body concentrations found in these disorders.
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SUMMARY
1, Observations upon the relationship between ketone-bodies and
insulin release at rest have been reported in chapter 4 and this 
chapter reports studies on ketone-bodies and plasma insulin 
during and after two periods of exercise in two patients with 
acromegaly. Three normal subjects were also studied a,s controls.
2o In the acromegalics ketone-bodies concentrations rose during 
exercise and fell in the post-exercise period, whereas in the 
controls the concentrations changed little during exercise but 
rose above resting values immediately after exercise. The rises 
in ketone-bodies in both groups were associated with proportionate 
rises in plasma IRI concentrations. These changes in blood 
ketone-bodies and plasma IRI were more marked during and after 
the second period of exercise in both groups.
5. These observations support the previous finding (chapter 4) that 
ketones stimulate insulin release in man. They also provide 
more evidence for the suggestion chat ketones prevent ketosis by 
feed-back control dependent on insulin release.
CHAPTER 6
PATIENT WITH MUSCLE DISEASE 
(Mitochondrial inclusion body myopathy).
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INTRODUCTION
Experience gained in carrying out the projects reported in 
the pi-evious chapters on muscle metabolism during exercise in normal 
subjects and in patients with obesity have mtide it possible to examine 
ig/fc and carbohydrate metabolism in patients with diseases of muscle.
One disorder which has been studied is that of oculoskeletal myopathy, 
patients with which, present with progressive ptosis and external 
ophthalmoplegia. In this disorder electron microscopy has allowed 
delineation of intracellular abnormalities affecting organelles, A 
number of studies have reported abnormal histochemical and ultra- 
structural changes inside the mitochondria of muscle cells affected. 
(Bradley et al., 1969? Morgan-Hughes and Mair, 1975)° There is,
however, no information about the effect of the disorder upon metabolic 
processes. Investigations were designed, therefore, to provide more 
information about energy metabolism in this disease.
This work was carried out in conjunction with Dr@ D. Doyle 
(Neuropathologist, Southern General Hospital) who has performed the 
biopsies and is responsible for histological and histochemical studdes, 
but I am only responsible for the biochemical studies both at rest and 
during exercise.
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CASE REPORT
Abo, (institute of Neurological Sciences, Glasgow, 807875) 
v^ as a 49 yr old married man with two children, who was employed as a 
lorry driver. His mother died, of carcinoma of the stomach at 62 yr, 
and his father of a myocardial infarction at 67 yr. He had five 
siblings, three of whom were well, one had died of alcoholic cirrhosis 
(50 yr) and the other of ’stomach trouble’ (5I yr). There was no family 
histoiy of muscle disease, ptosis, or diabetes. Ho complained of 
drooping of his eyelids for many years, and he was av/are of trying to 
lift them with his forehead. He had also had very occasional double 
vision on lateral gaze for about 2-5 mcnths. These symptoms were worse
later in the day. Photographs indicated that he looked normal at 18 y.r,
but a left ptosis had become obvious at about 55 yr. He made no
complaint about tiredness when first seen, but later admitted that this
had become a problem for 1-2 yr; it was not related to time of day.
On examination his height was 1?6 cm and weight 62 kg. There 
was no obvious muscle wasting. He had wrinkling of his forehead, 
bilateral ptosis, and there was weakness of upward conjugate gaze and 
slight weakness of conjugate gaze to either side. Convergence was poor. 
His voice had a nasal quality but the palate moved normally» In the 
limbs there was no muscle fatiguability but slight v/ealcness of both 
triceps muscles and of the small muscles of both hands. All reflexes 
were normal , ' The remainder of the physical examination was negative.
Muscle biopsies
Biopsies were taken from the left triceps and the l.eft deltoid
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muscle under local anaesthetic, They were examined by light microscopy 
with routine stains. Glycogen distribution was identified by periodic 
acid Schiif staining (Hotchkiss, 1948) and fat by staining with Oil red 0 
(Lillie and Ashburn, 1945)* Specimens were also examined by electron 
microscopy (philips 201 electron microscope), goniometry (Philips 581 
electron microscope with double tilt goniometry), electron diffraction 
and X-ray microchemical analysis (’Sdax‘ (Energy Dispersive Analysis by 
X-ray)) with Philips 50^ - electron microscope, Histochemical analysis 
was carried out for the enzymes shown in table 6,1, Succinic dehydrogenase 
was examined by the method of Seligman and Rutenburg (l95’i); myosin 
ATPase by that of Padykula and Hermann (l955a? b); giucosan phosphorylase 
by that of Talceuchi and Kuriaki (1955)* and leucine arainopeptidase by 
that of hachlas al,, (195?)« The ocher enzymes were studied by the 
methods of Scarpelli e_t al,, (1958)*
Light microscopy with phase contrast and polarised light revealed 
virtually normal muscle and the abnormalities seen in stained preparations 
were minor. In the specimen from the left triceps muscle about 5% of the 
fibres were atrophic, some being exceptionally small in cross sectional 
area (20 p) with clusters of peripheral nuclei. In atrophic fibres 
there wore also some nuclei which were larger than normal (15 \x diameter) 
and these had very large nucleoli (5 p diameter). Some obviously 
abnormal fibres (approximately 2% of total) had unusually pale borders 
which had abnormal mitochondrial a,ggregates, The nuclei and nucleoli 
were larger in these areas. The remainder of the muscle fibres, although 
appearing normal, occasionally had internally placed nuclei and in a few 
scattered area.s these occurred in 5O/0 of the fibres. Longitudinal
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section showed that some nuclei were concentrated close to capillaries 
and these nuclei appeared larger than normal. The changes in the specimen 
from the left deltoid muscle were similan but only 1% of the fibres vrere 
atrophic. Atrophic fibres appeared in groups of up to six but no 
evidence was found of denervation as motor end plates and tex7ninal 
innervation appeared normal. There was a larger proportion of fibres 
with pale borders in this specimen than in that from triceps (about 5%),
In longitudinal section large nuclei were frequently seen in relation to 
capillaries. In both specimens glycogen was found to be reduced in all 
fibres. The concentration of fat in type I fibres was reduced and it was 
virtually absent from type II fibres : the fat which remained wa,s mainly
peripheral in the flores.
E]. e c ti'on mi or os copy (EM) (fig 6ol) of both specimens revealed no normal 
mitochondria. The least abnormality was the arrangement of cristae in 
concentric circles in the mitochondria rather than transversely as is 
found normally. Some mitochondria also showed crystal-like inclusions. 
These mitochondria were most numerous in the pale peripheral borders of 
the abnoi-mal fibres seen on light microscopy. The crystals appeared 
to be invested by the inner mitochondrial membrane which was not incor­
porated in their structure. Tiie crystals varied in length from Oo2 to 
5 u and were slightry curved. They were sometimes square but were 
usually oblong. Each crystal consisted of bands about 0.04 P in width 
separated from adjacent bands by a clear region 0,008 u across. The 
bands had light and dark longitudinal stripes (0.008 \x side). Although 
the majority of crystals had such a pattern? in some the bands were 
arranged obliquely and others had a grid-like structure, Goniometry 
confirmed that some of the crystals were curved and it :;as possible to
Pig (6.1): Electron micrograph of the crystalline inclusion bodies
in mitochondria showing the patterns which are 
determined by the angle of incidence of the electron 
beam. Two mitochondria are shovm which do not contain 
crystals but have alncrmally arranged cristae (X 12,500),
Pig (6,2): Abnormal succinic dehydrogenase activity in a type I muscle
fibre. The intense zone of peripheral activity was 
. characteristic of the abnormal fibres. (X YOO).
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show that the differences in the appearances of the hands depended 
upon the angle of incidence of the electron beam on the crystal.
Electron diffraction and microchemical X-ray analysis wore non-contributary 
because of the low mass of the crystals. EM confirmed that there was a 
general reduction in the fat content of the muscle fibres,
Histochemical examination showed the usual distribution of frbre types 
with myosin ATPase? fibres of types I? II and Ila being distinguished.
Fibre typing however was more difficult with other enzymes. Marked 
abnormalities were observed in fibres of types I and Ila? 20% of all 
fibres being affected? but fibres of type lib were not clearly seen, No 
abnormalities were found in type II fibres. Abnormalities were 
principally seen in the activities of mitochondrial or predominantly 
mitochondrial enzymes but there were also changes in several enzymes in 
cytoplasm. In the biopsy from triceps there was a general reduction 
in the activity of succinic dehydrogenase but there was a peripheral zone 
of considerably increased activity in type I and type Ila fibres. In 
the biopsy from deltoid the activity of succinic dehydrogenase was also 
increased peripherally in type I and type Ila fibres (fig 6o2). Several 
other mitochondrial enzymes showed increased activity and similar changes 
were observed in cytoplasmic enzymes ? including lactate dehydrogenase,
Biochemical Response to Exercise
The biochemical changes during exercise in our patient wore 
studied on tw^ o occasions during and after a 58 minute period of exercise. 
The results were compared with those from 6 normal male subjects (aged 
28-44 as controls. The investigations were performed between 09,00 hr
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and lie00 hr after an overnight fast, A catheter was placed in an
antecu'bital vein and flushed with saline, IVo resting samples were
. ft
taken. Work was performed on a bicycle ergometer (Elma Schonander 
Constant load ergometer? M569) at 600 kpm for 50 min. Heart rate was 
recorded d'oring the investigation and for a further 15 min? using- 
miniature chest electrodes with an electrocardiograph. Blood samples 
were taken at 5 rnin intervals during exercise and then at 15? 58? 60 and 
90 min afterwards. The controls were investigated in a similar way? 
but their work load was adjusted to obtain a comparable increase in. 
heart rate to that in the patient (5OO - 100 kpm). In the second 
investigation expired air vras collected in a Douglas bag and analysed 
for Og and CO^ to determine oxygen consumption aid respiratory quotient (r) 
Measurements were made at rest and during exercise and recovery. The 
blood samples were analysed as described in.appendices I and II,
Similar maximum heart rates were achieved during exercise.
Glucose (fig 6,5)» Concentrations at rest were similar in the patient and 
the controls but there was a marked difference during and after exercise. 
The blood glucose rose to 155 mg% in the patient at the end of exercise? 
whereas there was no significant change in the controls.
Lactate (fig 6*4)• Concentrations at rest were similar but with 
exercise there was a rapid elevation in the patient to 12«5 P mol/ml 
compared with 4-8 p mol/ml in the controls. The concentration in the 
patient declined after exercise but had not returned to the resting 
value 98 min after the end of exercise,
Ijrruvate (fig 6*4)* Concentrations at rest were similar and the exercise
Fig (6 ,5)ï Plasma IRI (qU/ml) and blood glucose (mg% in the
patient ---- ©) and six normal control subjects
(0-----0) (- SEM) during and after 50 min of exercise,
indicated by the solid bai% .____
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caused a rapid elevation. The highest concentration in the patient 
(0*59 M inol/ml) was achieved 15 min after the end of exercise. After 
this the concentration declined but had not returned to the resting value 
by the end of the investigation. The maxirirarn lactate/pyruvate ratios 
were greatly elevated in the patient (4OO70 above resting) compared with 
the controls above resting).
Plasma FI'A (fig 6,5). Concentrations at rest in the patient were 60fo 
higher than in the controls on the first occasion but similar on the 
second. On both occasions concentrations declined during exercise
compared with the controls, in which they rose.
Blood glycerol (fig 6,5)° Concentrations at rest in the patient were 
higher than in the controls on the first occasion but similar on the 
second. In both studies they rose to nearly twice the mean level .in 
the controls by the end of exercise. The concentration then declined 
in both the patient and the controls, the resting values being achieved 
by the end of the investigations.
Total blood ketone-body (fig 6.6). Concentrations at rest in the 
patient were five times higher than in the controls on the first occasion 
and within the normal range on the second. The concentrations fell 
during and after exercise whereas they rose in the controls. On the 
first occasion the 5™hydroxybutyrate/acetoacetate ratio for the patient 
was 2 o24 before exercise and rose to 4*40 after 5 min of exercise and then 
fell progressively to loO 50 min after exercise. In the second exercise 
investigation on the patient the changes were similar. In the controls 
the mean value at rest was 2.16 and it fell to lo36 after 5 min of
exercise. After 'j>Q min of exercise it v/as 2«83 and 50 min later it had
risen to 308.
Pig (6,5)5 Plasma PPA (|j. equiv/ml) and blood glycerol ((iuiol/ml)
in the patient (O and six normal control
subjects (0--- -O) (“ SEM) during and after $0 min of
exercise, indicated by the solid, bar.
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Plasma III (fig 6*5). Concentrations at rest were similar but the 
exercise caused a fall in plasma III in all studies. The fall was 
greater in the controls after 20 min of exercise. After this the 
concentrations rose, both in the remaining part of exercise and for 15 min 
afterwards. The concentration v;ac much greater 15 min after exercise 
in the patient (200p of resting) than in the controls (l55% of resting). 
The concentrations returned to resting values by the end of the 
investigations.
Plasma IIGH (fig 6*7). Concentrations at rest were similar but with 
exercise there v/a.s a rapid elevation in the patient to 41 u'C/ml c-.mpared 
with 27 in the controls. The concentrations then declined but had not 
returned to the resting values by the end of the investigations,
Oxygen consumption at rest was 0<,24 l/min. The values at 6, 20 and 50 
min birring exercise were 1*54 l/min, I .58 l/min and 1,45 l/min. The 
oxygen consumption then returned to normal 20 min after the end of 
exercise. R values were 1 ,04 at rest, they fell progressively during 
exercise to a, minimum of 0,74 at the end of exercise. The value 20 min 
afterwards was 0,84»
The effect of heparin upon lipolysis
The investigations were carried out in the morning after pn 
overnight fast according to the method of Pineburg ejt ad^ ., (1972). Corn 
oil (60 g) which had been emulsified with egg albumin (I5 g) was given 
orad-ly. This was followed 5 hours later by an intravenous injection of 
heparin (50 mg). Venous blood samples were tahen before ingestion of 
the corn oil. a.t 88 min intervals and then at I5 min intervals after the 
injection of heparin for a further 2 hours. The test was repeated on
Pig (6,7) ! Plasma HGH (fiU/ml) in the patient (@— and 
six normal control subjects (O-— --O) (- SM) 
during and after $0 min of exercise, indicated by 
the solid bar.
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another occasion omitting the corn oil. The blood samples were 
analysed for ITA and ketone-bodies (acetoacetate plus ^-hydroxybutyrate) 
as already described. Following the ingestion of the corn oil plasma 
FFA concentrations remained unchanged and just prior to the injection 
of heparin the concentration v/as OoSO pcquiv/inl. The concentration 
45 min after the injection of heparin was 2.-,4 pequiv/rnl and it then fell 
to a value of 1,8 penuiv/ml 25 min later. In the control investigation 
on the patient injection of heparin alone also caused, a rise in the 
concentratiuns of FF'a , bur this was less than that obtained after 
ingestion of corn oil. The rise in FFA concentrations after heparin 
were associated with a considerable rise of total ketone bodies.
Glucose tolerance test
A standard glucose tolerance test .was performed after an 
overnight fast. Glucose (50 g) was given orally and blood samples 
were obtained at 50 min intervals for 2-g hours. Lactate5 pjccuvate, 
glucose and plasma IRI were estimated as in the exercise investigation. 
The rise and the subsequent fall of both glucose and plasma IRI were 
similar to those of normal subjects. The tolerance to a glucose load 
was therefore normal in the patient.
DISCUSSION
Abnormal muscle mitochondria have been reported in several 
apparently unrelated conditions. The first report of a muscle disorder 
with abnormal mitochondria was made in 1959 when increased metabolism was 
found. The patient's mitochondria contained, large crystalline 
inclusions (j-!rnst,er et al.» 1959ü Luft et al., 1962), Mitochondrial
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abnormalities without associated hypermetabolism have been reported 
in childhood (Shy et^  oJ. ? I966), In one of these, 'megacoïii.al myopathy', 
rectangular inclusion bodies were observed in the muscle mitochondria. 
Mitochondrial inclusions have also been reported in the skeletal muscle 
of adults (Shafiq et al., I967; bradley ad.,,1969)0 None of these 
reports included observations upon the effect of the muscle disorder 
upon me tabolism,
In this study the patient had an abnormal metabolic response 
to exercise compared with controls. Concentrations of lactate and 
pyruvate during exercise rose to values above those observed in the 
controls. He also showed a rapid rise in blood glucose concentration. 
These observations suggest that although glycolysis was proceeding Miere 
was a block to complete oxidation of carbohydrate via acetyl CoA and the 
tricarboxylic acid cycle.
The lactate/pyruvate ratio rose during the first part of 
exercise in the patient above those observed in the controls. Some 
elevation is the usual response and is probably due to a rapid fall in 
the ratio of cytoplasmic nicotinamide adenine dinucleotide/reduced 
nicotinamide adenine dinucleotide (NAD/NADH) (Krebs, I967)» This 
cytoplasmic activity is normally linked to the concentration of NAD/MIH 
in mitochondria but may be independent (Devlin and 'Bedell, I960). These 
changes in the mitochondria may be reflected in the ratio of the 
concentrations of 5-hydroxybutyrate/acetoacetate in the blood (billiamson 
j 1967)» In the patient tnis ratio first rose and then fell,
69
whereas the converse was ohsesTved in the controls. Such finding's are 
obtained \;ith relative celTalar hypoxia (Alberti et al., 1971). The 
changes in these ratios are therefore in keeping with the suggestion 
already made of a block of oxidative metabolism for carbohydrate.
There was also a much greater rise in blood glycerol concen­
tration in the patient compared with controls suggesting greater fat 
mobilisation in the patient. Lipolysis results in production not only 
of glycerol but also PFA. The rise in the concentration of plasma FFA 
during exercise which occurred in the controls, and is the noz-mal 
finding, was, however, absent in the patient. Tests of lipoprotein 
lipase activity had shown that there was no block in the normal production 
of FFA. The depression of plasma FPA in the patient during exercise may 
therefore have been due to either greater catabolism of PFA or re- 
estérification to fat. There was no evidence from the muscle biopsies 
that deposition of fat was occurring excessively in the muscles studied. 
Normally ketone-body concentrations rise during the post-exercise period 
(Courtice a,nd Douglas, 19565 Johnson ejt a d , 1969) but this change was 
absent in the patient. The block of carbohydrate metabolism could 
result from increased fat oxidation to acetyl CoA, a process which is 
known to block further pyruvate oxidation (Garland and Randle, I964) 
and cause accumulation of pyruvate and lactate. This would also account 
for some of the elevation of glycerol for this is normally metabolised 
through the glycolytic pathway via a-glycero-phosphate.
The rapid rise of blood glucose implies both decreased carbo- 
hydx’ate utilization during exercise and also active glucose production 
by the liver. Pathways subserving carbohydrate storage as glycogen were
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noimalÿ however, as adduced from the normal glucose tolerance test.
The block of carbohydrate metabolism did not prevent the patient 
exercising and it is probable that energy production depended upon 
metabolism of fat as mobilization was occurring and yet there was no 
accumulation of FPA during exorcise and of ketone-bodies after exercise. 
Additional support for the conclusion that fat was actively metabolised 
by the patient was the finding that the patient had a relatively low R 
(COp production/Og consumption) during exercise. R normally rises in 
severe exercise to a value of lo5 - 2o0, The value above unity before 
the investigation might result from hyperventilation but it would be 
unlikely that this would have driven off so much CO^ prior to exercise 
that 50 min later the R would still be below normal values, as occurred. 
This argument is also supported by the histochemical findings of 
increased activities of enzymes involved in oxidative metabolism such as 
succinic dehydrogenase and cytochrome oxidase inside the abnormal mito­
chondria.
There were also differences in the hormonal responses to 
exercise of the patient compared with the controls. Plasma IRI concen­
tration was depressed to a lesser extent in the patient during exercise 
compared with the controls and he had a greater increase after exercise. 
During exercise there is an increase in circulating catecholamines 
(von Euler ana Hellner, 1952), which may explain the failure of the 
increased glucose concentration in the patient to stimulate insulin 
release, as adrenaline and nor-adrenaline inhibit insu].in release (Kris 
ol el0, 1966; Porte and Williams, I966), The higher concentrations of 
plasma IRI in the patient compared with controls after exercise coula,
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however, be related to the increased blood glucose as concentrations of 
blood catecholamines return rapidly to normal, the fall being of the 
order of 60% in 5 min (jolinson et al., 1974)»
Plasma HG-H concentrations were higher in the patient during 
exercise. The role of HGH during exercise has not been clearly 
established. It has been suggested that it causes lipolysis and enhances 
the availability of FPA (Hunter et al., I965) and therefore the 
difference in FFA response to exercise in our patient compared with the 
controls may be related to the differences in HGH concentration.
However studies of patients with hypopituitarism have shown, that it is 
not essential for FFA release (Johnson jet ^1„, 1971)»
There appear to be considerable differences in the metabolic 
effects of disorders in which abnormal mitochondria are found. The 
patient with myopathy described by Bradley et al,, (I969) had mitochondria 
changes on which appeared similar to those in the patient reported in
this study. However in contrast, they found excessive fat in muscle
fibres. The two patients described by Coleman al«, (1967) had
increased activity of succinic dehydrogenase and other enzymes but no EM
studies were reported. These patients however also had abnormal 
accumulation of fat in muscle fibres. Mitochondrial aggregates have 
been described by Engel (I964) in the muscle fibres from three patients, 
but these mitochondrial aggregates lacked succinic dehydrogenase activity, 
thus differing from the abnormal mitochondria in the patient reported in 
this study. The patient described by Luft et al., (I962) had increased 
metabolic activity and they considered that this occurred in spite of a 
defect in mitochondrial enzyme organisation. The increased fat metabolism
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dtœing exercise which we now report is computable wi'bh their findings. 
These observations indicate that exorcise provides a useful tool for 
examining the metabolism of abnormal mitochondria. An abnormal 
metabolic response to exercise has been found and I suggest thar studies 
of furbher patienbs may aii.low delineabion of specific patterns of 
metabolism of value in diagnosis.
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SUlllARY
le A maie patient (49 J^) presented with bilateral ptosis of
15-20 yr duration and. weakness for 1-2 yr. Muscle biopsies were 
performed from the deltoid and triceps muscles and studied by of
histology, histochemistry aud electron microscopy*
2. .Routine histology showed only minor changes; 2-5% of muscle
fibres had pale borders in which there were aggcegates of mitochondria 
and 1-5/0 of fibres showed atrophy, Histochemical examination showed 
increased activity of succinic dehydrogenase in mitochondria and lactate 
dehydrogenase in cytoplasm. Electron microscopy showed crystalline 
inclusions in many subsarcolemmal mitochondria.
5 , Metabolites were studied during and after exercise on an
ergometer and revealed remarkable differences from normal. Blood 
lactate rose to 12*5 d mol/ml and pyruvate to 0,59 d mol/ml compared 
with up to 4cO and 0*16 p, rnol/ml respectively in controls* Concen­
trations of ketone-bodies an.d free fatty acids fell during and after 
exercise whilst they rose in the controls.
4» These observations imply a major mitochondrial defect which
causes dramatic biochemical changes in fuel supply in blood duiring 
exercise. The changes suggest that fat metabolism was accelerated in 
this patient and was related to a block of carbohydrate utilization as 
fuel e
CHAPTER 7
A COMPARISON OF TREA.TI-IEN‘T OF OBESITY WITH FEMFIH.RAMINE AND WITH
DIETARY RESTRICTION
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INTRODUCTION
The first part of this thesis has provided evidence that 
obesity causes marked changes in the patterns of carbohydrate and fat 
metabolism during exercise. Compared to head thy subjects, fat people 
show higher concentrations of blood glucose and glycerol during exercise 
and blood ketone bodies during and after exercise (original observations 
together with discussion are given in chapter 2), As there are 
differences in blood concentrations of metabolites the pattern of 
utilization of fuel by working muscle is probably altered as a resulr of 
obesity* In obesity there seems to be a block to muscle glucose uptake 
which is related to the degree of fatness (Butterfield £t ply y I965),
In this situatlcn if muscle is not used for glucose disposal, the glucose 
must presumably be stored as fat in adipose tissue for use when required 
by muscleo When dietary measures alone fail to correct the metabolism in 
obesity, drugs such as amphetamines have been used, but their value is 
short lived and amphetamines have the side effect of stimulating the 
nervous system. Recently fenfluramine, a derivative of amphetamine but 
said to have fewer side effects was introduced as an appetite depressant 
in the treatment of obesity (Munro _et , I966), SeveraJ. investigations 
have suggested, however, that part of its action is related t ) a direct 
effect on carbohydrate and fat metabolism. The drug improves glucose 
tolerance, possibly because it increases glucose uptake by muscle (Butter­
field and Whichelow, I968), There is also evidence for a direct effect 
on adipose tissue. Fenfluramine has a lipolytic activity and may depress 
lipid synthesis in '^ ';itrp (Dannenburg and Kardian, 19675 Wilson and 
Galton, 1971)0 During therapy with the drug there are increases in
15
concentrations of FFA, glycerol and total ketone-bodies (Pawan, 1969)0 
Whether these effects of fenflnramine are direct or secondary to dietary 
restriction has been unclear. The present study was undertaken to 
examine further the effect of fenfluramine on fat and carbohydrate 
metabolism in man and to compare the results with the effect of dietary 
restriction, which has been shown in chapter 5 to also cause marked 
increase in fat metabolites in blood*
METHODS
Subjects
Ac Treated with fenfluramine ; (Table 7* 1A) Six
volunteer subjects who were overweight (5 male, 1 female, aged 24-47 yr) 
were studied for five weeks while taking fenfluramine. They took an 
unrestricted diet and carried out their usual activities. The dose of 
fenfluramine was 40 nig in the first week, 60 mg for the second and third 
weeks and 80 mg for the last two weeks*
B* Treated with partial or complete starvationî (Table 7« IB) 
Four subjects (2 male, 2 female, aged 22-60 yr) undergoing dietary 
restriction therapy for obesity were also studied. Two of the patients 
received a diet of 6OO calories for 12 days and two received water only 
with added vitamins, for five weeks*
C* Treated with fenfluramine and reduced diet: (Table 7® IC)
Ti'fo subjects who were overweight were studied. One of these (C* McHd 
was given a 6OO calorie diet for 24 days. In the second half of the 
period he also received fenfluramine (100 mg daily). The second subject
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(SoTc) was also given 600 calories for 24 days but received fenfluramine 
(lOO rag) daily for the first 12 days.
Procedure :
Body weight was measured at intervals for five weeks.
Venous blood was taken between 09*00 and 09*30 lir after an overnight fast, 
at the beginning and at four day intervals throughout the investigation 
period. Blood samples were treated as described in appendix I and 
analysed for glucose, lactate, pyruvate, acetoacetate, y-hydroxybutyrate, 
glycerol and free fatty acids.
RESULTS
All subjects were overweight, but the group who underwent
dietary restriction were somewhat shorter and heavier than those
receiving fenfluramine, as judged from their reciprocal pondéral indices
(ht/i/'f) or their % wt above their ideal wt (Metropolitan Life Insur*ance 
V wr
Co* figures quoted in Giegy, 1962)*
Subjects treated with fenfluramine compared with those treated with 
dietary restriction
With both treatments weight loss occurred. Those undergoing 
dietary restriction lost more (4*3 - 20*0 kg) than those receiving 
fenfluramine (2*0 - 7*7 kg : table 7*l)° Luring the five weeks of 
investigation the concentrations of plasma FFA (Fig 1,1) increased 
considerably. The concentrations were much higher in those undergoing 
dietary restriction (p <0*01). The changes in blood glycerol concen­
trations (Fig 7ol) were similar to the changes in plasma FFA*
Pig (7.1): Plasma FPA ( | j l equiv/ml, mean « SIM), blood glycerol and
total ketone-bodies ( ji mol/ml, mean - SEM) , during 
fenfluramine therapy (6 obese subjects, Ê ) and dietary 
restriction (4 obese subjects, © ), as only-two subjects 
, underwent dietary restriction for more than 12 days their 
individual results are shown.
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Fig (7.2): 5“hydxoxybutyx’ate/acetoacetate ratios (mean ™ SEM) in
the six obese subjects treated with fenfluramine ( B ) 
and four obese subjects treated with dietary restriction 
( O ). (see legend of Pig 7*1 for further details).
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The concentrations of ketone-bodies (acetoacetate + $- 
iiyd3:oxybutyratej Fig 7*^0 became greatly elevated in the subjects under­
going dieta,ry restriction whereas there were much smaller increases in 
those receiving fenfluramine » The initial ratios of 5“*hydroxybutyx*ate/ 
ücetüacetaLe were not significan11y different between the two groups 
(p > 0e05)» There was, however, a marked difference in the subsequent 
changes; the ratio increased in those subjects wbo underwent dietary 
restriction, whereas the ratio decreased in those receiving fenfluramine 
(Fig 7*2). Glucose concentrations fell in the subjects undergoing total 
starvation. During the first week, however, when the ketone-body 
difference became apparentp there was no statistical difference in glucose, 
lactate or pyruvate concentrations between the two groups.
Subjects treated with fenfluramine and reduced diet
The observations in two patients treated with a combination 
of dietary restriction together with fenfluramine were in accord with the 
findings in the groups treated by either dietary restriction or fen­
fluramine alone. In the patient who had a 600 calorie diet and then took 
fenfluramine, the ratio of ^^hydroxybutyrate/aoetoaoetate concentrations 
initially increased and was depressed during the period he took the drug 
(Fig 7*5, b). In the other patient who was also treated with a 600 calorie 
diet but took fenfluramine for the first 12 days, the ratio was initially 
depressed but rose above resting values when fenfluramine therapy v/as 
stopped and the dietary restriction was continued alone (Fig 7«3 y A). The
glucose concentrations did not appear to be affected by fenfluramine*
Ho consistent changes occurred in lactate or pyruvate concentrations in 
either patient*
Fig (7.5):
top, 5-bydroxybutyrate/8.cetoacetate ratios‘(a ) in one patient
(S*T.) who underwent restricted diet for 24 days with 
fenfluramine therapy in the first 12 days ( # ), (b ) and 
in six subjects with fenfluramine (from Fig 7.2; E# ), 
bottom, 5“bydroxybutyrate/acetoacetate ratios (c) in four subjects
treated with dietary restriction (from Fig 7.2; ® ) and 
(b) in one patient (c.McH) who underwent restricted diet 
for 24 days with fenfluramine therapy in the second half 
of the period ( X ).
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DISCUSSION
Several trials have indicated that fenflurainine is of value 
in the treatment of obesity (Hnnro at al«, I966). The introduction to 
this thesis explained that this v;ork began because of curiosity about the 
action of fenflur'amine for5 although widely used, the rationale remained 
unlmownc The studies reported in this chapter were designed to 
investigate whether the metabolic effects of the drug axe related to 
reduction of food intake or whether there is a direct effect oC fen­
fluramine on pathways of fat metabolism.
In starvation there is an increase in the concentration of 
plasma FFA;. probably due to increased lipolysis. During fenfluramine 
therapy in our invcstiga/bion there was a rise in the plasma concentra b.ion 
of PDA by 60% (Dig Hi). The increase may have been due to a decrease 
in the rate of re-esterification of fat as fenfluramine inhibits the 
metabolism of glucose to u-glycerophosphate in adipose tissue and decreases 
fat synthesis, perhaps by interference with the acylation of glycerol™^- 
phosphate at the acyl transfer reaction (Dannenburg and Kardian, 19-7 5 
Wilson and G-alton. 1971). The higher concentrations of ketone-bodies 
in the subjects undergoing dietary restriction compared with those taking 
fenfluramine reflects the differences in their plasma FFA concentrations.
Despite the raised concentrations of total ketone-bodies in 
the blood in all the subjects during the investigation, the ratio of
If
5™hydroxybutyrate/acetoacetate decreased in these talcing fenfluramine 
whereas the ratio increased in the starved subjects. An increase in the 
ratio is the usual change with dietary restriction, and occurs because of
79
a fall in a ratio of oxidised and reduced nicotinamide-adenine 
dinnclootide (NAD/ITADII) , since oxidation of fatty acids results in the 
production of KADH. MADE increases the catalytic conversion of 
acetoacetate to 3-Eydroxyhutyrate (Williamson et a]_,, I967). The 
depression of bhe ratio by fcniiuramine is therefore unlikely to be 
related to a fall in NAb/ldADH as in both groups fatty acid oxidation was 
occurring as adduced from the elevated ketone-body values» This would 
change the ratios in the opposite direction to that observed, A decrease 
in the ratio of ^^hydroxybutyrate/acetoacetate would occur if the 
peripheral utilisation of acetoacetate was decreased. However, this 
explanation is also unlikely as the rise in ketono^bodies was very small 
with fenfluramine and the effect on the ratio was also produced by giving 
fenflur'amine during starvation when the rise in ketone^bodies was much 
greater. Another explanation for the change' in the ratio is that the 
drug causes decreased activity of the enzyme ^-hydroxybutyrate dehydrogenase 
in the liver. This may result from reduced synthesis of lecithin, an 
obligatory co-factor for the enzyme (Gotterer, I967). Lecithin synthesis 
depends on an adequate supply of ct-glycerophosphate, the production of 
which is affected by fenfluramine (Wilson and Galton, 1971)c
It is possible that the increases in FFA and total ketone-- 
bodies observed in the group treated with fenfluramine were due to an 
effect of partial starvation, because of a reduction in appetite due to 
the drug. However, the differences observed in the $-hydroxybutyrate/ 
acetoacetate ratio in this group compared with the patients undergoing 
dietary restriction indicate that fenfluramine is an aclive compound 
affecting metabolic pathways of fat metabolism. The relationship of
80
these changes to the causation of fa.t mobilization with fenflm'ainine still 
remained to he explored and observations upon the relationship of growth 
hormone to these changes are reported in the next three chapters.
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SÜ1#IARY
1» Five subjects tsücing fenfluramine daily (4O-8O mg) for five
weeks and four subjects undergoing dietary restriction for the 
same period without drug therapy, were investigated. Venous 
blood sam%)les were talcen for estimation of FFA, glycerol, 
ketone-bodies, lactate, pyruvate and glucose,
2. In both groups the level of FFA, glycerol and ketone-bodies
rose, but to a much greater extent in the group undergoing 
dietary restriction. The ratio of ^-hydroxybutyrato/acetoacetate 
increased in this group while in those receiving fenfluramine the 
ratio decreased.
5o The differences in ketone-body level and ratios between the tv/o
groups may be related to an effect of fenfluramine upon enzymes 
involved in ketone-body metabolism. These observations imply a 
fundamental difference between the metabolic effect of fen­
fluramine and that of dietary restriction.
CÏÏAPTTE 8
ORAL GLUCOSE TOIÆEANGE TESTS DURING TRL'ATESNT WITH PEîïï'LURAMINE 
COMPARED WITH DIETARY RESTRICTION IN THE SAME SUBJECTS
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INTRODUCTION
In the previous chapter it was shown thar fenfluramine given 
with a low calorie diet causes increased concentrations of 'FJi'A and 
ketone-hodies in the blood. It has also been shovai that weight 
reduction by diet or drugs such as fenfluramine is associated with an 
increased peripheral uptcdce of glucose (buttcrficsld _et al,, 1971).
These changes during fenfluramine therapy raised the problem of whether 
these effects are the results of vjeight reduction caused by the lower 
dietary intake or by the direct effect of the drug on fa,t and carbohydm/be 
metabolism. To investigate the effect of fenfluramine on carbohydrate 
metabolism a glucose tolerance test was carried out on three occasions.
The first was before therapy. The second was after two weeks of dlebary 
restriction, and the third was after two weeks on both dietary restriction 
and fenflur'amine treatment. The investigation wa.s carried out in a 
continuous four weeks period.
METHODS
Sub.iects £ Five patients with obesity were investigated in this study 
(tabic 8ol). All the subjects were studied for four weeks, with the 
exception of W.R, and H.Ce who completed the control investigation only.
Proceduret The subjects were admitted to hospital! for the whole 
investigation. Initially they were brought to the laboratory ard an oral 
glucose tolerance test (50 g) was performed. The subjects were then 
given a low calorie diet (6OO calories) for four weeks. Fenfluramine in
Table 8.1s Individual data on age, height, weight and reciprocal
pondéral index.
Sex Age
yr
Height
ora
Weight
kg
Reciprocal
pondéral
index
Weight loss 
Kg
Diet alone Fenflura­
mine Diet
8.Th. M 56 170 96<0 37.03 2.5 2.8
C.Moh, M 51 180 92.5 59.82 2.7 2 .5
J.D. F 54 165 78.8 59.00 2.0 2.2
W.R. M 51 168 80.6 59.65 ■ - -
H.G. F 26 I65 79.8 58.57 - —
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a dally dose of 100 mg was added to the diet in the last two weeks of 
this dietary regimen » Glucose tolerance tests were repeated before 
and after fenflur-amine therapy under conditions similar to those of the 
first test. All glucose tolerance tests were performed in the morning 
after overnight fa,st with subjects resting in bed. Several ve^'ous 
blood samples were taken; in the fasting state and then at- g ho;- intervals 
for 2^ hr after an oral load of glucose. The samples were -breaded as 
described in appendices 1 and 2 and ai'ialysed for glucose, HGH and IRI,
RESULTS
Glu^cqse (Fig 8ol)s Fasting morning blood gl.icose concentrations 
were lower with fenfluramine and with diet alone than in the control 
investigation. Fenfluramine caused a marked increase of glucose 
tolerance so that the absolute -values of blood glucose concentrations at 
any time throughout the test were lower than in the control study. Diet 
alone however, caused a decrease of glucose tolerance and the concentrations 
of blood glucose were considerably higher at 60, $0, 120 and I30 min during 
the tost -chan in the control study0
Plasma. IRI (Fig 8 ol)s Fasting plasma insulin concentrations during 
fenfluramine therapy were similar to those with reduced diet alone, and 
on both occasions the values were lower than on the control occasion.
The rise in the levels of plasma IRI during the test paralleled the 
glucose concentrations, thus the levels of plasma IRI were lower through­
out the test with fenfluramine. On the control occasion and with 
fenflur'amine the marimum rise in plasma IRI occurred 60 min after glucose
Fig (8.1): The changes in the obese subjects of blood glucose (mg%),
plasma IRI and HGH (p. units/ml) after ingestion of a 
solution of glucose (50 g) at the time indicated. Control 
study (5 subjects: X); reduced diet with fenfluramine
(3 subjects; @ ); reduced diet alone (5 subjects: O).
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ingestionj whereas with diet alone the maximum occurred at ^0 rain.
Plasma HG-H (.Pig 0,1) s Fasting morning plasma HGH concentrations were 
lower with f enf lur-amine than in the control study, With diet alone; 
however* the fasting levels were higher than in the control study. In 
both the control investigation an.d with diet alone ; glu.cose cs.used a, 
depression in the concentrations of HGH at ^0 min and 60 rain later, but 
with fenfluramine, glucose caused little change. On all three occasions 
the concentrations rose after the depression. The values at I50 min 
after glucose load were higher with fenfluramine than in the control studyj 
but they were lower than with dietary restriction alone,
DISCUSSION
The present observations are in good agreement with the 
recognised impairment of carbohydrate metabolism in obesity (Uort%, 1969)» 
and showed an improvement by fenfluramine therapy. The altered carbo­
hydrate metabolism obser\red in obesity and discussed in chapter 2 has 
been attributed to a metabolic block in peripheral uptake and oxidation 
of glucose by muscles (Butterfield et al,, I969I. Skeletal muscle has 
also been found to be the primary site of insulin resistance in obesity 
(Rabinowitz and Zieler, I962), The consequent hyper-insulinaemia found 
in obesity would facilitate fat synthesis and its deposition in adipose 
tissue. In this study, there is a difference in glucose tolerance 
between the therapy with fenfluramine and diet alone, although the loss 
of weight was similar on both occasions. With fenfluramine, there was 
an increase in glucose tolerance, whereas v/ith diet; alone the tolerance
89
was decreased at 90, 120 and I90 rain. Similar changes have been foimd 
v;ith fenfluramine by Asmal and co-workers (1971)» in their study of the 
effect of weight reduction on carbohydrate metabolism. They suggested 
that weight reduction by both fenflurajnine and diet improve the peripheral 
uptake of glucose. The present observation on diet alone, ]iowever, 
shows a decrease in glucose tolerance, which may indicate that weight 
reduction by 1enflur-amine is unlikely to be the main cause of the 
improvement of glucose tolerance. ihrthermore, the small degree of rneajT 
weight loss (2<,6%) does not parallel the marked increase in glucose 
tolerance with fenfluramine. Therefore fenfluramine may produce direct 
metabolic changes and hence cause an increased glucose tolerance,
Sev63:al processes could have been affected by fenfluramine and so alter 
the tissue response. These could have included a, greater rise of plasma 
insui.in in response to the glucose load and increased sensitivity of 
glucose transport mechanism to insulin, A fur-ther possibility is that 
the capacity of the cells to fix insulin may be altered.
In this study however, the rise of plasma insvJJ.n in response 
to glucose was reduced by fenfluramine, whereas with diet alone, the rise 
was delayed even though the response was similar in the early part of the 
test on both occasions. These findings suggest that fenfluramine 
improves glucose tolerance by increasing the sensitivity of the peripheral 
muscles to insulin. It is also possible that decreased glucose tolerance 
with dietary restriction could be caused by the rise in the concentrations 
of PPA and I-LGH which are known to result in a decrease of insulin 
sensitivity (stein ej; , 1962; Garland and Randle, I964). With 
fenflur'amine the fasting concentrations of plasma IT'A were lower than on 
diet alone perhaps due to the drug inhibitory effect on lipolysis which
86
has been experimentally stimulated by nor-adrenadino and growth hormone 
(Banricnburg and Kardian, 1969)= The finding reported in this chapter 
of increased sensitivity of tissues to insuJ-in dm:ing fenfluxciinine
0-
therapy raises the possibility that the drug might be active bypoglyC|^mic 
agenii in diabetes mellitus. The action of fenfluramine in diabetes was 
therefore studied and the results are reported in tlie next chapter.
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S U i ' i M A R Y
1... Five patients with obesity undergoing dietary restriction
with and without fenfluramine were studied. The subjects were 
given a reduced diet of 600 calories for four weeks. Fenfluramine 
in 8, daily dose of 100 mg was then added to diet therapy in the 
last two weeks of the study. Glucose tolerance tests were 
performed before starting the therapy and after each two weeks- ioC, 
before and after fenfluramine. 'Venous blood samples were taken 
for the estimation of blood glucose, plasma IRI and HGH,
2. Fenfluramine increased glucose tolerance and reduced the
insulin response during an oral glucose tolerance test. Reduced 
diet alone however, caused a reduction in glucose tolerance and a 
delay in the rise of insulin response to the glucose load.
3» The hypoglycemic effect of fenfluramine therefore appesrs uo
be due, at least in part to a direct effect of the d.ru.g increasing 
the tissue sensitivity to insulin.
GlIAPTER 9
SlN<&'l-E* ADMINISTRATION OF FENFLURAMINE IN NORMAL 
SUBJECTS AND IN PATIENTS VdTH DIABETES MELLITUS
8 8
INTRODUCTION
Til the previous chapters it was shown that fenfluramine given 
with a low calorie diet causes concentrations of plasma FFA and blood 
ketone-bodies to rise. Increased glucose tolerance and reduced 
insulin response to glucose load were also observed with fenfluramine 
and low calorie diet. They imply that the metabolic changes with 
fenfluramine include a direct effect which is not necessarily secondary 
to dietary restriction. These changes might have been due to the drug's 
action on pathways in peripheral tissue regulating glucose transport 
and insulin metabolism. Since most of the metabolic processes which 
are knov;n to be altered by fenfluramine are influenced by hormones, it 
is also possible that the beneficial effects of this drug are mediated 
through alteration of endocrine activity and studies of the effect of 
the drug on growth hormone release are given in the next chapter. It 
is the purpose of the present study to examine fat and carbohydrate 
metabolism in relation to plasma HGH and IRI after acute administration 
of fenfluramine in normal subjects and the results showed that fenfluramine 
causes a slight fall in the concentration of plasma HGH. Abnormalities 
of fat and carbohydrate metabolism associated with high levels of HGH 
have been reported in diabetes mellitus (Randle _et a_l, , I963). The 
plasma HGH level fluctuates in this disorder, but is frequently very 
high for long periods of time (Lundbaek, 1971)« The hyper-secretion 
of HGH may lead to the development of angiopathy in some cases of 
diabetes which maiy lead to severe retinal changes. Attempts to suppress 
growth hormone release in these patients has been made by pituitary 
extirpation (hypophysectomy) as the use of various pharmacological 
agents have failed to give satisfactory resul.ts (Hansen, 1971)-
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An opportunity to examine further the effect of fenflurainine 
on HGH release in relation to fat and carbohydrate metabolism is 
provided by the study of patients with diabetes. 1 have tlioi-efore 
studied a group of patients with diabetes. They were given fenfluraminf^ 
intravenously at rest to dotermine the way in which their metabolic 
responses to the drug differ from those of normal subjects. The 
changes in the patterns of blood metabolites which resulted are discussed 
in relation to the drug actions on HGH and IRI release.
METHODS
Effect of acnte injection of fenfluramine in normal subjects; Seven 
healthy volunteers (5 male and 2 female, aged 24™54 with mean lit vf 
164 cm and mean wt of 7^,2 Kg were studied. They were not receiving 
any drugs at the time of the investigation and were eating a normal diet. 
The subjects were brought to the laboratory between 09,00 - 10,00 hr 
after overnight fast, A catheter was placed in an antecubital vein and 
intravenous fenfluramine (20 mg) was administered. Blood samples were 
taken before the injection and 5» 10, 20, 30, 45» 60, 90 and 120 min later.
Effect of acute injection of fenfluramine on patients with diabetes 
mellitus: Five female patients with diabetes (aged 43~60 yr) with
mean ht of I58 cm and mean wt of 83 Kg were studied in the same manner as 
described above. Their mean blood glucose concentrations after overnight 
fasting was I60 mg/lOO ml (- 12 mg SUM) and they were studied while 
investigated for diabetes when no therapy had been started. The blood 
samples were treated as described in appendices I and II, and were 
analysed for metabolites and hormones.
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RESULTS
llffect of acute injection of fenl/’Iuramine in normal sub je ots
Blood glucose and plasma IRI (Fig» 9=l)« The initial concentrations
of both bio on glucose and plasma IRI were wiliiin the rionu-il ra.nge run 
remained unchanged by fenfluramine throughout the period of invesbi(.Ration.
Plasma FFA and blood g;lycerol (Fig, 9<>2); Before the injection of 
fenfluramine the concentrations of plasma FFA and blood glycerol were 
0*96 h equiv/ml (-■ 0,04 h equiv Sld'i) and 0,048 p mol/ml (- 0„006 \i mol 
SEf^l) respectively. After fenfluramine there was a rise .in the concen­
tra uion of FFA v/hich was first observed 60 min after the injection of 
the drug. The rnaxinumi rise occurred at the end of the investigation.
FFA values at 60, 9^ e.nd 120 rain were significantly different from rest 
(p < 0 *09; 0*01 and 0*01), blood glycerol concentrations, however, were 
not significantly altered by fenfluramine, although they fell slightly 
in the early part of the investigation. Increased ratios of FFA/glycerol 
were observed at 60, 90 and 120 rain after fenflux’amine injection*
Total ketone-bodies (Fig* 9<-3)‘ Fenfluramine caused a rise in the 
concentrations of total ketone-bodies which was first observed 60 min 
after the injection. The maximum at the end of the investigation was 
significantly different from those before the injection (p 0*01). The 
ratio of J-bydroxybutyrate/acetoacetate was decreased from 2.06 (- 0 ,15) 
to 0*56 (t 0 *06) 5 min after the injection. Decreased ratios were 
maintained for a fuirther 25 rain, after which a progressive rise towards 
the initial values was observed. The value at the end of the 
investigation was slightly lower but not si.ynificantly different from 
that before the injection.
Fig (9.1): Blood glucose (mg%) and plasma IRI (pU/ml; mean - SEM)
in seven healthy subjects after administration of 
fenfluramine (20 mg i,v.).
Fig (9.2); Blood glycerol (|i mol/ml), plasma FFA (p equiv/ml) and
FFA/Glycerol ratio; mean - SBH in seven healthy subjects 
after administration of fenflur'amine (20 mg i.v.).
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Plafïüia HGH (Fig 9«4)ô The initial concentration of plasma HGH v;as 
2 |iU/inl (“• 0*5 |ih FeniliiraminG caused an immédiate fall in
the concentration to a minimum at ^0 min. ïïGH concentration retuimed 
to pre-injection value at 60 min and then rose.
of acute inje_c'bion oJ‘ fenriuramino on patients_ “ril
Blood glucose (Fig 9*5): Before the injection of fenfluramine the
concentration of blood glucose was 160 mg lb (- 12 mg .S£3'4)<= After 
fenfluramine there was a, fall in the concentration of glucose whrâh was 
first observed. 5 min after the administration of the drug. The minimum 
values at 49 min were significantly different fro.j those before the 
injection of fenfluramine (p < 0,01), The concentrations then rose 
to aohJ.eve pre-injection values ^0 rain later. Plasma IRf concentrations 
however were not significantly altered by fenfluramine,
Plasma FFA and HGH (Fig 9o9): The initial concentration of FFA was
1.05 [.I equiv/inl (•*'■* 0*02 j, equiv Sil'i). Fenfluramine caused a rise in 
the concentrations of FFA which was first observed 45 min after the 
injection. The maximum rise occurred at 90 min. The values at 45) 60 
and 90 min were sifpiifleantJ.y higher than those before the injection 
(P G 0*05)0 Plasma HGH concentrations before ti^ e injection of 
fenfluramine were 7 = 0 |jl U/inl (- 2*9 d P obPi). The drug caused the 
concentrations of plasma HGH to fall immediately after the injection to 
reach a minimum at 30 min. The values at 20 and 90 rain were significantly 
lower than the initial value (P G 0*01). HGH concentration then returned 
to pre-injection value within 60 rain after the injection of fenfluramine.
Fig (9*5)ï Blood glucose (mg%), plasma FPA (p equiv/ml) and HGH 
(|iU/ml; mean - SEM) in five diabetic patients after 
administration of fenfluramine (20 mg i.v.).
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DISCUSSION
In this study of the effects of intravenous adrainistration 
of fenflurajnine to noxTnal subjects, the drug caused a deloyod rise in 
both j.’t'i;. and ketone-body concentrations. FFA release uourd occur if 
fenfluramine stimulates fat mobilization from adipose tissue, but this 
is unlikely since the rise of FFA was not accompanied by a parallell rise 
in blood glycerol. Another explanation for the rise in the concentration 
of FFA is a decreased rate of lat rc— esterificarion in adipose tissue.
This may result from reduced synthesis of ^-glycerophosphate from 
glucose, the oxidation of which is reduced by fenfluramj.no in adipose 
tissue (.Dannenburg and Ifardian, 1969)0 Furrthcxmore fenfluramine has 
been snovm to interfere with the acylation reaction and leads to the 
accumulation of long chain acyl GoA in liver hernogenates (Wilson and 
Galton, 1971)' Such a suggestion is consistent with the findings 
reported in chapter 7* The rise in the values of ketone-bodies 
concentrations is probably secondary to the rise in the concentration 
of FFA and their subsequent oxidation in the liver. Increased rate 
of ketone-body production is always accompanied by elevation of the 
ratio of ^'"bydroxybutyrate/acetoacetate, probably as a result of 
decreased ratio of FAD/FADE at the site of 9-hydroxybuty:cate dehydrogenase 
within the mitochondria, as in starvation. With fenfluxamine however, 
the ratio was depressed, mostly within 5 min of the injection of 
fenfluramino, and a low value was maintained to the end of the 
investigation. This also is compatible with the previous finding 
reported .in chapter 7 in which it was suggested that fenfluramine affects 
enzyiics regulating ketone-body motahoilnm. The most striking finding 
was the effect of fenfluramine on HGH concentrations in the ulasraa.
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Although the initial concentrations of HGH were low, they fell slightly 
in the first five minutes aTter the injection of fenfluramine^ This 
may he due to a central depressive action on centres in the hypothalamus 
regulating the release of KGtl, as fenfluramine is known to have an 
effect on contres in the hypothalamus regulating appetite (poxwell el fjl =? 
1968). It was surprising that the drug had no effect on fasting blood 
glucose and plasma XRI concentrations in normal subjects, but when it 
was given to patients with diabetes iiiellitus a marked fall in the 
concentration of blood glucose was observed. This fall disappeared as 
soon as there was a rise in plasma FFA concentration. Subsequent to 
carrying out this investigation the observations of Turtle and Burgess 
(1973) have been reported and the resales are ct-rsistent, Blood 
glucose depression may have been due to the drug's action upon peripheral 
uptake of glucose (Butterfield and Whichelow, i960). The action was, 
however, of short duration and another explanation could bo dependent 
on FFA concentrations as FFA are known to interfere with glucose 
metabolism (Garland and handle, I964). In the patients with diabetes 
mellitus fenfluramine also caused a marked fall in plasma HGH concentration 
similar to the changes observed in normal subjects. This is consistent 
with the suggestion that fenfluramine may interfere with pathways in 
the hypothalamus regulating the release of HGH. The possibre 
importance of HGH in diabetes mellitus has already been discussed in 
the introduction to this chapter. It was explained that the high 
concentrations of HGH found in diabetes may be causative in the develop­
ment of blood vessel pathology.
The findings reported in this chapter of both glueose^row Lb 
hormone suppression by fenf l.uramine suggest that the drug may be of
94
value in clinical management of diabetes mellitus.
A basic problem in the observations upon HGH reported in this
chapter is that at rest plasma HGH concentrations are low Jn norma:! 
subjects (2™6 plJ/ral). In diabetes mellitus concentrations are
variable although higher values are observed (6-10 pU/ml). The action
of fenflui'amine on HGH release was therefore studied during exercise in 
normal subjects, as release of HGH usually occurs during exercise.
These observations together with studies on the art ion of fenflura.mj.ne 
on HGH release in acromegaly are reported in the next chapter.
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SlJI'liARY
N O . SUBJECTS
1* The effects of acute administration of fenflurajmine were studied
at rest in seven healthy volunteers, Feniluraudne (20 mg) 
was given intravenously to all the subjects after an overnight 
fast.
2. Fenf luraioine caused a fall In tjie concen tra tions of td a a ma KGK
iiru'nediately after the injection and for 30 min afterwards.
The drug also affected plasma FFA and blood ketone-bodies 
concentrations.
DIABETES mCLLITUS
3» The effect of fenfluramine was observed in five patients with
diabetes mellitus, A fall in the concentration of IIGH was 
also seen in the diabetics. Their blood glucose concentrations 
were lowered by fenfluramine, but retui-ned to pre-injection 
values soon after the release of FFA.
4 . These observations suggest that fenfluramine has in addition to
a peripheral action on fat and carbohydrate metabolism, a central
action affecting the release of HGH. These effects were more 
marked in the diabetics suggesting that the drug should be 
evaluated in the medical management of diabetes mellitus.
CHAPTER 10
EXERCISE AFTER ACUTE ADMIHI STRATI OH OP FIIjFLU RAI4IHE
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INTRODUCTION
V/hon the acute effect of fenfluramine was studied in norjiial 
individuals ana in patients with diabetes, changes in tne concentrations 
of HGH were observed. Although the initial concentrations of ]iGH were 
low, feefluramine caused a depression in the levels of plasma hG}i when 
subjects were a.t rest (chapter 9) « This effect of fenflucaiuine might 
have been due to a depressant action on centres in the central nervous 
system regulating appetite and food intake (Foxwell _e^t al., 1963). 
Experimental observations on animals have indicated the hypo Llialcujics as 
a possible site for the action of the drug (Anand, 19711 Anand and 
Blundells 1971)= The hypothalamus influences the secretion of hormones 
of the anterior pituitary, including growth hormone, via intermediary 
neurohormones (McCann, 1970)= It is therefore possible than alteration 
of release of growth hormone may occur with drugs affecting the hypothalamus 
The resting levels of HGH: are however very low in normal individuals 
(2-6 pU/rnl) and I therefore decided to observe the action of the drug in 
conditions in which HGH concentrations are raised, and chose exercise and 
acromegaly. Exercise is a situation known to stinmlate the release of 
HGH (Hunter and Greenwood, 1964% Hunter et, al* ; 1965), and I have 
studied the effect of fenfluramine on the release of HGH and insulin in 
exercise in normal volunteers.
Hypothalamic dysfunction may result in acromegaly in some 
indiviuuals. In acromegaly the hypersecretion of HGH is not always 
autonomous (Cryer and Daughaday,- 1969; Lawrence ot. cH,, 1970) and the 
level may rise with an appropriate stimulus such as exercise (Johnson 
and Rennie, 1975)= I have therefore studied a group of patients with
07
acromegaly v/hen given fenflurani.ne. One patient v;as also exorcised 
after being given the drug. The present observations in normal subjeclo 
and patients with acromegaly indicate the suppressive action of fen­
fluramine on HGH release.
METHODS
The effect of acute injection of fenfluramine in normal volunteers
Five healthy male volunteers (aged 24-p8 yr) with mean hb of 174 cm 
and mean wt of 78»2 kg, exercised on a bicycle ergorneter on two separate 
occasions. On both occasions the subjects had fasted overnight, and 
exercised for 20 min at 600 kpm, followed by a period of rest of $0 min. 
Blood samples were taken from a catheter in an antecubital vein. Two 
resting saiiiples were talcen, further samples were also tahen at 5 min 
intervals during exercise and then at 15, $0, 60 and 90 min after the 
exercise. On the second occasion fenfluramine (20 mg i.v.) was given 
between the resting samples and exercise was started 5 min later. Heart 
rate wa.s recorded with a continuous electrocardiograph.
The effect of acute injection of fenfluramine o n ,patients with acromegaly
(a) At rest Four patients with acromegaly (t’lree female and one male, 
aged 44-72 yr) with mean ht of l6l cm and mean v/t of 72*3 kg were studied. 
Their mean resting plasma HGH level after overnight fasting was 65<>5 pb/ml 
(- 14*7 pH SEM) and they were studied dur’ing investigation for acromegaly 
when no other therapy was being given. On the day of the investigation, the 
patient had fasted overnight and rested in bed, A catheter was placed in a;
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antecubital vein and icnflur'amine (20 mg i,v.) was administered. Venous 
samples were taken before the injection, and 5? 10, 20, 30? 45? 60 and 
90 min later.
(b) l^ercise One ma'i e patient with acromegaly (aged 21 yr; ht 174 cm; 
wt 76 kg) pras studied on two separate occasions in the same manner as 
described above. His resting plasma HGl level after overnight fasting 
was 76-74 pb/ml and no treatment or replacement therapy had been started.
The blood saiaples were treated as described in appendices 
I and II and analysed for glucose, lactate, py.ruvate, acetoacetate, 
5-hydroxybutyrate, FFA, IRI and HGH.
RESULTS
The effect of acute injection of fenfluramine in_normal volmiteers
Lactate and pyruvate (fig 10,l) Resting blood lactate concentrations
were similar on both occasions. Luring exercise the concentrations rose 
to a maximum at I5 min when there was no significant difference between 
the two occasions. The lactate concentrations returned to resting levels 
60 min after exercise. The changes in pyruvate concentrations were similar
Glucose (fig 10,2) There was no difference in the concentrations of 
blood glucose on the two occasions. Exercise caused a fall in the 
concentrations at 5 min in the control investigation, but with fen­
fluramine bhe fall was more marked after I5 min of exercise when the 
concentration was significantly different from that of the conrrol study  
(F <.0o05). Although the levels during recovery were not staristically
Fig 10:1 Blood lactate and pyruvate levels (p mol/ml, means - SEil) 
in five subjects during and after two periods of 20 rain 
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different at any one time on the control occasionj the concentrations 
were consistently higher and returned to the resting' level ly min after 
exorcise, whereas with fenf].uramine the concentrations remained below 
the resting level throughout the remaining period of investigation^
FFA (fig 10:$) Resting plasma I'FA concentrations were not 
significantly different on the two occasions. Exercise caused similar 
rises in the concentrations of FFA with the maxima at the end of 
exerciseo In the control investigation the concentrations rcturnod to 
resting levels by the end of the investigation, whereas with fenfluramine 
the concentrations of FFA roiaalned higher in Lhc pust-exerciso period 
although they were only significantly different from that of the control 
study at $0 min after exercise (p < ChOl).
Ketone-bodies (fig 10:$) Resting levels of total ketone-bodies 
(acetoacetate plus $-hydroxybutyrate) r’ere not statistically different 
at rest. Exercise caused a small fall in concentrations on the control 
occasion, but with fenfluramine the fall was more marked (P < 0«01).
On both occasions, the levels rose after the initial fall, both in the 
remaining part of exercise and for 1$ min afterwards. The concentration 
was much greater at 1$ min after exercise on the control occasion (10C$1 
of resting) than with fenfluramine (l4/u of resting). In the remaining 
period of the investigations the levels of ketone-bodies slowly returned 
toward the resting value.
Plasma IRI (fig 10:2) Resting concentrations of plasma IRI were not 
statistically different on the two occasions. The concentration fell 
during exercise in the control study, but rose with fenfluramine so that 
the difference in the ccnoontretions between the Iwo studies was
Fig (lOep) Plasma FFA (u equiv/ml) aaid blood ketone bodies (ti mol/mlj 
means t SSM) in five subjects during and after two periods 
of 20 min exercisej
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icani th.roughout exercise (P < 0,0^). In the control investi/;ation 
the level of llfX returned Lo tlie restinr; value Id min after exercise, 
but with fenfluramine the level returned more slowly ana remained above 
the resting value.
Plasma HGH (fig 1 0 At rest nlasma, HGIT were stmi 1 ar on both 
occasions. During exercise there was a rise of 600>'c in the level 
toward the end of exercise on the control investigation. With fen­
fluramine y however, the rise was abolished,
% e  effect of acute injection of fenfj.uramine on patients_wi.th acromcgaly
(a) At rest (fig 10:ha) fenfluramine caused the concentration of 
HGil. to fall 2U'Io and 2iS-'/o 20, JO and 45 min after the injection, 
respectively (P < O.Ol), The concentration returned to the original 
concentration 60 min after the injection,
(b) Ey.ercise (fig lOsJb) On the control occasion exercise caused 
a progressive rise of HGH to a maximum of J2% above the resting level, 
whereas with fenfluramine the maximum was 17% above resting level.
DISCUSSION
Exercise improves the peripheral uptake of glucose and its subsequent 
utilization. Increased glucose utilization also activates ketone-body 
utilization in exercised muscle. Fenfluramine caused a greater fall 
in the concentrations of blood glucose and kot^no-bodies during 
exercise vdncn ?nay be attributed to increased peripheral uptake of 
glucose and its subseqscM I, util izsitioru Increased glucose utilization 
by exercising muscles depends on the concentration of glycogen within
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the muscle. Although I have not stiidiod muscle glycogen content, It 
is unlikely that decreased glycogen concentration in the muscle is 
the couso of the changes with fenfluramine because lactate and pyruvate 
concentrations were not altered, Fenfluuai'iinc, however, caused a rise 
in the concentration of plasma 111 during exorcise instead of the U:,u/.il 
fall. This increase could have contributed to differences in the level 
of blood glucose and ketone-bodies, respite the rise in the level of 
plasma III with fenfluramine the changes in FFA with exercise were 
similar on both occasions. In the investigation wi.th fenfluramine, 
however, the level of FFA remained higher in the post-exercise period. 
This might su^^gcst that fat mobilization is not appreciab.ly affected by 
fenfluramino, althe ugh the drug may reduce the rate of fat re-esterifi- 
cation. This supports the observation that in vitro fenfluramine 
inhibits the metabolism of glucose to u-glycerophosphate in adipose 
tissue and decreases fat synthesis (Wilson and Gallon, 1971)»
The secretion of HGH from the anterior pituitary is 
influenced by the hypothalamus through an intermediary neurohormone 
system which is probably controlled by adrenergic mechanisms (Fuxc and
If
Hokfelt, 1969; Wurtman, 1970; Forhman, 1972)» Some drugs, such as 
L-DOFA (Eddy .et af., 1971? Kansal e^t al *, 1972) and amphetamine (fesser 
et_ af., 1969)9 cause increased nor-adrenalino synthesis or turnover in 
brain and stimulate the release of HGH probably by stimulating hypo­
thalamic activity. The cause of HGH release with exercise may therefore 
result from increased nor~adrenaline in the hypothalamus. Fenfluramine, 
however, depletes cerebral amines and decreases their concentration 
particularly in the hypothalamus (Costa £t a/l., 1971, Ziance et al,, 
1972)5 and it may, therefore, interfere with HGH release by affecting
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the adroriorgic activity of the hypothalamus. This mechanism may also 
explain the lailuro of the fall in glucose concentrations to stimulate 
ÎÏGH production in the investigation with ferflu.rainine, for hypoglycaomia 
also acts via its effect on adroncrgic mechanisms in the lo.airi (flackard 
and Keidings Pelder, 1JGA),
In acromegaly, HGH release may still occur in response to 
some stimuli such as a glucose load and exercise (Cryer and Daughaday, 
19691 Lawrence et al,, 1970), indicating that the hynothalamic-pitultarv 
axis is still active in some patients. In the patients of this study 
fenfluramine caused a depression in Tne concentration of liGH at rest 
and the rise in HGH during exercise in one patient was attenuated by the 
drug. These observations suggest that the drug may be of value in the 
medical management of acromegaly. There are, however, other situations 
particularly childhood and adolescence in which the drug might have 
undesirable effects on growth. Short periods of treatment in patients 
with obesity in these age gx'oups therefore require further study, in view 
of the observations now reported from which I conclude that fenfluramine 
interferes with, pathways in the central nervous system regulating the 
release of HGH.
10:
SUMMARY
1. In order to investigate the effect of fenflirrainine or, hormone! 
ana metaUulic changes with exercise, five nozmal volunteers nave 
been studied during and after 20 minutes of steady exercise on a 
bicycle ergomoter after injection of fenfluramine (20 mg irvr}^
2, Fenfluramine abolished the rise of xjlasma growLh hcitione wnich 
occurred in control investigations, Fenfluramine also affected 
plasma insulin, blood glucose and ketone-body levels.
The acute effect of fenfluramine on the release of growth horiiione 
was examined funther by studying its effect in patients with 
acromegaly. A marked depression of growth hormone occurred 
both at rest and with exercise,
4» These observations indicate that fenfluramine has a direct effect 
upon pathways controlling growth hormone release. It also 
suggests that this action may have practical use in the medical 
treatment of acromegaly 2'
CHÂPTFIi 11
ORAL GLUCOSK LOAD AFTER NICOTINIC ACID
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IIWRODUCTION
In chapter 0 it wa.s shown that oral administration of fen­
fluramine results in a si^poifleant improvement in glucose tolerance 
aft.e'- i/he ■irg'^ stion oj. glucose by patients with obesity. It was
Suggested that a part of i us action may he due to a direct effect on 
factors regulating the peripheral uptake of glucose. Increased rate 
of fat utilisation, is known, to upset the peripheral metabolism of glucose
as in obesity axiC diabetes (Randle et al., 196b). Drus’s that lowfu- lat
mobilization such as nicotinic acid may provide additional infoi-mation 
about the effect of drugs on carbohydrate metabolism.
The administration of nicotinic acid causes depression of blood 
cholesterolj FFA and ketone bodies (Gurian and Adlersbergj 1959;
It ti
Carlson and O.ro, 19o2; Bjorntorp, I965). These changes may be secondary 
to the inhibition of fat mobilization by nicotinic acid.
Factors such as effects of rising blood glucose and insulin
might also influence the concentrations of fat metabolites.
The reports on the effect of nicotinic acid on blood glucose 
are contradictory. Both hyper and hypoglycemia have been reported 
(Mirsky et al,, 1957> Parsons5 1961), although an impairment of carbo­
hydrate tolerance seems to be more generally accepted in diabetes mellitus 
particulorly (Molnar of. y 1964)0 Little is known about the effect of 
nicotinic acid on insulin metabolism. It has been shov.n that the drug 
has an insul .inase inlri.bitory effect in man (Mirsky et_ cd. , 1957)* To 
e}[amine the effects of nicotinic acid on carbohydrate metabolism a. glucose
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tolerance test was carx-ied out and plasma IHI ano HGH were determined 
during the test.
MJtl'dODS
Subjects: Seven subjects, four female (aged pO, jGy 50, 52 ,yr) and
three male (aged 54, 5^s 62 yr) were studied on three morningFu They 
had mean heighi;s of 16'5 cm and mean weights of 65 kg. The subjects 
were volunteersj none of whom wan known to have abnormal fat and 
carbohydrate metabolism.
Pxrnedures s
lo Oontrol glucose tolerance best. A.ftex‘ catheterization, the 
subjects ingested 50 g glucose orally within 2 min. Blood samples were 
taJcen beforehand and at I5 min intervals for the first hour. Further 
blood samples were also taken at 30 min intervals for a further 2 h.
2. Glucose tolerance after nicotinic acid. On second occasion,
a glucose tolerance test was performed as described above except that 
nicotinic acid (20 rag) was given orally 10 min before the glucose load.
Control study with nicotinic acid alone. On the third 
occasion nicotinic acid (20 mg) was given alone and blood samples were 
taken for I5O min in the same manner as on the previous occasions.
RESULTS
Glucose (fig ll«l)î Nicotinic acid given alone had no effect 
on the fasting concentration of blood glucose, but it caused a hccroasc
Fig (ll.l); The changes (mean - SMA) in seven subjects of blood 
glucose (mg%), plasma insulin (pU/ml) and blood 
lactate (p, mol/ml) after a control glucose load
(@ ------- E3 )j glucose load after nicotinic acid
administration ( © -------- © ), and after nicotinic
alone (  )( ).
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of glucose tolerance when it was given before the glucose load. After 
nicotinic a.cid the concentrations of glucose were higher- but si.grJ fic-'intlrv 
different from the control values at only on (p < 0.0$).
Plasma Irl (Fig 11<.1)î Fasting concentrations of III were
similar on the Lhree occas.i ons. nicotinic acid alone axel not alter them,
The glucose load caused a rise in the concentration of H U  to a peak a/b 
45 mtn on both with or without nicotinxc acid, With nicotinic acid the 
concentrations were relatively higher, bub not significantly different 
from that of the control at any point throughout the test. The joncwn- 
trations then returned to resting values by the end of the investigation.
Lactate (I'ig 11.1 ) ; Fasting concentrations of blood 3 acta be
were similar on the three occasions. They rose after glucose load both 
in the control and after nicotinic acid to a maximum at 60 min,, but with 
nicotinic acid alone the concentrations remained unchanged. Luring the 
glucose tolerance test lactate concentrations were relatively higher with 
nicotinic acid compared with those of the control investigation, but 
were significantly different at 45, 60 and 90 min after glucose ingestion
(p < 0 .05).
DISCUSSION
In this study of glucose tolerance after the oral administration 
of nicotinic acid the concentrations of glucose were higher after 
nicotinic acid than control values although significance was only reached 
at 90 min, Thiw intolerance to glucose, although of only a small 
degree, occurred despite similar response of insulin in both studies of
10?
glucose tolerance. The lactate concentrations were significantly 
higher during the test after nicotinic acid. Uptake of glucose by 
muscle in the presence of insulin is impaired in diabetes, acromegaly 
8,nd after dietary restriction (llimsworth, 1959= Butterfield, lOol),
In those disorders hOli concentrations arc increased and p Lasma UFA is 
frequently raised, RFA has been shown to reduce sensitivity to insulin 
by impairing phosphorylation of glucose and diminishing the effect of 
insulin on membrane trailsport of glucose (Xipnis, 1959; Newsholme and 
Ha^ndle, 1961 ; Randle ^  , 1965)» Impaired glucose tolerance ufter
nicotinic acid administration is, however, unlikely to be due to increased 
tissue resistance to insulin via changing RRA and HGH, as nicotinic acid 
and glucose caused a fall in plasma IRA aud HGH rather than a rise,
Impairment of glucose tolerance might also be an effect of 
nicotinamide, a metabolite of nicotinic acid. Nicotinic acid does not 
directly interfere with tissue respiration, but nicotinamide produces 
hyperglycemia (Bergman and Nislicki, 1955). This occurs as a result of 
suppression of tissue respiration, with inhibition of the activity of 
those enzymes which contain nicotinamiue such as NAB and NAUR (Riegelson 
et al., 1951)0
Since nicotinic acid had no effect on fasting concentration of 
blood glucose when it was given alone and since it is known to cause liver 
damage (Parsons, I96I), it is possible that its effect may depend upon a 
delay in glucose uptake by hepatic tissues. In the liver, the rate 
limiting step for glucose uptake is controlled by hexokinase. It is 
possible that nicotinic acid may fa.cilitate glycogen breehdown by 
lowering plasma RRA resulting in increased production of glucosc-d-phocphat;
ICÜ
This would inhibit the activity of hexokinase and thus hepatic uptake of 
glucose. Metabolism of glucose would then proceed and be the explanation 
of the increase in lactate concentration., whether the effect of 
nicotinic acia on glucose tolerance via nicotinainide or secondary to 
the lowered plasnja PFA is ui.iclear. The effect of nrcorrnic acxci on fat 
mobilization and related effects have therefore been studied during 
exercise and the results ere given in the next chapter.
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summaia:
lo To investigate the effect of nicotinic acid on carbohydrate
metabolism, seven healthy suhjecto were stndhvd p.fter oral glucose 
with and without the drug. The suhjects were also studieo when 
nicotinic acid \ra,B administered al.one. Venous blooh samples 
were taken at regular intervals and were analysed for glucose, 
lactate, FPA, Hi I and HGli.
2« The hyperglycemia and lactacmia after the aoministration of
glucose was increased with nicotinic acid. The rise in plasma.
IRI in response to the glucose load was similar with and withcu: 
nicotinic acid. The effects of nicotinic acid on blood glucose 
and lactate concentrations were no b produced when the drug was 
given aloneo
5o These studies suggest that nicotinic acid caused the disposal
of glucose to be reduced and anaerobic glycolysis to be increased, 
even though insulin release was not altered by the drug.
CHAPTER 12
EXERCISE AFTER NICüTINlG ACID
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IhTfOnUGTIOH
The s'Liiu.ies of oral administration of nico cinic acid reported 
in the previous chapter showed a significant increase in blooa lactate 
concentration after glucose .ingestion compared wi lh control studies.
A minor degree of decreased tolerance was also observed, Whether these 
effects of nicotinic acid result from interference v:ith tissue respiration 
or were secondary to the chfuiges in PFA is nob clear. Studies have boon 
conflicting during exercise. Carlson et a,l,, (iRbi), found that during- 
exercise nicotinic acid had no significant effect on the concentration
vt . . .
of blood lactate, Bergstrom and his colleagues (1969), however, fomnl 
a significant increase in blood lactate associated v.dth £i decrease in 
glycogen in working muscle. Since most of the metabolic processes 
during exercise are under the control of endocrine antivi by, 11 is 
possible that the drug may alter the pattern of homonal activity in 
response to exercise. It was the purpose of the present study to exsnine 
the effect of nicotinic acid on the pattern of metabolic and hormona.1 
responses to exercise,
METHODS
Sub.jects s Five healthy male-volunteers (aged 24 - 59 yr ; mean height
174 cm; mean weight ?8 kg).
Procedure ; The subjects exercised on a bicycle ergometer at 600 kpm
for 50 min on two separate occasions after fasting overnight. Blood 
samples were taken from a venous catheter. On the second occasion
nicotinic acid (20 mg) v;as given orally between resting samples and
Ill
exorcise was started. 10 niin later. The techniques for catheterization, 
handling' of blood samples ana. monitoring the Jieart rate are describee in 
appendices I and II.
RESULTS
Nicotinic acid administration caused a generalized flush and 
a feeling of warmth about 10 min after the beginning of exercise. It
gradually disappeared about 50 - 60 min after taking the tablets. One
of the subjects developed a skin rash around the elbows and knees.
Heart rate i The changes in heart rates during exercise and recovery 
were similar on both occasions.
Blood metabolites
Pyruvate (pig 12.l): Resting pyruvate concentrations were not
significantly different. They rose to a maximum at 15 min of exercise
in the control study whereas with nicotinic acid the maximun occurred 
at 20 min of exercise. Pyruvate concentrations were higher with 
nicotinic acid both during exercise and in the recovery period, but 
significance was reached at only 20 min during exercise (p -c 0 .05),
Lactate (Pig 12.1)s At rest blood lactate concentrations were 
similar* and rapid elevation occurred during exercise. The concentration 
was significantly higher after nicotinic acid (p 0 ,05) at 25 min 
during exercise and at I5 min afterwards,
PFA and Glycerol (pig 12.2): At rest the ooncenrrarions of
plasma PFA were signilicantly lowered by nicotinic acid (p 0*05)»
Pig (12.1): Blood pyruvate and lactate levels (p mol/ral; mean - SM)
in five subjects before, during and after two periods
of 50 min exercise.
Control period (o-------- D ); with nicotinic
acid (©--------0).
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Durinf'’ exercise the concentrations rose in the control study to a 
I'naxj-mnjri at the end of exercise, \/iUi nicotinic acid, hov.revcrj thr rise 
was abolished (p < CnOOl)* In the control investigation the concen­
tration re burned to the resting value 60 min alter exorcise 5 whereas 
after nicotinic acid the concentrations rose only alter the end of 
exercise to a maximum 60 min later. The concentration then retiu^ned 
slowly but remained ahove the resting value, The changes in glycerol 
concentrations on the two occasions were similar In pattern to those of 
plasma t'FA.
Ketone-bodies (tig 12.21; Ppstirg levels of total ketone-bodie£
were similar and concentrations at the end of $0 min of exercise ■,.'cre not 
significantly different. After exercise the concentrations increased 
considerably both in the study after ingestion of nicotinic acid and the 
control investigation. The maximum values occurred in the study with 
nicotinic acid and they were obseryed ^0 min after the maximum in the 
control study. The pealc values were significantly different (p < 0,01).
Glucose and plasma IRI (FIG- I2,$): The concentrations of blood
glucose and plasma IRI were not significantly different at any time 
throughout the investigation, although they fell during exercise and rose 
immediately afterwards.
Plasma HGH (Fig 12.4): Resting plasma HGH concentrations were
not significantly different on the two occasions. The concentrations 
rose to a maximum at the end of exercise, where the concentration was 
significantly higher after nicotinic acid administration (p < 0,05)® In 
the control investigation the concentrations returned to resting valuoo bg 
the end of the investigation, whereas with nicotinic acid the concentrations
Fig (l2*3>î Blood glucose (mg^) and plasma IRI (pU/mlj mean - SM) 
in five subjects before, during and after two periods
of 50 min exercise• Control period (0---------0 );
with nicotinic acid ( © -------- ©),—
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of 1>G][ reniained higher in iho post-exerciee period, and were significantly 
di-fforent at I5 min after exercise (p " ChOh),
DISCUSSION
Nicotinic acid reduced the r.i se of I'FA and glycerol v/hich 
normally occur during exex'cisoc Increased fat mol)iliz.ation during 
exercise probably results from increased adrenexyd.c activity (Basu ,
i960 ; Havel et al,5 I965)- Nicotinic acid prevents the increase in 
the concentration of PDA nhioh follows injection of nor-adrencline 
(Carlson and Oro, I962) and this action may account for the failure of 
FFA concentrations to rise during exercise after the administration of 
nicotinic acid.
At the end of exorcise both FFA and glycerol concentrations 
rose dramatically with nicotinic acid to a maximum $0 min after exercise. 
Similar findings at rest have been reported by Pereira (1967) and he 
suggested they might be due to greater activity of the pituitary and 
adrenal glands. The greater response of HGH during exercise in the 
study with nicotinic acid compared with the control occasion is in keeping 
with this suggestion. The mechanism by which nicotinic acid stimulates 
the release of HGH is not clear, but since PFA supply was diminished 
after nicotinic acid, it is possible that HGH release was exaggerates as 
a feedback response (Tshushima et al,, 1970)»
There was probably no difference between production and 
utilization of ketone-bodies on both occasions, as the concentrations 
hardly alter during exercise» Normally in the pos G~exercise period when
Ill
the •D.tj.lization of keuone-^bodies as a fuel is decreased; there is a. 
rise in ketone-body concentrations (Courtice ana burglas, 19)6; Johnson 
et ale. 1969) <• As with F?A, the incnaoase was greater after nicotinic 
acid suggesting that the drug had not blocked Fl'A oxidation in trie liver»
The higher lactate and pyruvote concentration during exercise 
after the administration of nicotinic acid suggests that the drug either 
increased- the rate of glycolysis or decreased the rate of lactate disposal 
The latter possibility seems unlikely, however, since the ratio of 
lacta te/pyruvcvte and the rate of their disappearance was sinh.lar on both 
occasions. In addition, jt-rgstroiri et al*. (1969) have found that after 
the administration of nicotinic acid much glycogen is decreased during 
exercise. It seems more likely, therefore, that the rate of lactate 
production was increased consequent on greater glycogen breakdown, 
Lactaemia may have been exasperated by lactate entering the circulation 
from the liver as a result of sympathetic activation of hepatic glycolysir
In studies reported in the previous chapter glucose tolerance 
was impaired after nicotinic acid administration and lactate production 
was increased. It was suggested that this action of the drug may depend 
upon a delay of hepatic uptake, of glucose and not be due to a defect in 
the peripheral metabolism of glucose.
In the present study the blood glucose concentration did not 
rise with nicotinic acid after )0 min of exercise implying that there was 
an increase in the rate of glucose utilization possibly due to the acute 
reduction of plasma FFA enhancing the utilisation of glucose by active
t)
muscle (Bergstrom et al,, I969; Lassers qt al,, 1972),
.115
SUMMARY
1, To investigate the effects of nicotinic acid on metabolic and 
hormonal changes with exercise, five healthy volunteers have 
been studied during and after ^0 min of moderate exercise on a 
bicycle ergometer after o:cs,l administration of nicotinic acid 
(20 mg)o
2, Nicotinic acid caused a greater rise in i)y.cuvat.e a"d lac' ale 
concentrations during exercise, compared with control investigation^ 
Nicotinic acid also abolished the usual rise of both RFA and 
glycerol concentrations during exercise? but caused a massive 
release of PFA and glycerol in the post exercise period. After 
exercise the rise of ketone bodies concentrations was gi'eater 
after nicotinic acid administration. HGH response to exercise
was also altered by nicotinic acid,
5» These observations indicate that nicotinic acid interferes with
the mobilization of fuel substrate during exercise, thus 
inhibiting fat mobilization and enhancing the rate of glycolysis.
CHAPTM 15
ETm^L ALCOHOL ALTL H'IMAîï GROWTH 
HORl'IOHE RELEASE
;[i6
INTRODUCTION
Studies on the release o.!,‘ growth hojuione in noiivùCi subjects 
and in pa.tients with acromegaly or \vith diabetes mellitns have been 
described in chapter 9 and. 10o Although the nnvurnri.snis involved i-n ■i.v.r.. 
secretion of growth hoi',none from the pituitary gland have not been 
delineated, experimental observations suggest tjiat the hyjjo Ihaltmius 
plays an important role in this process by releasing an intermediary 
nourohormone (Martin, 1975)» It vjas therei.b.«-e, thoughtlrAcly that 
alteration of growth hormone secretion would occur with djugs affecting 
hypothalamic activity* Evidence supporting this was provided by the 
observations that fenfluramine, an appetite depressant agent which is 
known to deplete amines in the hypothalamus (Costa ad., 1971? b-iancp- 
e_t ^ , 1972) reduced the rise of grow th hormone induced by exercise in 
normal subjects a.nd also in patients with acromegaly. It was suggested 
in chapter 10 that fenfluramine has a direct effect on pathways in the 
hypothalamus regulating the release of growth hoi-mone.
Ethanol is also known to interfere with the metabolism of 
cerebral amines (Gursey and Olson, I96O). It is possible that alcohol 
may also afi'ect the release of growth hormone. Although a. rise in plasma 
HG-H and cortisol after alcohol administration has been recognised (Bellet 
et al», 1970; Bellet et al». 1971), no information appears to be 
available about the possible effect of alcohol on plasma growth hoimonc 
concentration during exercise. Studios were therefore designed to 
examine the effect of acutely administered alcohol on growth hormone 
release during subsequenL exercise in no 1mal suojects. Since hypothalamic
i:i7
and pituititry function j s known to bo disturbed in patients wivb chronic 
alcoholism (Merry and. Marks, 1969)5 exercise studies in Ihis situation 
may provide additiona.1 inl'ormation a.bout the role of the bypothai.aiuus in 
regulating the release of growth hormone. The exercise response of six 
subjects with chronic alcoholism was also studied.
These studios were carried out in association with Riu RoJ, 
Chalmers who was interested in the metabolic response to exercise after 
alcohol administration. Assays of growth hormone and insulin during 
these investigations however, were persona]ly made and these results 
constitute the subject of this chapter «
METHODS
Effect of ethyl alcohol on growth hoimone release in 
normal volunteers ;
Subjects ; Six trained male athletes (age 20 - 2J yr, mean ht 
174 om{ mean wt 68 k^ participated in this investigation* The subjects 
were students at Jordanhill College for physical education. hone of them 
had taken alcohol on the day before the investigation and they were taking 
normal unrestricted diet.
Procedure ; The subjects exercised by running round a track in 
the gymnasium on two separate occasions. On both occasions the subjects 
had fasted overnight and exercised for pO inin covering distances from 
4 6 1cm* Blood samples were taken from a catheter placed in an
antecubital vein. Two samples v/ere taken at rest ; further samples were 
taken at 10 min intervals during exercise ai^ d at 9, 20, 50 and 80 min after
exorcise» The exercise was interrupted on the coi.iip.letion of each 
3.0 min oi exorcise period for ijlcod sampling. Cn the sec on a occasion 
tliey (li.-ank Ooo g/kg hocy weight oi ethyl alcohol he tween the resting 
samples and started the exercise 10 min later*
REPDL'i'S
Plasma HG-H (Pig 13*l)s Besting ïïGH concentrations were not siggiificantly 
différent with and without alcohof. They rose to a, maximu,, at 20 min of
exercise in the control stud.y whereas with alcohol the maximuia occurred
at the end of exercise. Plasma HGli concentrations were higher with 
alcohol both during and after exercise but differences were significant 
only at the end of exercise and at 9 min after exercise.
Lactate concentrations were similar at rest on both occasions, 
(control study s 0^75 |JJTnol/ml mean- fjmol Sill ; with alcohol: 0,72
pmol/ral mean - 0,1 liraol 81%), During exercise the concentrations rose 
to a maximum at 10 min when there was no significant difference between 
the two occasions, (Control study: 8,4 gmol/ml mean ~ 1,5 i-unol 8 Eli ;
with alcohol: 8,1 (.imol/ml mean - 0,7 iJxnol SEM), Lan tat e concentrations
fell during both the remaining part of exercise and the recovery period 
in both investigations, but \;ith alcohol, they were still significantly 
above the resting value 80 min after the end of exercise (2,6 pmol/ml 
mean - 0 ,4 limol 8EM; p 0 ,01),
The concentrations of blood pyruvate increased rapidly during 
exercise to achieve maximum at 10 min of exercise on both studies. The
maximum values were significantly lower with alcohol (0,19 ;unol/ml mean 1
Fig (15.1); Plasma HGH (|iTJ/mlj mean ~ BWl) in six healthy suhjecto 
during and after two periods of 30 min exercise. 
control period (tl-------- ü); with alcohol (#------- -
Fig (13,2): Plasma HGH (pU/ml; mean ~ SEM) in five healthy control
subjects (h   m ) and six patients with chronic
alcoholism (©-------- # ) during and after 20 min of
exercise.
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0,09 pjiiol OLri) than tlie con trol invco li^^ation (0»23 |iitio1/ü;1 rjoon - 0*09 
liinol hiill)o ïnc pyrnvo.te concentre Lions alco reTiainea ci/riiricandy 
loner both d n r i the ] enaining pcrioà oi' exercise and. lor >0 min rJ'ccr- 
v;a.rr!R (p . Ü,.Ob) with alcohol coircTi.red with control stndyn
The lactate/Tyyru.Ycite ratio increased o.nring exorcise bn t 
recovered very quickly a.f'ter exercice in the control observations.
Alcohol however led to hipher lactate/pymvate ratios dnriny; exerci se 
which remained elevated.
Blood gJ.ucose changed very little dnri.jiy exercise on the oontrcl 
investigationc With alcohol howcvcry blood gJn.c-ose hod ih.llen by ?5/- 
by the end of exercise and fell a further 2Of., on the post-exercise period.
The changes in plasma IT'A tind lAI concentrations showed no 
differences between the control study and that with alcohol.
■Effect 01 exercise on growth horraone release on 
patients with chronic alcoholism
Subjects : Six male subjv.-;cts (age 40-48 yr ; mean ht 179 cm;
meari wt 68 kg) with chronic alcoholism and five healthy male controls 
(age 26-dO yr; mean ht I76 cm; mean wt 70 kg) were studied. The patient 
were studied. 1 - 2  weeks after they had been admixted to the psychiatric 
unit for treatment of their chronic alcoholism, hone of them had xaken 
alcohol since admission*
Procedxu'e; Patients ana controls attended to the laboratory 
after an overnight fast, The nature and the effects of the investigation 
had been explained to the patients who had all volunteered to participante
120
in it. bubjoots exercised for a period of 20 ; lin on a bicycle crgcjnoic/r 
at a fixed vc;i load of oOO kpm/min. heart /afe was recordec during 
exercise end for further lb min a.f ter-- ards us in,; a;/ ol.eo t/[-<-ioL'ruiogL-apiu.
A catheter v:an placed in the arm vein and blooc; camples aero taken before 
exorcise* at b min intervals during exercise and then nt 1 ')(). 6o ar'''
90 min after exercise.
In all investigations the blood samples were treated as described 
in appendices I and II and personally analysed foj- HGHj 111 and for 
metabolites by hr. Chalmers.
}/EbULTS
The changes in lactate, glucose, IT'A and ÏRI concentration;: 
shoved, no differences between the controls a.nd the olcohclics*
Plasma HGH (pig Id«2): Plasma HGH concentrations were simila,r at rest
in the patients and the controls. HGH concentrations rose in both groups. 
The highest value was achieved at the end of exercise, but the concen­
trations were 4G% higher in the controls (lO pU/ml mean- lo5 d'd 8EM) than 
in the patients (6 uU/ml mean ~ O08 pH 8Mi). In patients and controls 
HGH concentrations fell in the period following exercise to approximately 
pre-exercise values at 60 min after the end of exercise.
Discussion
These results indicate that the release of grow^th hormone with 
exercise is greater I'ollowing the ingestion of alcohol by normal subjects. 
The means by which alcohol produces such a change during exercise are
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still imknu.ru Hypoglyoeraia (Hunter _et al^ ., I969). fall 01 plasma 1.FA 
(Hartog et al,, lÿd^j ana a rise cl blood lactate (button pt al «, ly'ok; 
have been reported as a possible slimuli for pi educing an increase in 
plasma HG1Ï concentration diming exercise. The last two possibilities 
appear to be unlikely in this situation, because tne changes of plasma 
FFA and blood lactate during exercise were similar with and without 
alcohol. The findings of a significcmt drop in blood glucose a,nd a, rise 
in plasma HGH concentrations during exercise with alcohol suggest the 
possibility ilia t hypog.l y cemia might be a fa.ctor. Tliere .is also the 
possibility that alcohol produced the greater elevation of HGH by 
sensitizing the release mechanisms to such other stimuli,,
The secretion of HGH from the pituitary gland is controlled by 
tiie hypothalojuus through o..n intermodiaj.y neurolj.ormone system which is 
probably dependent on catecholamines transmission (porhman, 1972;
Martin, 1979; Meriraee and iiabin, 1979/- Gursey and Olson (I96O) have 
shov/n that in the rabbit the administration of ethanol is followed by a 
rapid release of serotonin and nor-adrenaline from brainstores. It is 
therefore possible that alcohol interferes with HGH production by directly 
affecting the aminerglc activity of the hypohhalsmus, The reports of
Jenkins and Connolly (I968) and other workers (bollet ? 1971 ; Kerry
and Marks, 1972) who found that in normal individuals an amount of 
alcohol sufficient to produce mild to moderate intoxication, stimulates 
pituitary and adrenal activity as assessed by the release of cortisol and 
HGH. This and the present observation of a greater gi'O-.rlh hormone response 
to exercise after alcohol by normal subjects are consistent with an acute
122
stimulating effect of alcohol on pa Inways rcgulaui.n/.: the release of r/fr,
Morn'y and Marks (19o9) observed thaL pla.sma cortd.ccJ. concen­
tra, tiens in pe, L.d ents wi Lh chi'onic aiconoliarn were paraèoxicaliy cicprecccc 
after alcohol admind.strationT’ney cuggesteu Lhai. chronically self 
aciiTiinifttored alcohol has a depressor effect on hypothalo,mic pituihary 
function. Tnis suggestion is supported by the present observation of a 
lower growth liormone response to exercise in chronic alcoholics.
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siniMïïy
1, In Oî'der in :investd.gctn t)io mlicct of alcohol on homonnl and 
metabolic changes with exorcise, six patj.ents wit;; chronic; alcoholism 
were s'cudied. 8.1 x healthy volunteers ’were also studied during and aito- 
90 min of exercise following ingestion of alcohol (Oo5 g'/kg body weight) *
2. Acutely administered alcohol caused an increased response oi' 
groivth hormone. Alcohol also affected blood glucose, pyi.utalc and lo.oio,te
5. In chronic alcoholism the growth hormone response to exercise was
reduced,
4. These observations indicate that alcohol acts acutely by
sensitising the release mechanism for growth hormone probably in the 
hypothalamus «
5* The failure to obtain normal increase in plasma growth hormone
during exercise in patients with chronic alcoholism suggests that chronic 
abuse of alcohol suppresses or'reduces the ability of the central nervous 
system bo release growth hormone.
CHAPTER 14
GENERAL SUMMARY AND CONCLUSIONS
-l2/f
In 'Iho introduction to this thesis 1 explained that the 
purpose of these investipulions was first to establish the usual res-onrc 
of blood metabolites and Vio:miones to various stimuli, and in particular 
exercise. The second puxposo was to ccmparc the responses i.n altered 
iiu hi'itionol or- iwhnologicei states and fallowing tne adminrstratlon cl 
somo pharmacological agents such as foniluramine, nicotinic acid and 
alcohol. Exercise was chosen because it produces greater demands on 
tb.o metabolic processes. In this situation any metabolic or hormonal 
effect of pharmacological agent, pathological or nutritional states could 
bo expected to be magnified.
The finding reported in chapters 1, 2, 9 cmd 6 demonstrated 
that the size and the direction of blood metabolites and hormones changes 
during exercise vary with physical fitness, nutritional state and 
pathological conditions *
Compared to healthy untrained subjects, trained athletes 
efficiently mobilize fuels stored as glycogen in liver and fat in adipose 
tissue as indicated by the amount of glucose and glycerol released. In 
addition, they hove lower concentrations of blood lactate and pyruvate 
during exercise and of -plasma FFA and blood ketone-bodies during and after 
exercise. This would indicate that the FFA mobilized during exercise 
is apparently more efficiently oxidized in trained athletes. In untrained 
subjects however, incomplete oxidation of fat causes a considerable rise 
ill blood ketone-bodies after exercise. In addition to these biochemical 
adaptations, training appears to result in modifications in the endocrine 
aotivi'by* These are reflected in smaller responses of growth hormone 
and insulin in physically trained individuals than untrained subjects nuring 
exercise.
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Plasma insulin levels are known to be docreoscd both by 
lower blood glucose concentrations and by increased catoci' oj amine 
concentrations (bills, 1962 ; kayliov/ et al,, I969). The changes 01 
blood glucose is not in the same direction as pj.asma insulin (chapter 1), 
and the reason for this is not clear but the increasing levels of ca tv- 
cholariines in response be exercise may reduce the insulin response, 
bower blood catecholamines have been reported in man after a training 
programme (Hartley et al., 1972) and this may permit the higher concen­
trations of insulin in athletes.
The studies on the metabolic effects of obesity and therapuulic 
starvation described in chapter 2 and 3 demonstrated that energy is 
provided apparently more from the oxidation of fat and fat derived 
substrates. This was more marked during starvation as indicated froi.i 
the size and the direction of both FFA and ketone-bodies changes. In 
starvation utilization of ketone-bodies occurred dm?ing exercise in spite 
of the availability of glucose. This is in keeping with the suggestion of 
Owen and co-workers (I967) that in starvation, the utilization of ketone- 
bodies could be an adaptation by the body to spare glucose for the 
requirements of the nervous system. In addition to these adaptations, 
starvation also sensitizes the mechanism for grov/th hormone release.
Growth homone is a potent lipolytic hormone which may act during 
starvation to mobilize more fat for energy demand.
The studies on the relationship of ketone-bodies to jnsu]in 
release described in chapter 4 demonstrated that in man the administration 
of ketones stimulates the release of insulin which in turn caused the fall 
of plasma FFA and blood glucose. These observations support the suggcstic:
J.WO
.inof Nobo.no and Maciison (I964) that hyporko conomia by stimula tiny j./inul  
modulates fa.t mobilization from adipose tissue and liiuii.o the iisoaactlon 
of ketone body. nvidonco for this surgestion was provided, by the Ijigii 
correlation (r. 97 i P A. O.Op) between the highest observed corioent '-ai'ions 
of plasma ins'iiLin and blood kotone-bodies in patients vslth acromegaly, v/ho 
showed an abnormal peak in blood kotonc-bodics and plasma insulin during 
exercise, but hardly any post-exercise kotosis (chapter 5)»
The studies on the patterns of metabolic and hormonal changes 
during exorcise in normal man and in patienrs with obesity (chapber J., 2 
and 9) provided a background from \;hich to compare fat and. carbohydmte 
metabolism in patients with diseases of muscle. One disorder studied 
here v/as a case of oculoskelelc.il myopathy. In this patient, histochemistry 
and electron microscopy demonstrated an ultrastruetural abnormality of the 
muscle mitochondria. There were also metabolic abnormalities with exercise. 
Blood la.ctate and pyruvate rose, but to a much greater extent than normally 
expected. Concentrations of ketone-bodies and FFA fell during and after 
exercise \/hilst they rose in the controls.
Experience gained from the previous studies on the metabolic 
and hormonal responses to exercise in normal ma.i and in patients with 
obesity or muscle disorders (chapter 1, 2, 9 and 6) have made it also 
possible to compare metabolism in man following the administration of pharmaco- 
logical agents such as fenfluramine, nicotinic acid and. alcohol.
Studies on the metabolic effect of fenfluramine in patients 
with obesity described in chapter 7 and 8 demons crate that the action of 
fenfluramine may be due, at least in part, xo a direct effect 01 xne drxig
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on carbohydrate and fat metabolism. It improves glucose tolerance, 
possibly become glucose upbalco by muscle is increo.sed (buttorlield and 
bhicliolov/j 1966). Comparing the metabolic ofr'ects of this drug’ and the 
effeot of dietary restriction, it was shown that concentrations of plasma 
FFA, blood glycerol and total ketone-bodies increased, but the size of 
these changes v.ns much loos with fenfluramine. The changes during 
fenfluramine therapy could have been due to appetite suppression since a 
reduction of dietary intake would facilitate fat mobilization and. ketone 
body production. However an entirely metabolic effect of fenfluramine 
on ketone-body metabolism has been observed as reflected by the changes in 
the ratio of 9-bydroxybutyrate/acetoaoetate which fell afte.;.- Ihe adminis­
tration of fenfluramine but rose with dietary restriction. These 
observations imply that the metabolic changes wdth fenflux’ainine include 
a direct effect, and are not necessarily secondary to reduced dietary intake.
Further observations were made of the effects of administration 
of fenfluramine intravenously in normal man (ch.d,pter 9 and lO). Studies 
in resting subjects reported in chapter 9 showed a decrease in plasma HGH 
concentrations. Since exercise stimulantes growth hormone release, 
observations of the changes in gx-owth hormone release during exercise were 
ad so made. Observations in animals have indicated that the hypothalamus 
is a possible site for the action of the drug (Anc-uid, 1971; Anand and 
Blundell; 1971) and growth hormone release could be an index of hypothalamic 
activity (Frohman, 1972; Martin, 197$)o Fenflirramine also abolished the 
rise of plasma, HGH during exercise. This effect was e.xamlnoci further by 
studying patients with acromegaly (chapter lO), a condition in which plasma 
HGH is elevated. In these patients a marked depression of gnrowth hormone 
occurred both at rest and during exercise. The secretion of growth hormone 
from the anterior pituitary gland is controlled by the hypothal/amus through
128
an intermc'difjxy nei.xrohornione system which is dependent cn C£itcchol,-j':.ine 
trancniicG.io}} (ihrohman, 1972; Ihirtin, 1979/<■ llo\;cvcr, since icni’.Vcr.aminc 
depletes cerebral amines particularly in the hypothalaniue ((X>s'h:-i. _et ad. ,
1971 ; Ziarice _et al. , 1972) an effect on catecholamine transmission may 
explain the failure of exercise to bhhinjlalu growth ;uri:;cne pruducoion 
following fenfluramine injection.
The suppressive action of fenfluromine on growth release was 
studied further in pntinnts with diabetes rnellitus (chapter 9)- in 
diabetes rnellitus, plasma HG-H concentrations fluctuate but are frequenti.y 
found to be considerably elevated for long periods (Lundbaok.., j 971 ). In 
the patients studied here, fenfluramine caused a fall in the concentra,tions 
of plasma KGE. Blood glucose concentrations were also reduced. This 
fall in blood glucose may be attributed to the increased periphora.l upto.ke 
of glucose (Butterfield and Whichelow, I968). From these observations 
it was concluded that fenfluremine interferes with central nervous system 
regulation of the release of growth hormone, and also has a direct metabolic 
effect on processes in peripheral tissue regulating fat and carbohydrate 
metabolisn.
Studies on the metabolic effect of nicotinic acid described in 
chapter 11 and 12 demonstrate that this drug interferes with one or more of 
the metabolic pathways regulating fat and carbohydrate metabolism. It 
reduces glucose tolerance and enhances lactate production, possibly because 
glucose assimilation by the liver is reduced (Hiettinon et al *, I969). 
Nicotinic acid ad.so interferes with the mobilization of fuel substrates, 
inhibiting fat mobilization in adipose tissue and enhancing the rate of 
glycogenolysis in liver and muscle. The acute reduction of fat
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mobilization i'ollowing nicotinic acid adrainisurr/tion appoaro to stimulate 
the release of growth hormone durin;: exercise.
Studies on the metabolic effect oi alcohol dcccribed in 
chapter 1$ riemonctrale tijat acutely administered alcohol causes an 
increased response of grov/th hormone to exorcise in normal subjects,
In patients with chronic alcoholism the response of growth hormone to 
exercise was reduced. These observations suggest that alcohol acts 
acutely by sensitizing the release mechanism for growth hoj/mone probably 
in tho h;>n30thalamus 0 Tlio failure to obtain a, normal increase in pJasma 
growth hormone during exarcii se in pa.tients with chronic alcoholism suggest 
that chronic abuse of alcohol reduces the ability of the central nervous 
system to stimulate the release of growth hormone.
From these observations of the metabolic effects of phaimaco- 
logical agents which affect fat and carbohydrate metabolism, I conclude 
that while they may act directly by an action on metabolic pathways in 
the liver or in peripheral tissues like muscle, they also act indirectly 
by modifying endocrine activity.
APPEl^DIX I
1)0
TECHNIQUES
Bi o chem 1 cal 'J'e chniq ue s
A . Prepa rahlon ol^ ji; 1 o sarnn.Les
14 ml blood v/as taken on each occasion from a foreaxm ve.i.n 
by an indwelling oanula, 5 ml of this blood was immediately added to 
,5 ml 10% (v/v) ice-cold perchloric acid in a pre-weighed plastic 
universal container. This was shaken vigorously and stored in the cold 
until the protein precipitate could be centrifuged down. The remaining 
10 ml of blood were placed i.n lithium he par ini zed tube and oentri.f ugeo 
for 10 min at 2o500 i n .p n n , The separated plasma was 'pipetted off ca.no. 
stored at -10°G.
B . Treatment of protein free filtrate
After the removal of denatured blood by centrifugation at
18,000 r.'pnrio for 20 rain, the clear supernatant was decanted into a 
graduated 'tube and the volume noted. The specimens were neutralised 
with 20% potassium hydroxide (1,5-2 ml) using universal indicator. The 
•biibes were re-centrifuged for^5 min and the volume noted again. The 
insoluble potassium perchlorate was allowed to precipitate completely 
by allowing the tubes to stand at 4^0 for $0 min. The supernatant was 
then decanted into plastic tubes, which were stored at -10°C for subsequent 
analysis.
A dilution factor was calculated from the volume of blood 
taken and tlie volume of alkali added, as follows s™
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B l god. y q ly jqe -i; 5. ^
Blood volume ' .Acid volume
Spectrophotometric measurements were carried out on Hilger & wa'bts 
nv spectrophotometer.
C. Analysis of blood pyruvate and blood acetoacetate
These two metabolites were measured on the same sample by
modifications of the methods of Hohorst et a].*, (1959) for pyruvate and
Williamson _et , (1962) for acetoacetate. Tho pyruva,te was reduced
to lactate with excess of M D H  using a phosphate buffer (O.IM, pH 7,0),
pyruvate *i- NADH + if' L - Lactate 4- NAD
pH 7oO
The reaction was catalised by excess lactic dehydrogenase 
(Hohringer & Co,, London) and the decrease in optical density due to the 
oxidati.on of NADH measured at 54-Ohm. The acetoacetate was analysed under 
the same conditions by the enzyme D-(”)“’f3'~hydroxybutyric dehydrogenase 
(Bohringer & Co., London) which catalyses the reaction of acetoacetate to 
5-hydroxybutyrate,
Acetoacetate -i- NADH 4- H^ 5-hydroxybutyrate NAB
pH 7oO
d
Acetoacetate is slowly decarboxylated to acetone in neutral solution, so 
this analysis had to be carried out immediately after the acid samples 
were neutralised,
B. Analysis of blood glucose
Blood glucose was determined by the method of Bergmeyer and 
Bernt (I863) using the enzymes glucose oxidase and peroxidase (Bohringer
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& Co,, London),
- r  m  ,  . , n  r r  C-i-UCOse Oxi.dase _I, Glucose 4- 0^ ■!' H^O  ____ — _ __ Gluconic acia. + LpOg,
T - T  TT r\ ri ‘ • • T ’ peroxiCiasG . . .  • ' / - i t *  • • -i •II, -h 0--aianisio.ine - ■. oxio.isea 0-'dianisn,dine,
III, Oxidioofl 0“-o;i an i p,;i d:iT!e + H  v stable coloured solution.
Glucose oxidase catalyses the conversion of I>-glucose to 
D-gluconic acid and the hydrogen peroxide formed is decomposed by 
peroxidase. The oxygen liberated oxidises O-dianisidine to form a 
stable orange brown complex at pH 7*0. Tho optical density of the 
reaction mixture was measured at 4-40 nrti after incubation in tho dark at 
y fc for 1 hr.
Duplicate samples of 0,05 ml were analysed in relation lo 
glucose standard of different concentration. 0.5 ml, 0,75 ml and 1,0 ml 
of Oo2 nM standard glucose was used.
Eo Analysis of blood 5^hydroxybutyrate
This was determined by the method of Williamson £t ad., (1962) 
using the enzyme ]>-[3-hydroxybutyric dehydrogenase to catalyse the
•■f
oxidation of 5-hydroxybutyrate to acetoacetate in the presence of excess 
NAD.
Acetoacetate + NADH 4 H ' D-OH butyrate HAD
I pH 8 .g
W
Hydrazin
Acetoacetate was removed in the foimi of its hydrazone in alkaline medium 
by using hydrazine buffer (pH 8 .9). The change in optical density due 
to the formation of NADH was measured at 34O nm.
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I<\ Analysis of blood lactate
Thin was dotermined by the method of Hohorst et al., , (1159) 
using tlie enzyme laactic acid dehydrogenase to catalyse tho oxide.tion of 
lactate to pyruvate in the presence of excess NAD.
,TUXT
L - lactate 4 NAD frhrRüc pyruva,to 4 MDI'i -i- It '
pH 9 A  t
Hydrazine
An alkaline medium was used (pH 9 = 5) .^nd the pyruvate removed in the 
form of its hydrazone.
The change in optical density due to the formation of NALH 
was measured at 540 nm.
G. Analysis of blood glycerol
This was determined by the method of ICreutz (1962) using 
the enzyme glycerokinase to catalyse the phosphorylation of glycerol by 
ATP to h-glycerol-l-phosphate. The ADF formed was phosphorylated back 
to ATP with PEP forming pyruvate which was then reduced to lactate with 
NADH in the presence of lactic acid dehydrogenase,
The v/hole reactions were as follows
G Kglycerol 4 ATP u-glycerophosphate 4 ADP
Mg
PEP 4 ADP yPVK pyruvate 4 ATP
pyruvate 4 NADH 4 H ' DDH L-lactate 4 NAD
pH 7 = 0
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Since 1 molecule of glycerol ^ 1 molecule of lABR the optical density 
Gjia/Jige a I 5 JO nm due to the disappearance of KABll was propor tiohal to 
the glycerol concentration,
H , Analysis of plar^ iia FFA
Plasma FFA. were determined >y the method of Itaya and hi 
(1965), Chloroform with pH 7,0 phosphate buffer of 0«,IPi was used to 
extract the plas.^ '^'a FFA. The extracted FFA were complexes with copper 
triethanol amine to soluble copper salt. After separation of the phases 
by centr.i.fuging cu.id removal of the top watery phase by filtcration 
through ordinary filter paper, colorimetric estiii-'ition was carried out 
with the dye soaium diethyldithiocarbaj'nr.te. The colour developed by 
the dye wis measured immediately at 440 nm. All FFA determinations 
were carried out in duplicate using 0,2 ml samples of plasma in relation 
to palmitate standard of different concentrations, 1 ml, 2 ml, 3 ml,
4 ml and 9 ml of 0,1 mI4 palmitate standard was used.
APPENDIX II
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IlAMG-Bil-UlIO ASSAY
Tbt! opHitin fc o f  rcLu loJj'L ijiiirioaw yay Loo lm ic iizyy  l ia s  made
possible the routine measurement of physiological levels of many peptide 
hormones re biological fluids « The basis of the method ip<--; fnil oi?s ;
The essential principle of these techniques is the competition for the 
binding site of a fixed amount of anti-hormone (anti-A) between a, known 
amcnmt of %-adioactively labelled pru:*e hormone (A*) and unknown amount of 
unlabelled hormone (a )« A+ anti-A + A* A ; anti-A :A " -p A", As
a result of the competition, the amount of labelled hoi-mone bound to 
antibody will drop as the concentration of unlabolled hormone increases. 
After the reaction has been allowed to approach completion, the 
antibody-boimd hormone is separated from free hormone and the distribution 
of radioactivity determined, The sensitivity of this reaction depends
upon three requirements :
1* The availability of radio-iodinated hormone, whose affinity 
for antibody is similar to that of the unlabelled hormone,
■ 2, An anti-serum having a high energy of reaction.
3* A double equilibrating incubation system (3 days at 4^C for each),
To choose a sensible method of efficient separation, the 
following criteria should be considered :
1, Complete separation.
2, Simplicity, speed and reproducibility,
3» Ability to detect non-specific effects occurring during the
assay, such as datage to labelled hormone and the effects of 
protein on both the antigen-antibody reaction and the 
separation procedure itself.
1 3 6
4* Cost of material.
3, Ease of processing a largo nutnbei' of samples.
The advantages anci disadvantages of the most important 
techniques recorded in the literature may he assessoci with those criteria :
A. Ciirornai0-cloctrophoresis on Vuiatman paper t In tliis me Lhod the
free hormone becomes absorbed on the paper at the point of application 
while antibody-bound hormone moves with plasma proteins, ChroiDato- 
electrophoresis as described by Yalow and forson (I36O) is a highly 
reliable method allowing excellent control of the reaction; elaborate 
apparatus is, however, required and the method is time-consuming.
Be Chemical precipitations The ant.i.oody-bound. hormone may be 
precipitated either with sodium sul.pha.te (Grodsky and For sham, I960) or 
ethanol (Heding, I966) under conditions in which the free hormone is left 
in the supernatant fluid. This method is simple and a large number of 
samples can be processed rapidly. The materials are relatively 
inexpensive. The disadvantage is that the non-specific effects of 
protein in this technique are considerable and difficult to control, 
making it unsatisfactory for plasma samples.
0, Differential adsorption onto solid material; charcoal; In this 
method the antibody-bound hormone remains in solution while free hormone is 
adsorped on charcoal. The adsorption of free hormone on charcoal 
described by Hunter (197I) to suitable for insulin. It is readily 
reproducible, fairly easy to pier form and. reasonably rapid. Furthermore 
charcoal allows detection of damage to labelled hormone and it is a 
relatively inexpensive material, IJnliKe insulin, adsorption of free 
human growth hormone (IIGH) is dependent on the molarity and pH of the
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buffec; used in the syste*.: and, therefore, difficult to control,
D. Ij-u iurnjpreciu.Lto/tionr As described by Horgon and Lazarcw (iyoi) 
the antibody-bound hormone is precipitated by the reaction witli a second 
anti-ccruju directed against the iramunog] obulins of the anti-hormono serum. 
The method satisfies almost all the criteria except triat the materials 
are relatively expensive. It also depends upon the availability of a 
second antibody specific enough to precipitate all the bound hormone «
This method has been modified and used routinely as a standard method 
for KG'Ho It may also be used for insulin as a compsnison -witii the 
char coal teohnique.
Radi.o-imrauno assay for Human Growth Horrr-onc (HGH)
Further details of this two anti-body system are as follows t
1* lodination of HGHs The method used is that of Greenwood et al», 
(1963) with minor modifications.
Materiais
(a) (125"’X) Iodides Sodiuin (123”-X) Iodide (lMS-3) (obtained 
from the Radiochemical Centre, Amersham). The material is 
specific between p H '7-9, free from reducing agents and carrier 
free the specific activity being /]—12 mC/pg Iodine.
(b) Human Growth Hon.aone î (obtained from the 1ÏRC biological 
Standard Division, London). Each vial, contains approximately 
1 mg of HGH (Raben preparation) with lactose. The material 
is dissolved in small amounts of bidistilled water, and if 
necessary a drop of O.IM HaOH is added. The clear solution
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is then diluted with OcOpM phosphate buffer to a concen­
tration of 250 pg/ml and stored at
(c) Cliloramine-fj.G (BJhih An alar grade),, A solution of
5 mg/rnl in O.O5 buffer is freshly made up a.t th«j time of 
the iodination.
(d) Sodium metabisulphite Analar grade): A solution
of 5 ing/ml is freshly made up at the time of the iodination,
(e) Potassium iodide (B.DJh Analar grade): A solution of
10 mg/ml is made up freshly on the day of the lodination
and kept aside from other rea,gentSo
(f) Bovine Serum Albumins (B/D.H, Fraction V)
(i) 58 mg is dissolved in 1 ml of O0Q7M barbitone
buffer and placed in a polystyrene 5 )nl vial for 
collection of the protein eluate from the column.
(ii) 20 mg is dissolved in 1 ml of the Ejame buffer and
is used to saturate the column of Sephadex G-bOr
(g) Gephadex G-58: obtained from Pharmacia (Great Britain) ltd.
One gram of G—50 is added to 50 ml of O.OTM barbitone buffer
the day before the lodination. The beads are allowed to 
settle in a beaker and the fines are poured as a thick slurry 
into a column lOCmX iCm, and washed with more buffer, 
column is then saturated with bovine serum albumin by adding 
1 ml of a 20 mg/ml solution directly on the top of the gel 
load. The protein is allowed to sink in and the column is 
then washed with at least ^0 ml of 0,07M barbitone buffer.
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(h) Buffers ;
(i) pH 8.6 barbitone buffer 0.07 M, This is mac.G up
by dissolving 1*84 S of barbitone in 400 ml of
hot distilled water followed by 10,3 E of sodium 
barbitone added to the cooled solution. The 
volume is then made up to 580 ml and stored at: 4^8, 
Fresh dilutions of p parts of this concentrate 
buffer and 2 parts of distilled water are made 
up on the day of use.
(ii) pH 7«4 phosphate buffer 0.05M. This is ms.do up
by dissolving 5®68 g of Na^HpO^ and 1,33 8 of
BaHgpO^, HgO in 100 ml of distilled water.
This also can be stored at 4^ 8^ and diluted 1 in 10 
with distilled water,
lodination procedure
The whole reaction is carried out in a fume cupboard, 10 pi 
of the isotope is drawn up using an oxford pipette and placed precisely 
at the bottom of the reaction vial (conical plastic tube clamped in a 
vertical position over a magnetic stirrer). Another 10 pi of isotope is 
added to a flask labelled ’’starting material” containing 200 ml of 1% KI 
in 0,07 M barbitone buffer. After addition of the isotope 20 pi of 0.5 M 
phosphate buffer pH 7*4 are added. The magnetic stirrer is then switched 
on and a small stirrer added (the stirrer consists of a small piece of 
steel wire sealed inside a glass capilla.ry tube). From this point 
forward until the lodination reaction mixture is placed on the column
speed is essential, 5 ig of human growkh hormone in 0,02 m'j of 0,050  
phosphate buffer is added. This is followed by 100 pg of ehlora.rn;i.rie-T 
in 0,02 ml of the same buffer, yO seconds lal.ei-j S80 pg of sodium 
metabiEiulphite in 0.1 mi of buffer is added to stop the reaction, 
followed by 2 mg of KI in 0*2 ml of buffer. The mixture ,ls then 
transferred to the top of the sephadex G-50 Column, The reaction vial 
is washed with a further O .4 mi of KI Solution and this is added to trie 
Column once the initial mixture has sunk into the gel bed. The whole, 
procedure takes about 5 min. The eluate fractions from trie column are 
collected in 5 ml plastic vials using 0*07 M barbitone buffer pll 8.6.
Iod3.nation f 1 ow Sheet
O0O2 ml 0 .5 Ii phosphate buffer 
0.01 ml Isotope (I25-I)
0*02 ml HGH in buffer - 5 
O0O2 ml Chloramine-T
mixed for 30 seconds 
0.1 ml Sodium metabisulphite
0.2 ml potassium iodide
Top of column Sephadex G-5O 
Oo4 ml wash with potassium iodide
Fractions
1 .5 ml Hold up volume (H.H.V.)
4 .0 ml protein
5*0 ml salt peak (sl)
5.0 ml ” " (S2)
5*0 ml ” ” (85)
121
SETTING UP AH ASSAY
Reagents
1. 0*0511 phosphate buffer pH 7«4''7*5<*
This is made up by dissolving 2,85 g of Ha^HpO^ and. 0*67 g of
KHgpO^ in 500 ml of hot distilled water. To this is added
Sodium EDTA 1*86 g
Bovine serum albumin 1*5 6
Sodium chloride 4=5 8
Sodium Az.ide 0.1 g
2. Human growth hormone standard® liiC standard A, calibrated against 
WHO international reference preparation is used for the assay. The
stock standard of 25O p.g/ml previously prepared for the lodination
procedure is diluted with pnosphate albumin buffer to 100 pH/ml, 
divided into 100 pi aliquots and stored at -20^0*
5. Rabbit anti-human growth hormone serum, DR16, Wellcome,
The content of each bottle (0*5 nil of 1:1000) :i.s reconstituted with 
phosphate albumin buffer to a dilution of 1:8000,
4» Donkey anti-rabbit precipitating serum..(daRS) ,
The content of each vial is diluted (1:5) with phosphate albumin 
buffer, divided into 5 aliquots and stored at -20^0.
5. Plasma samples for assay; the samples are thawed shortly before use
and can be kept in a cool area at about 4 'o until they have been used
in the assay. All samples must be mixed well before use. Ttiey may
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need to be centrifuged, to remove strands of fibrin forjeed during 
storage that may otherwise inter.fere ■witii the measuneunn.L of thü 
volumes of somples to be used in the assay,
60 Human growth hormone (see lodination page 139 h
Assay procedure
The minimum nunber of samples in any one assay is 30.
Each saviple is assayed in duplicate and a standard cuo?ve is included- in 
every assay (table l). The standard consists of I4 tubes : two tubes
as controls which contain antibody with labelled HGH, a further two as 
blanks wlich contain only labelled HGH, and the remaining tubes with 
increasing amoimts of standard HGH (10 pb/ml), The final volume of 
each tube being made up to 1 ,0 ml diluent.
Table 1 : Example of standard graph
"T"
Tube No. Anount of HGH 
(pH/ml)
Diluent
(ml)
% Bound Graph reading Anti-Log unu iluted HGH 
1-LÜ/ml
].A 1.0, 64
2A 0 . 2 5 0.975 51
3A 0*5 0 . 9 5 38
4A loO 0 . 9 0 25
5A 2 . 0 0.80 14
6A 4oO 0 . 6 0 10
7A 1 . 0 5 4
1 O.lml plasma 0 . 9 0 35 1.78 0 * 6 0 6 . 0
2 0,lnl plasma 0 . 9 0 3 3 . 5 1.80 0 . 6 3
1
6 . 3
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ASSAY FlkW SnEFT
1*0 nil Standard lîGîI Soluklon 
or
unlcnown plasma sample 
1:10
50 f.il anti-HGH Serum 
1:0000
V o
mix and incubate at z] C for 3 days
50 pi (125-1) IÎGII
2 ng/ml
mix and incubate at 4 0 for 5 days
V
50 pi Rabbit serum (islOO)
50 pi Donkey ARS (1:5)
V
mix and incubate at 4°0 for 24 h
0loO ml diluent and centrifuge at 4 0, 2300 rpm 
for 30 min
Decant supernatant, count precipitate for 2 min,
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Gome observa i: ion s on tha preci pi lion iri idic ciouble_-"'an-t;l bocy
Immoino-asscy for HGH
1® The effect of human plasma (Fig l); vrtien short precipitation
periods were used, human plasma consistently red.uced precipitate 
radioactivity to below the levels found in the cont3:'Ols. This 
effect was less mrrkcd after '.Longer periods of procipita'oion® 
Increasing the concentration of the second antibody (D-ARS) in 
the system led to more rapid precipitation of bouud hormone, but 
even under these conditions human plasma delayed precipitation 
to some extento
2. The effect of Ethylene diamine tetracetic acid (EDTA) (Fig 2); 
in the absence of human plasma EDTA was found to accelerate the 
precipitation of antibody bound HGH. EDTA was also found to 
increase the radioactivity of the precipitate in the presence of 
human plasma.
Fig (l); Precipitation of bound HGH by 50 ul of DilHS 1:5
in the presence of 1 ng of unlabelled HGH in diluent (O); 
and 1 ml volume of undiluted hum^ plasma (@) ; 1:5 dilution
of human plasma (x) î 1:10 dilution of human plasma
Pig (2); The effect of O.GIM EDTA on the precipitation of HGH
by 50 |il of DAHS 1:5 ih the presence of 1 ng of unlabelled 
HGH in diluent (o); diluent 4- EDTA (©) and 1 ml of 1:10 
dilution of human, plasma (s) j 1 ml of 1:10 dilution of hurian 
plasma A- EDTA (X) »
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AllS/iY :rOR IN GULI}] ( j  l )
Since the oj-lrlr.a,l method nas rcported that chrrcoa.1 cCoicd v.ith 
can almost instantly absorb irec inaulin (ïloxd.ert e^l al^ l$6y), 
developments have been described, variable non-spccii’ic iactors i;r.;r 
influence assay résulte particularly the ei'ioci; of protein and the vol-T.e 
of plasma sample in the incubation mixture vlicn low hormone concentre'tone 
are under study.
The procedure for first and second incubation an the estimation of IRI 
(standards and imknown plasma samples) is very similar to that of HCdl; 
except that albumin pre-treated charcoal is used for the separation of 
free from bound insulin as described by Hunter and Ganguli (1971)? with 
minor modification.
Reagents
1, Phosphate buffer pH 7*4~7o5 (concentrated stock solution)
This is made up by dissolving 7.8 g of Mall^pO^ - 2H2O and
101*19 g of HUgllpO^ in 900 ml of hot distilled water. The
volume is then made up to one litre and stored at room temperature.
2, Phosphate/albumin buffer pK 7°4
This is made up by dissolving 0*6 g of bovine serum albumin in 
200 ml of phosphate buffer diluted 1 :4 with distilled water.
Human insulin standard (HR71); Wellcome
The stock solution is stored at a concentration of 1 jnU/lO pi 
in plastic tubes in dilute bill (m/'IQO), At two montiily intervals
146
one tube is opened, and t.tio contents ailuted with oiluLo 101 
containing Ü.29'/.: bovine serum albumin to IGO y b / , divided 
into 100 jil alic[Uots and stored at -20°C, One so.cii tube is 
opened for each assay*
Guinea pig anti-'pork insulin antiscrun (MT4I) hell come 
The co.ntent of each bottle (0*9 ml of I'lOOO) is diluted to 
1:20,000 with phosphate albumin buffer.
123j I jj^ jicjulin (IMJS), Radiochemical Centre j Amersham, iJngl.and 
With a specific activity of approximately 90 f.iC;l/pg‘ is diluted 
to a concentration of 10 ng/ml with phosphate albumin buffer :-md 
stored in plastic tubes at -20^^C. One sucn tube is opened and 
used at a concentration of 1 ng/ml,
6, Charcoal Slurry: 1 g charcoal Norite Nk is suspended in
Go3 g/lOO ml bovine serum albumin/phosphate buffer pR 7o4 and 
mixed with a magnetic stirrer for 90 min, 1 ml of this suspension 
is added to each tube.
7, Plasma, samples: the samples are treated as previously described
for HGH assay, 0
:i47
ASSAY FLOW SBüüT
loO ml standard, insulixi solution 
or
unkuo'i-m plasma sample 
1:10
50 fil anti-insulin serum 
1:20000
Nk
O,. ...mix and incubate at 4 C for 3 days
\/
30 pi (123-1) insulin 
1 ng/ml
V
mix and incubate at 4 0 for 3 days
1*0 ml charcoal slurry
V
mix for 1 min and centrifuge at 4^0, 
2300 rpm for 30 min. Decant 
supernatant, wipe inside carefully 
with absorbent paper and count for 
2 min.
Yalûdi !ç/ of_ the No thod
The charcoal-coated albumin method for as cay cf Ihl was ascoccrc. 
follows (1-2), It v;ciG also compared with the double antibody 
technique (3).
lo Assay of known amounts of insulin in increasing dilution c» " hv.aan 
plasma:
The results of assays carried out on increasing dilutions i■ the 
same plasma (originally con baining 50 ull/ml) are sho-wn in • ■e.llc 2, 
Good agreement was found between the results at different dr'J ution 
but the sensitivity of the method decreased using plasma velumos 
above 0*3 ml s'.milar to the observations with HGh (p , 144 ).
Table 2 : Insulin assayed in dilutions of a single picr.ma
plasms, dilution 1/20 1/10 1/5 1/2
Insulin pU/ml 48,30 47*80 47.10 40.30
- SEM - 0.92 1 1.02 " 1,58 - 2oJ..5
n 3 5
2, Recovery of known amounts’ of insulin added to hunan plasma:
Human plasma samples were assayed after the addition of 2 = 3'"40 pU 
of human insulin/ml by the albumin coated-charcoal method and by 
the double antibody technique. The results tend to be higher 
by the double antibody technique than by the coated charcoal nw.thod 
(table 3).
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$. Comparison of two assay procedures;
A series oi‘ plasma samples were assayed by both the a.Ibpmin 
coated oh;xrcoal method and the doiild.e anllbudy technique. An 
excellent linear correlation was found between the two techniques 
(r;U.99) (Fig 3).
Fig (5)î Linear correlation between charcoal-albiiunin technique 
and the double antibody technique (r, 0.99)*
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